研究者詳細

顔写真

ノムラ シユウヘイ
野村 周平
Shuhei Nomura
所属
災害科学国際研究所 災害医学研究部門 グローバルヘルス政策学分野
職名
教授
学位
  • 博士(疫学・生物統計) (インペリアル・カレッジ・ロンドン公衆衛生大学院)

  • 修士(保健学) (東京大学)

  • 学士(薬学) (東京大学)

プロフィール

東北大学災害科学国際研究所・大学院医学系研究科 グローバルヘルス政策学分野 教授(現職)。慶應義塾大学医学部 特任教授、国際医療福祉大学大学院 特任教授を兼務。専門は疾病負荷、グローバルヘルス、栄養科学、パンデミック対策(PPR)、災害・健康危機管理(Health EDRM)。データに基づく意思決定支援を通じ、国内外の保健医療政策形成に深く関与する。 

▼ 疾病負荷研究(GBD)を中核とした活動 世界160カ国・1万7千人超が参画する国際プロジェクト「世界の疾病負荷研究(GBD)」において、2022年より科学評議員を務め、日本における疾病負荷の推定をリードしている。 国内では、国の健康づくり政策「健康日本21」をはじめとする国の主要な政策に対し、疾病負荷の視点から科学的根拠を提供し、その目標設定や達成状況の評価に継続的に貢献している。 2024年、GBDを主導する米国ワシントン大学(IHME)と慶應義塾大学とのMOU締結を主導し、日本初のGBD研究拠点を設立、統括代表に就任した。 

▼ 国際政策への関与 日本のグローバルヘルス政策立案に継続的に関与。国の「グローバルヘルス戦略」といった基本方針の策定・改訂プロセスで有識者として参画し、保健分野の 政府開発援助(ODA)戦略や成果の定量化を通じて政策形成に科学的根拠を提供する。 G7サミットをはじめとする国際的な政策議論にも寄与し、広島サミット(2023年)の「G7グローバルヘルス・タスクフォース」などで構成員を務める。 ODAの動向を可視化する分析ツール「VODA」の開発も手掛けた。 2023年より政官民プラットフォーム「グローバルヘルスと人間の安全保障運営委員会」フェロー。また、ゲイツ財団など国際機関への政策助言を行うドイツの組織 SEEK Development のコンサルタント(2019年~)も務める。さらに、2025年12月より、国際医学誌『The Lancet』が設置する The Lancet Commission on Health Systems Performance Assessment のコミッショナーを務め、各国の保健システムの成果をいかに測定・比較し、政策改善につなげるかをめぐる国際的議論に貢献している。また、2026年には、ランセット・グループとして2011年の『The Lancet』本誌以来約15年ぶりとなる日本特集で、『The Lancet Regional Health – Western Pacific』に掲載された、国内改革と国際保健戦略を扱う2本の政策レビューの座長・責任著者を務めた。

▼ 専門分野別の活動

  • 食・栄養分野 「世界栄養報告(GNR)」専門家パネル委員などを務め、NCDs(非感染性疾患)目標達成の遅れに警鐘を鳴らし、政策提言を行う。日本政府主催「東京栄養サミット2021」では、世界初の「栄養アカウンタビリティ・フレームワーク」立ち上げに貢献。この枠組みは、次期「パリ栄養サミット(2024年)」に向けた国際諮問グループでの議論の基盤となるなど、G7首脳コミュニケ等での「健康的な食生活の促進」といった国際アジェンダの形成にも反映されている。
  • パンデミック対応 新型コロナウイルス感染症パンデミック下の「超過死亡」モニリングを統括。厚労省アドバイザリーボードへの情報提供。データ可視化サイト「超過死亡ダッシュボード」を開発・運営し、情報発信を推進している。アジア太平洋レジリエンス・イノベーションセンター(CAPRI)のシニアフェロー、国際政治経済誌「The Economist」新型コロナ後遺症に関する諮問委員なども兼任する。
  • 災害・健康危機管理 (Health EDRM) 2011年福島原発事故直後からの南相馬市での活動を基点に、災害時の健康リスク研究に従事。高齢者の避難リスクに関する研究は、国会原発事故調査委員会での協力調査員としての活動を通じ、原子力災害対策指針の改訂にも活かされている。また、世界保健機関(WHO)災害・健康危機管理リサーチネットワーク(TPRN)のメンバーとして「WHO初の災害時研究ガイドブック」作成に貢献。東日本大震災を事例とした疾病負荷の定量化ガイダンス(日本語版監修)なども手掛ける。

▼ 経歴 東京大学薬学部薬科学科(2011年卒)、同大学院国際保健学専攻(2013年修了)。国連開発計画(UNDP)タジキスタン事務所及び世界保健機関(WHO)本部でのインターンを経て、インペリアル・カレッジ・ロンドン公衆衛生大学院にて博士号(疫学・生物統計学)取得(2019年)。東京大学助教(2016年)、慶應義塾大学特任准教授(2019年)・特任教授(2024年)等を経て、現職。

経歴 22

  • 2026年4月 ~ 継続中
    慶應義塾大学 医学部 医療政策・管理学教室 特任教授

  • 2026年4月 ~ 継続中
    東北大学 大学院医学系研究科 グローバルヘルス政策学分野 教授

  • 2025年10月 ~ 継続中
    東北大学 災害科学国際研究所 グローバルヘルス政策学分野 教授

  • 2025年7月 ~ 継続中
    国際医療福祉大学 大学院医学研究科「食・栄養と健康」社会連携講座 特任教授

  • 2024年1月 ~ 継続中
    大阪大学 感染症総合教育研究拠点(CiDER) 連携研究員

  • 2023年5月 ~ 継続中
    Center for Asia-Pacific Resilience and Innovation (CAPRI) シニアフェロー

  • 2022年11月 ~ 継続中
    ワシントン大学 保健指標評価研究所 世界の疾病負荷研究(GBD)科学評議会

  • 2021年6月 ~ 継続中
    国立健康危機管理研究機構 感染症疫学センター 所外研究員

  • 2021年4月 ~ 継続中
    世界栄養報告(GNR) 独立専門家パネル委員

  • 2019年1月 ~ 継続中
    SEEK Development コンサルタント

  • 2018年11月 ~ 継続中
    南相馬市立総合病院 地域医療研究センター 客員研究員

  • 2018年4月 ~ 継続中
    国立がん研究センター がん対策研究所 予防研究部 外来研究員

  • 2024年8月 ~ 2026年4月
    慶應義塾大学 グローバルリサーチインスティテュート 特任教授

  • 2019年10月 ~ 2024年7月
    慶應義塾大学 医学部 医療政策・管理学教室 特任准教授

  • 2016年12月 ~ 2024年7月
    東京大学 大学院医学系研究科 国際保健政策学教室 特任助教

  • 2021年10月 ~ 2024年3月
    公益財団法人東京財団政策研究所 主席研究員

  • 2018年3月 ~ 2024年3月
    ビル&メリンダ・ゲイツ財団 日本事務所 コンサルタント

  • 2021年1月 ~ 2023年12月
    世界保健機関(WHO) 健康開発総合研究センター 研究アドバイザー

  • 2017年7月 ~ 2020年3月
    独立行政法人国立国際医療研究センター グローバルヘルス政策研究センター 特任研究員

  • 2014年7月 ~ 2014年9月
    世界保健機関(WHO) 災害リスク・人道支援部門政策実施評価局 インターン

  • 2013年4月 ~ 2013年9月
    東京大学 グローバルヘルス・リーダーシップ・プログラム フェロー

  • 2012年8月 ~ 2012年10月
    国連開発計画(UNDP) タジキスタン共和国事務所 災害リスク管理部 インターン

︎全件表示 ︎最初の5件までを表示

学歴 4

  • インペリアル・カレッジ・ロンドン 公衆衛生大学院 疫学統計学教室

    2013年9月 ~ 2019年2月

  • 東京大学 大学院医学系研究科 国際保健政策学教室

    2011年4月 ~ 2013年3月

  • 東京大学 薬学部

    2007年4月 ~ 2011年3月

  • 聖光学院中学校高等学校

    2001年4月 ~ 2007年3月

委員歴 14

  • 厚生労働省 社会保障審議会・人口部会

    2026年6月 ~ 継続中

  • The Lancet Commission on Health Systems Performance Assessment

    2025年12月 ~ 継続中

  • 内閣府経済社会総合研究所(ESRI) 健康の価値の計測・記録方法に関する研究会

    2025年5月 ~ 継続中

  • 内閣感染症危機管理統括庁 感染症危機に向けた合理的な感染対策の実施等に関する意見交換会

    2025年4月 ~ 継続中

  • 日本国際交流センター 「グローバルヘルスと人間の安全保障」運営委員会

    2023年12月 ~ 継続中

  • 日本国際交流センター 2023年G7グローバルヘルス・タスクフォース

    2022年8月 ~ 継続中

  • 世界保健機関(WHO) 災害・健康危機管理に関するグローバルリサーチネットワーク(TPRN)

    2021年11月 ~ 継続中

  • パリ栄養サミット(N4G)国際諮問グループ

    2024年10月 ~ 2025年3月

  • 日経・FT感染症会議 感染症危機に強い社会を構築するための人材共創プラットフォームワーキンググループ

    2024年4月 ~ 2024年10月

  • エコノミスト・インパクト 新型コロナ後遺症に関する諮問委員会

    2024年6月 ~ 2024年9月

  • 厚生労働省 大臣官房国際課 国際保健・協力室 「世界のUHC達成のために我が国が実施すべき施策に関する調査事業」検討委員会

    2023年12月 ~ 2024年3月

  • 日本国際交流センター グローバルヘルス・ガバナンス研究会

    2021年4月 ~ 2022年3月

  • 日本国際交流センター 保健分野のODAのあり方を考える特別委員会

    2019年10月 ~ 2021年3月

  • 厚生労働省 国際保健に関する懇談会

    2015年8月 ~ 2017年4月

︎全件表示 ︎最初の5件までを表示

研究キーワード 8

  • 非感染性疾患の予防・管理

  • パンデミックに対する予防、備え及び対応 (PPR)

  • 栄養科学と政策

  • 災害・健康危機管理 (Health EDRM)

  • ユニバーサル・ヘルス・カバレッジ (UHC)

  • 国際保健外交

  • 国際保健政策

  • 世界の疾病負荷 (GBD)

受賞 9

  1. 2025年世界で最も影響力のある研究者トップ2%, 生涯

    2025年9月 Stanford University / Elsevier

  2. 2025年世界で最も影響力のある研究者トップ2%, 単年

    2025年9月 Stanford University / Elsevier

  3. 2024年世界で最も影響力のある研究者トップ2%, 生涯

    2024年9月 Stanford University / Elsevier

  4. 2024年世界で最も影響力のある研究者トップ2%, 単年

    2024年9月 Stanford University / Elsevier

  5. 2023年世界で最も影響力のある研究者トップ2%, 生涯

    2023年10月 Stanford University / Elsevier

  6. 2023年世界で最も影響力のある研究者トップ2%, 単年

    2023年10月 Stanford University / Elsevier

  7. 2022年世界で最も影響力のある研究者トップ2%, 単年

    2022年11月 Stanford University / Elsevier

  8. 2021年世界で最も影響力のある研究者トップ2%, 単年

    2021年10月 Stanford University / Elsevier

  9. 明日の象徴

    2014年9月 「明日の象徴」組織委員会

︎全件表示 ︎最初の5件までを表示

論文 306

  1. Global, regional, and national prevalence of second-hand smoke and attributable disease burden in 204 countries and territories, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023 査読有り

    GBD 2023 Second-hand smoke Collaborators

    The Lancet Public Health 2026年9月7日

    出版者・発行元:

    DOI: 10.1016/s2468-2667(26)00168-4  

    ISSN:2468-2667

  2. Global, regional, and national burden of HIV/AIDS, 1990–2023, with the estimated burden attributable to intimate partner violence and forecasted impacts of funding cuts through 2030: results from the Global Burden of Disease Study 2023 査読有り

    GBD 2023 HIV Collaborators

    The Lancet HIV 2026年8月18日

    出版者・発行元:

    DOI: 10.1016/s2352-3018(26)00147-5  

    ISSN:2352-3018

  3. Measuring the composition and availability of human resources for health by sex in 204 countries and territories, 1990–2023, and workforce gaps for universal health coverage: a systematic analysis for the Global Burden of Disease Study 2023 査読有り

    GBD 2023 Human Resources for Health Collaborators

    The Lancet Public Health 11 (9) e604-e629 2026年8月18日

    出版者・発行元:

    DOI: 10.1016/s2468-2667(26)00145-3  

    ISSN:2468-2667

  4. A Mixed-Method Study of Unhealthy Feeding Practices Among Mothers of Children Aged 6–23 Months from an Internally Displaced Person Camp, Kayin State, Myanmar 査読有り

    Htet Zaw Shein, Napaphan Viriyautsahakul, Shuhei Nomura, Wandee Sirichokchatchawan

    Nutrients 18 (16) 2680 2026年8月17日

    DOI: 10.3390/nu18162680  

  5. Psychiatric standardized claim ratios by rurality and deprivation in Japan: A nationwide ecological study with contextual suicide mortality 査読有り

    Masahide Koda, Shuhei Nomura, Makoto Kaneko, Nahoko Harada

    Psychiatry and Clinical Neurosciences Reports 5 e70392 2026年8月10日

    DOI: 10.1002/pcn5.70392  

    ISSN:2769-2558

  6. Disability and sexual and reproductive health outcomes among women in Cambodia: a cross-sectional analysis of the 2021–22 demographic and health survey 査読有り

    Mariko Fukao, Haruka Sakamoto, Su Myat Han, Sayaka Horiuchi, Hanako Iwashita, Samith Mey, Shuhei Nomura

    Frontiers in Reproductive Health 8 2026年7月31日

    出版者・発行元:

    DOI: 10.3389/frph.2026.1897583  

    eISSN:2673-3153

  7. Global Burden of Elevated LDL-C: Findings From the Global Burden of Disease Study 2023 査読有り

    GBD 2023 LDL Cholesterol Collaborators

    JAMA 2026年7月29日

    出版者・発行元:

    DOI: 10.1001/jama.2026.8628  

    ISSN:0098-7484

  8. Mapping drivers of life expectancy change in Asia from 1990 to 2023 査読有り

    GBD 2023 Asia Life Expectancy Collaborators

    Nature 2026年7月22日

    出版者・発行元:

    DOI: 10.1038/s41586-026-10739-6  

    ISSN:0028-0836

    eISSN:1476-4687

  9. Global, regional, and national trends in the morbidity gap and contributing diseases, injuries, and risk factors, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023 査読有り

    Simon I Hay, Paul Nam, Haaris Saqib, Susan A McLaughlin, Catherine Bisignano, Samuel M Ostroff, Marie Ng, Shuhei Nomura, Austin E Schumacher, Christopher J L Murray

    The Lancet Public Health 11 (8) e487-e505 2026年7月21日

    出版者・発行元:

    DOI: 10.1016/s2468-2667(26)00098-8  

    ISSN:2468-2667

  10. Global, regional, and national burden of road injuries 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023 査読有り

    GBD 2023 Road Injuries Collaborators

    The Lancet Public Health 2026年7月20日

    出版者・発行元:

    DOI: 10.1016/s2468-2667(26)00141-6  

    ISSN:2468-2667

  11. Japan's health system toward 2040: structural challenges and a renewed social contract 査読有り

    Lisa Yamasaki, Haruka Sakamoto, Hideki Hashimoto, Naoki Kondo, Osamu Kunii, Yusuke Tsugawa, Sarah Krull Abe, Satoshi Ezoe, Shinichi Egawa, Renzo R. Guinto, Ataru Igarashi, Angkana Lekagul, Kaung Suu Lwin, Mitsuru Mukaigawara, Ho Namkoong, Yoshitaka Nishino, Santosh Kumar Rauniyar, Eiko Saito, Kenji Shibuya, Keizo Takemi, Kun Tang, Takahiro Tabuchi, Hana Tomoi, Tomoko Suzuki, Shuhei Nomura

    The Lancet Regional Health - Western Pacific 72 101920 2026年7月15日

    DOI: 10.1016/j.lanwpc.2026.101920  

    ISSN:2666-6065

  12. Japan's global health engagement in the Western Pacific: diagnosing structural inertia and a framework for human security diplomacy 査読有り

    Haruka Sakamoto, Lisa Yamasaki, Sarah Krull Abe, Satoshi Ezoe, Shinichi Egawa, Renzo R. Guinto, Hideki Hashimoto, Ataru Igarashi, Angkana Lekagul, Kaung Suu Lwin, Mitsuru Mukaigawara, Ho Namkoong, Yoshitaka Nishino, Naoki Kondo, Osamu Kunii, Santosh Kumar Rauniyar, Eiko Saito, Kenji Shibuya, Keizo Takemi, Kun Tang, Takahiro Tabuchi, Hana Tomoi, Yusuke Tsugawa, Tomoko Suzuki, Shuhei Nomura

    The Lancet Regional Health - Western Pacific 72 101921 2026年7月15日

    DOI: 10.1016/j.lanwpc.2026.101921  

    ISSN:2666-6065

  13. TICAD9 and the UHC Knowledge Hub: Strengthening Japan-Africa Health Cooperation 査読有り

    Aminu Kende Abubakar, Usman Hafsat, Olukunmi Omobolanle Balogun, Shuhei Nomura

    International Journal of Health Policy and Management 15 9750 2026年7月7日

    DOI: 10.34172/ijhpm.9750  

  14. Associations between Antimicrobial-Resistant Gram-Negative Infections and Climate-Related Exposure in a Tertiary Medical Center in Central Luzon, Philippines 査読有り

    Paul L. C. Chua, Emerald J. O’Brien, Shuhei Nomura, Sophearen Ith, Chris Fook Sheng Ng, Azenith May H. Rafanan, Julie Anne, B. Cabantog, Masahiro Hashizume, Miguel Antonio Salazar

    Environment & Health 2026年7月1日

    出版者・発行元:

    DOI: 10.1021/envhealth.5c00842  

    ISSN:2833-8278

    eISSN:2833-8278

  15. Association of municipal rurality and area deprivation with cause-specific mortality in Japan: a nationwide ecological study 査読有り

    Masahide Koda, Nahoko Harada, Shuhei Nomura, Yusuke Tsugawa

    BMJ Public Health 4 (3) e004913-e004913 2026年7月1日

    出版者・発行元:

    DOI: 10.1136/bmjph-2026-004913  

    eISSN:2753-4294

  16. Global, regional, and national burden of tuberculosis and multidrug-resistant tuberculosis by HIV status, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023 査読有り

    GBD 2023 TB HIV Collaborators

    The Lancet Infectious Diseases 2026年7月1日

    出版者・発行元:

    DOI: 10.1016/s1473-3099(26)00295-1  

    ISSN:1473-3099

  17. Why healthy life expectancy estimates diverge: insights from survey-based, administrative, and model-based metrics across Japanese prefectures, 2001–2019: a comparative ecological study 査読有り

    Shuhei Nomura, Akifumi Eguchi, Daisuke Yoneoka, Hana Tomoi, Lisa Yamasaki, Yuta Tanoue, Takayuki Kawashima, Aoi Kataoka, Yuri Ito, Naoki Kondo

    Population Health Metrics 24 (50) 2026年6月10日

    出版者・発行元:

    DOI: 10.1186/s12963-026-00488-z  

    eISSN:1478-7954

  18. From Vulnerability to Invisible Infrastructure: A Scoping Review of the Connor-Davidson Resilience Scale (CD-RISC) in Disasters for Super-Aging Society 査読有り

    Hyejeong Park, Hiroyuki Sasaki, Motohiro Tsuboi, Shuhei Nomura, Shinichi Egawa

    The Tohoku Journal of Experimental Medicine 269 (2) 135-144 2026年6月4日

    出版者・発行元:

    DOI: 10.1620/tjem.2026.j069  

    ISSN:0040-8727

    eISSN:1349-3329

  19. Global burden of enteric infectious diseases, diarrhoeal diseases, and corresponding aetiologies, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023 査読有り

    GBD 2023 Diarrhoeal Disease and Enteric Infectious Diseases Collaborators

    The Lancet Infectious Diseases 2026年6月2日

    出版者・発行元:

    DOI: 10.1016/s1473-3099(26)00194-5  

    ISSN:1473-3099

  20. Updated trends in the global prevalence and burden of mental disorders, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023 査読有り

    GBD 2023 Mental Disorder Collaborators

    The Lancet 407 (10543) 2040-2064 2026年5月23日

    DOI: 10.1016/s0140-6736(26)00519-2  

    ISSN:0140-6736

  21. Forecasting Stomach Cancer Burden from High Sodium Intake in Japan, 2022–2050: Scenario Analysis of Demographic Disparities 査読有り

    Constanza De Matteu Monteiro, Daisuke Yoneoka, Shuhei Nomura

    Nutrients 18 (10) 1641 2026年5月21日

    DOI: 10.3390/nu18101641  

  22. Global, regional and national burden of ischemic heart disease attributable to suboptimal diet, 1990–2023: a Global Burden of Disease study 査読有り

    GBD 2023 IHD & Dietary Risk Factors Collaborators

    Nature Medicine 32 1454-1478 2026年3月30日

    出版者・発行元:

    DOI: 10.1038/s41591-026-04250-8  

    ISSN:1078-8956

    eISSN:1546-170X

  23. Global, regional, and national burden of meningitis, its risk factors, and aetiologies, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023 査読有り

    GBD 2023 Meningitis & Antimicrobial Resistance Collaborators

    The Lancet Neurology 22 (5) 451-468 2026年3月27日

    出版者・発行元:

    DOI: 10.1016/s1474-4422(26)00101-8  

    ISSN:1474-4422

  24. Diabetes and psychological distress posed greater risks than model-inferred risk of radiation-induced cancer after the Fukushima disaster: An application of the loss of happy life expectancy indicator 査読有り

    Michio Murakami, Akihiko Ozaki, Kyoko Ono, Shuhei Nomura, Yoshitake Takebayashi, Masaharu Tsubokura

    Acta Psychologica 264 106563-106563 2026年3月26日

    出版者・発行元:

    DOI: 10.1016/j.actpsy.2026.106563  

    ISSN:0001-6918

  25. Global, regional, and national levels and trends in maternal mortality, progress towards the Sustainable Development Goals, and mortality from COVID-19 infection in pregnant women, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023 査読有り

    GBD 2023 Maternal Mortality Collaborators

    The Lancet Obstetrics, Gynaecology, & Women's Health 2 (5) E375-E424 2026年3月26日

    出版者・発行元:

    DOI: 10.1016/s3050-5038(26)00047-6  

    ISSN:3050-5038

  26. Global, regional, and national burden of breast cancer among females, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023 査読有り

    GBD 2023 Breast Cancer Collaborators

    The Lancet Oncology 27 (3) 302-326 2026年3月2日

    DOI: 10.1016/s1470-2045(25)00730-2  

    ISSN:1470-2045

  27. Burden of chronic respiratory disease in Asia, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023 査読有り

    GBD 2023 Asia Chronic Respiratory Disease Collaborators

    The Lancet Respiratory Medicine 14 (3) 233-255 2026年3月

    DOI: 10.1016/s2213-2600(25)00404-7  

    ISSN:2213-2600

  28. Modeling incubation period and time of exposure using the four-parameter generalized gamma distribution 査読有り

    Daisuke Yoneoka, Takayuki Kawashima, Yuta Tanoue, Shuhei Nomura, Akifumi Eguchi

    10 (1) 2026年2月20日

    DOI: 10.1080/24709360.2026.2619272  

    ISSN:2470-9360 2470-9379

  29. Comparative Effectiveness of Behavioural Sodium-Reduction Interventions for Intensive Systolic Blood Pressure Control in Populations with Elevated Blood Pressure: A Systematic Review and Network Meta-Analysis 査読有り

    Prapichaya Prommas, Manae Uchibori, Santosh Kumar Rauniyar, Shuhei Nomura

    Nutrients 18 (3) 428 2026年1月28日

    DOI: 10.3390/nu18030428  

  30. Global, regional, and national burden of chronic respiratory diseases and impact of the COVID-19 pandemic, 1990–2023: a Global Burden of Disease study 査読有り

    GBD 2023 Global Chronic Respiratory Disease and Covid Collaborators

    Nature Medicine 2026年1月6日

    出版者・発行元:

    DOI: 10.1038/s41591-025-04077-9  

    ISSN:1078-8956

    eISSN:1546-170X

  31. Global burden of lower respiratory infections and aetiologies, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023 査読有り

    GBD 2023 Lower Respiratory Infections and Antimicrobial Resistance Collaborators

    The Lancet Infectious Diseases 26 (4) 341-361 2025年12月15日

    出版者・発行元:

    DOI: 10.1016/s1473-3099(25)00689-9  

    ISSN:1473-3099

  32. Cost–benefit analysis of pre-entry tuberculosis screening for incoming migrants to Japan: a focus on Nepalese migrants 査読有り

    Yoko Iwaki, Takayuki Hayashi, Shuhei Nomura, Shoko Shimamura, Rohita Gauchan, Michael C. Huang

    Health Economics Review 2025年12月13日

    出版者・発行元:

    DOI: 10.1186/s13561-025-00709-5  

    eISSN:2191-1991

  33. When disaster meets conflict: Bridging health, nutrition and equity in Myanmar 査読有り

    Kaung Suu Lwin, Su Myat Han, Shuhei Nomura

    BMJ Global Health 10 e020067 2025年12月11日

    DOI: 10.1136/bmjgh-2025-020067  

  34. Quantifying the fatal and non-fatal burden of disease associated with child growth failure, 2000–2023: a systematic analysis from the Global Burden of Disease Study 2023 査読有り

    GBD 2023 Child Growth Failure Collaborators

    The Lancet Child & Adolescent Health 10 (1) 22-38 2025年12月2日

    出版者・発行元:

    DOI: 10.1016/s2352-4642(25)00303-7  

    ISSN:2352-4642

  35. Global, regional, and national burden of chronic kidney disease in adults, 1990–2023, and its attributable risk factors: a systematic analysis for the Global Burden of Disease Study 2023 査読有り

    GBD 2023 Chronic Kidney Disease Collaborators

    The Lancet 406 (10518) 2461-2482 2025年11月7日

    出版者・発行元:

    DOI: 10.1016/s0140-6736(25)01853-7  

    ISSN:0140-6736

  36. Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023 査読有り

    GBD 2023 Disease and Injury and Risk Factor Collaborators

    The Lancet 406 (10513) 1873-1922 2025年10月12日

    出版者・発行元:

    DOI: 10.1016/s0140-6736(25)01637-x  

    ISSN:0140-6736

  37. Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023 査読有り

    GBD 2023 Causes of Death Collaborators

    The Lancet 406 (10513) 1811-1872 2025年10月12日

    出版者・発行元:

    DOI: 10.1016/s0140-6736(25)01917-8  

    ISSN:0140-6736

  38. Global age-sex-specific all-cause mortality and life expectancy estimates for 204 countries and territories and 660 subnational locations, 1950–2023: a demographic analysis for the Global Burden of Disease Study 2023 査読有り

    GBD 2023 Demographics Collaborators

    The Lancet 406 (10513) 1731-1810 2025年10月12日

    出版者・発行元:

    DOI: 10.1016/s0140-6736(25)01330-3  

    ISSN:0140-6736

  39. The global, regional, and national burden of cancer, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023 査読有り

    GBD 2023 Cancer Collaborators

    406 (10512) 1565-1586 2025年10月11日

    出版者・発行元:

    DOI: 10.1016/s0140-6736(25)01635-6  

    ISSN:0140-6736

  40. Sexual Inactivity in Japan: A Scoping Review 査読有り

    Peter Ueda, Sari Toki, Shuhei Nomura, Alice Pacher, Cyrus Ghaznavi, Haruka Sakamoto

    The Journal of Sex Research 1-26 2025年10月2日

    出版者・発行元:

    DOI: 10.1080/00224499.2025.2564192  

    ISSN:0022-4499

    eISSN:1559-8519

  41. Global, Regional, and National Burden of Cardiovascular Diseases and Risk Factors in 204 Countries and Territories, 1990-2023 査読有り

    Global Burden of Cardiovascular Diseases and Risks 2023 Collaborators

    JACC 86 (22) 2167-2243 2025年9月24日

    出版者・発行元:

    DOI: 10.1016/j.jacc.2025.08.015  

    ISSN:0735-1097

  42. Decentralized pandemic response and health equity: an analysis of socioeconomic disparities in COVID-19 mortality in Japan 査読有り

    Hasan Jamil, Aminu Abubakar Kende, Shuhei Nomura, Fumiya Inoue, Takao Suzuki, Stuart Gilmour

    e2025049-e2025049 2025年8月28日

    出版者・発行元:

    DOI: 10.4178/epih.e2025049  

    eISSN:2092-7193

  43. Global, regional, and national trends in routine childhood vaccination coverage from 1980 to 2023 with forecasts to 2030: a systematic analysis for the Global Burden of Disease Study 2023 査読有り

    GBD 2023 Vaccine Coverage Collaborators

    The Lancet 2025年6月24日

    出版者・発行元:

    DOI: 10.1016/s0140-6736(25)01037-2  

    ISSN:0140-6736

  44. Global, Regional, and National Burden of Nontraumatic Subarachnoid Hemorrhage 査読有り

    GBD 2021 Global Subarachnoid Hemorrhage Risk Factors Collaborators

    JAMA Neurology 2025年5月23日

    出版者・発行元:

    DOI: 10.1001/jamaneurol.2025.1522  

    ISSN:2168-6149

  45. Characterising acute and chronic care needs: insights from the Global Burden of Disease Study 2019 査読有り

    GBD 2019 Acute and Chronic Care Collaborators

    Nature Communications 16 (1) 2025年5月7日

    出版者・発行元:

    DOI: 10.1038/s41467-025-56910-x  

    eISSN:2041-1723

  46. Population aging exacerbates heat stroke-related ambulance transportations in Japan 査読有り

    Qiang Guo, Lina Madaniyazi, Shuhei Nomura, Kai Chen, Masahiro Hashizume

    Environment International 199 109506-109506 2025年5月3日

    出版者・発行元:

    DOI: 10.1016/j.envint.2025.109506  

    ISSN:0160-4120

  47. Global, regional and national burden of dietary iron deficiency from 1990 to 2021: a Global Burden of Disease study 査読有り

    GBD 2021 Dietary Iron Deficiency Collaborators

    Nature Medicine 2025年4月22日

    出版者・発行元:

    DOI: 10.1038/s41591-025-03624-8  

    ISSN:1078-8956

    eISSN:1546-170X

  48. Heterogeneity in willingness to share personal health information: a nationwide cluster analysis of 20,000 adults in Japan 査読有り

    Miho Sassa, Akifumi Eguchi, Keiko Maruyama-Sakurai, Takanori Fujita, Yumi Kawamura, Takayuki Kawashima, Yuta Tanoue, Daisuke Yoneoka, Hiroaki Miyata, Takanori Yamashita, Naoki Nakashima, Shuhei Nomura

    Archives of Public Health 83 (1) 2025年4月18日

    出版者・発行元:

    DOI: 10.1186/s13690-025-01599-z  

    eISSN:2049-3258

  49. Excess mortality during and after the COVID-19 emergency in Japan: a two-stage interrupted time-series design 査読有り

    Ganan Devanathan, Paul LC Chua, Shuhei Nomura, Chris Fook Sheng Ng, Nasif Hossain, Akifumi Eguchi, Masahiro Hashizume

    BMJ Public Health 3 (1) e002357-e002357 2025年4月5日

    出版者・発行元:

    DOI: 10.1136/bmjph-2024-002357  

    eISSN:2753-4294

  50. Three decades of population health changes in Japan, 1990–2021: a subnational analysis for the Global Burden of Disease Study 2021 査読有り

    Shuhei Nomura, Michio Murakami, Santosh Kumar Rauniyar, Naoki Kondo, Takahiro Tabuchi, Haruka Sakamoto, Yasuharu Tokuda, Nishali Patel, Jose Navarro de Pablo, Joseph L Dieleman, Angela Y Chang, Vegard Skirbekk, Sarah K Abe, Norito Kawakami, Erika Ota, Scott D Glenn, Chimedsuren Ochir, Hiroaki Miyata, Manami Inoue, Kenji Shibuya, Isaac Yeboah Addo, Mohammed Ahmed Akkaif, Syed Mahfuz Al Hasan, Waad Ali, Mohammad Al-Warda, Hany Aly, Anayochukwu Edward, Anyasodor, Jalal Arabloo, Ahmed Y. Azzam, Kavita Batra, Sonu Bhaskar, Samuel Adolf Bosoka, Ester Cerin, Vijay Kumar Chattu, Dong-Woo Choi, Bryan Chong, Samuel Demissie Darcho, Nicole Davis Weaver, Kuldeep Dhama, Robert Kokou Dowou, Temitope Cyrus Ekundayo, Ibrahim Faraha, El Bayoumy, Pietro Ferrara, Nuno Ferreira, Takeshi Fukumoto, Xiang Gao, Samer Hamidi, Simon I Hay, Yuta Hiraike, Mehdi Hosseinzadeh, Nayu Ikeda, Arit Inok, Md. Rabiul Islam, Masao Iwagami, Ammar Abdulrahman Jairoun, Mihajlo Jakovljevic, Inn Kynn Khaing, Mohammad Jobair Khan, Atulya Aman Khosla, Tea Lallukka, Thao Thi Thu Le, Munjae Lee, Seung Won Lee, Wei-Chen Lee, Raimundas Lunevicius, Medha Mathur, Hadush Negash Meles, Mohammadreza Mobayen, Jama Mohamed, Abdollah Mohammadian-Hafshejani, Yanjinlkham Munkhsaikhan, Christopher J L Murray, Ganesh R Naik, Samidi Nirasha, Kumari Navaratna, Phuong The Nguyen, Dieta Nurrika, Bogdan Oancea, Michael Safo Oduro, Takayoshi Ohkubo, Osaretin Christabel Okonji, Sok King Ong, Mahesh Padukudru P A., Jagadish Rao Padubidri, Romil R Parikh, Sungchul Park, Mahmoud Mohammed Ramadan, Shakthi Kumaran Ramasamy, Sheena Ramazanu, Elrashdy M., Moustafa Mohamed Redwan, Taeho Gregory Rhee, Cameron John Sabe, Vijaya Paul Samuel, Jennifer Saulam, Mohammad Ali Shamshirgaran, Premalatha K Shetty, Mika Shigematsu, Aminu Shittu, Emmanuel Edwar Siddig, Zhong Sun, Chandan Kumar Swain, Ruri Syailendrawati, Sree Sudha T Y., Jabeen Taiba, Masayuki Teramoto, Ngoc Ha Tran, Nguyen Tran Minh Duc, Dominique Vervoor, Muhammad Waqas, Kazumasa Yamagishi, Yuichiro Yano, Yuichi Yasufuku, Dong Keon Yon, Naohiro Yonemoto, Iman Zare, Zhiqiang Zhang, Hanqing Zhao, Claire Chenwen Zhong, Mohsen Naghavi

    The Lancet Public Health 10 (4) e321-e332 2025年4月

    DOI: 10.1016/S2468-2667(25)00044-1  

    ISSN:2468-2667

  51. Weibull-Type Incubation Period and Time of Exposure Using γ-Divergence 査読有り

    Daisuke Yoneoka, Takayuki Kawashima, Yuta Tanoue, Shuhei Nomura, Akifumi Eguchi

    Entropy 27 (3) 2025年3月19日

    DOI: 10.3390/e27030321  

  52. Global, regional, and national prevalence of adult overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021 査読有り

    GBD 2021 Adult BMI Collaborators

    The Lancet 2025年3月3日

    出版者・発行元:

    DOI: 10.1016/s0140-6736(25)00355-1  

    ISSN:0140-6736

  53. Global, regional, and national prevalence of child and adolescent overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021 査読有り

    GBD 2021 Adolescent BMI Collaborators

    The Lancet 2025年3月3日

    出版者・発行元:

    DOI: 10.1016/s0140-6736(25)00397-6  

    ISSN:0140-6736

  54. Global, regional, and national burden of suicide, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 査読有り

    GBD 2021 Suicide Collaborators

    The Lancet Public Health 10 (3) 2025年3月

    DOI: 10.1016/S2468-2667(25)00006-4  

    ISSN:2468-2667

  55. Perceptions and responses to COVID-19 through wastewater surveillance information and online search behavior: A randomized controlled trial 査読有り

    Michio Murakami, Shuhei Nomura, Hiroki Ando, Masaaki Kitajima

    118 105224 2025年2月15日

    DOI: 10.1016/j.ijdrr.2025.105224  

  56. Climate-related bilateral official development assistance (ODA) and vulnerability: A comparative study of allocation and effectiveness 査読有り

    Santosh Kumar Rauniyar, Nagisa Shiiba, Lisa Yamasaki, Hiroaki Tomoi, Hana Tomoi, Maura Kitchens Wes, Atsushi Watanabe, Shuhei Nomura

    4 (2) e0000382 2025年2月3日

    DOI: 10.1371/journal.pclm.0000382  

  57. The Unseen Aftermath: Associations Between the COVID-19 Pandemic and Shifts in Mortality Trends in Japan 査読有り

    Hasan Jamil, Shuhei Nomura, Stuart Gilmour

    International Journal of Environmental Research and Public Health 22 (1) 74 2025年1月8日

  58. Trading-Off Privacy and Willingness to Share Personal Health Information: A Survey of Municipal Employees in Fukuoka City, Japan 査読有り

    Shuhei Nomura, Yasumasa Segawa, Cyrus Ghaznavi, Takanori Fujita, Keiko Maruyama-Sakurai, Manae Uchibori, Akifumi Eguchi, Masaharu Ishigaki, Kazuto Fujiwara, Masayuki Kido, Hiroaki Miyata, Takanori Yamashita, Naoki Nakashima

    Health 16 (12) 1315-1331 2024年12月31日

    出版者・発行元:

    DOI: 10.4236/health.2024.1612091  

    ISSN:1949-4998

    eISSN:1949-5005

  59. Changes in Healthcare Utilization in Japan in the Aftermath of the COVID-19 Pandemic: A Time Series Analysis of Japanese National Data Through November 2023 査読有り

    Yuta Tanoue, Alton Cao, Masahide Koda, Nahoko Harada, Cyrus Ghaznavi, Shuhei Nomura

    Healthcare 12 (22) 2307 2024年11月19日

    DOI: 10.3390/healthcare12222307  

  60. Robust estimation of the incubation period and the time of exposure using γ-divergence 査読有り

    Daisuke Yoneoka, Takayuki Kawashima, Yuta Tanoue, Shuhei Nomura, Akifumi Eguch

    Journal of Applied Statistics 52 (6) 1239-1257 2024年11月6日

    DOI: 10.1080/02664763.2024.2420221  

    ISSN:0266-4763 1360-0532

  61. Global, regional, and national stillbirths at 20 weeks' gestation or longer in 204 countries and territories, 1990–2021: findings from the Global Burden of Disease Study 2021 査読有り

    GBD 2021 Global Stillbirths Collaborators

    The Lancet 2024年11月4日

    出版者・発行元:

    DOI: 10.1016/s0140-6736(24)01925-1  

    ISSN:0140-6736

  62. Changes in mortality during the COVID-19 pandemic in Japan: descriptive analysis of national health statistics up to 2022 査読有り

    Hirokazu Tanaka, Shuhei Nomura, Kota Katanoda

    Journal of Epidemiology 2024年10月27日

    出版者・発行元:

    DOI: 10.2188/jea.je20240158  

    ISSN:0917-5040

    eISSN:1349-9092

  63. Indirect and direct effects of nighttime light on COVID-19 mortality using satellite image mapping approach 国際誌

    Daisuke Yoneoka, Akifumi Eguchi, Shuhei Nomura, Takayuki Kawashima, Yuta Tanoue, Masahiro Hashizume, Motoi Suzuki

    Scientific reports 14 (1) 25063-25063 2024年10月23日

    DOI: 10.1038/s41598-024-75484-0  

  64. Determinants of sodium intake knowledge and attitude: a cross-national analysis of socio-economic and health factors 査読有り

    Santosh Kumar Rauniyar, Yuta Tanoue, Cyrus Ghaznavi, Hitomi Hayabuchi, Toshihide Nishimura, Yukari Takemi, Shuhei Nomura

    Public Health Nutrition 27 (1) e216 2024年10月22日

    DOI: 10.1017/S1368980024001551  

  65. Analysis of factors associated with public attitudes towards salt reduction: a multicountry cross-sectional survey 査読有り

    Tanoue, Y., Rauniyar, S.K., Uchibori, M., Ghaznavi, C., Tomoi, H., Ueta, M., Prommas, P., Cao, A., Yoneoka, D., Kawashima, T., Eguchi, A., Nomura, S.

    BMJ Open 14 (10) e086467 2024年10月16日

    DOI: 10.1136/bmjopen-2024-086467  

    ISSN:2044-6055

  66. Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050: a systematic analysis for the Global Burden of Disease Study 2021 査読有り

    GBD 2021 Tobacco Forecasting Collaborators

    The Lancet Public Health 9 (10) e729-e744 2024年10月

    出版者・発行元:

    DOI: 10.1016/s2468-2667(24)00166-x  

    ISSN:2468-2667

  67. Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 査読有り

    GBD 2021 Stroke Risk Factor Collaborators

    The Lancet Neurology 23 (10) 973-1003 2024年10月

    出版者・発行元:

    DOI: 10.1016/s1474-4422(24)00369-7  

    ISSN:1474-4422

  68. Progress and scenario-based projections of health service availability and coverage towards UHC in the post-conflict and post-pandemic Iraq: a Bayesian hierarchical regression approach 査読有り

    Hiroko Taniguchi, Md Mizanur Rahman, Ashraf Hussain, Shuhei Nomura, Ganan Devanathan, Masahiro Hashizume

    BMJ Open 14 (9) e080492-e080492 2024年9月30日

    出版者・発行元:

    DOI: 10.1136/bmjopen-2023-080492  

    ISSN:2044-6055

    eISSN:2044-6055

  69. Strengthening Public Health System Resilience to Disasters in Türkiye: Insights from a Scorecard Methodology 査読有り

    Ismail Tayfur, Perihan Şimşek, Abdülkadir Gunduz, Mayumi Kako, Shuhei Nomura, Benjamin Ryan

    104869-104869 2024年9月27日

    出版者・発行元:

    DOI: 10.1016/j.ijdrr.2024.104869  

    ISSN:2212-4209

  70. Lifestyle differences in the metabolic comorbidity score of adult population from South Asian countries: a cross-sectional study 査読有り

    Sabera Sultana, Shuhei Nomura, Chris Fook Sheng, Masahiro Hashizume

    AJPM Focus 100273-100273 2024年8月23日

    出版者・発行元:

    DOI: 10.1016/j.focus.2024.100273  

    ISSN:2773-0654

  71. Health Information Seeking on the Internet Among Patients With and Without Cancer in a Region Affected by the 2011 Fukushima Triple Disaster: Cross-Sectional Study 査読有り

    Yudai Kaneda, Akihiko Ozaki, Michio Murakami, Toyoaki Sawano, Shuhei Nomura, Divya Bhandari, Hiroaki Saito, Masaharu Tsubokura, Kazue Yamaoka, Yoshinori Nakata, Manabu Tsukada, Hiromichi Ohira

    JMIR Cancer 10 e49897 2024年8月21日

    DOI: 10.2196/49897  

  72. Factors influencing parental COVID-19 vaccination willingness for children in Japan 査読有り

    Mami Ueta, Alton Cao, Michio Murakami, Hana Tomoi, Stuart Gilmour, Keiko Maruyama-Sakurai, Yoshihiro Takayama, Yoshitake Takebayashi, Masahiro Hashizume, Rauniyar Santosh Kumar, Hiroyuki Kunishima, Wataru Naito, Tetsuo Yasutaka, Satoshi Kaneko, Hiroaki Miyata, Shuhei Nomura

    Vaccine: X 100528-100528 2024年7月18日

    出版者・発行元:

    DOI: 10.1016/j.jvacx.2024.100528  

    ISSN:2590-1362

  73. Factors associated with lifetime use of commercial sex work services among Japanese men aged 20–49: findings from a quasi-representative national survey, 2022 査読有り

    Cyrus Ghaznavi, Peter Ueda, Shuhei Nomura, Masahiro Ishikane, Shunsuke Uno, Haruka Sakamoto

    Sexually Transmitted Infections sextrans-2023 2024年6月13日

    出版者・発行元:

    DOI: 10.1136/sextrans-2023-055971  

    ISSN:1368-4973

    eISSN:1472-3263

  74. The importance of methodological vigilance: Reevaluating suicide trends in Japan post‐2022 査読有り

    Masahide Koda, Nahoko Harada, Shuhei Nomura

    Psychiatry and Clinical Neurosciences Reports 3 (2) 2024年6月7日

    出版者・発行元:

    DOI: 10.1002/pcn5.214  

    ISSN:2769-2558

    eISSN:2769-2558

  75. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 査読有り

    GBD 2021 Risk Factors Collaborators

    The Lancet 403 (10440) 2162-2203 2024年5月16日

    出版者・発行元:

    DOI: 10.1016/s0140-6736(24)00933-4  

    ISSN:0140-6736

  76. Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021 査読有り

    GBD 2021 Forecasting Collaborators

    The Lancet 403 (10440) 2204-2256 2024年5月16日

    出版者・発行元:

    DOI: 10.1016/s0140-6736(24)00685-8  

    ISSN:0140-6736

  77. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 査読有り

    GBD 2021 Diseases and Injuries Collaborators

    403 (10440) 2133-2161 2024年5月16日

    出版者・発行元:

    DOI: 10.1016/s0140-6736(24)00757-8  

    ISSN:0140-6736

  78. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 査読有り

    GBD 2021 Causes of Death Collaborators

    The Lancet 403 (10440) 2100-2132 2024年5月16日

    出版者・発行元:

    DOI: 10.1016/s0140-6736(24)00367-2  

    ISSN:0140-6736

  79. Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 査読有り

    GBD 2021 Fertility and Forecasting Collaborators

    The Lancet 403 (10440) 2057-2099 2024年5月16日

    出版者・発行元:

    DOI: 10.1016/s0140-6736(24)00550-6  

    ISSN:0140-6736

    eISSN:1474-547X

  80. Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 査読有り

    GBD 2021 Demographics Collaborators

    403 (10440) 1989-2056 2024年5月16日

    出版者・発行元:

    DOI: 10.1016/s0140-6736(24)00476-8  

    ISSN:0140-6736

  81. Characterizing Healthy Dietary Practices in Japan: Insights from a 2024 Nationwide Survey and Cluster Analysis 査読有り

    Shuhei Nomura, Akifumi Eguchi, Keiko Maruyama-Sakurai, Ruka Higashino, Daisuke Yoneoka, Takayuki Kawashima, Yuta Tanoue, Yumi Kawamura, Rauniyar Santosh Kumar, Takanori Fujita, Hiroaki Miyata

    16 (10) 1412-1412 2024年5月8日

    出版者・発行元:

    DOI: 10.3390/nu16101412  

    eISSN:2072-6643

  82. Trust in governments, public health institutions, and other information sources as determinants of COVID-19 vaccine uptake behavior in Japan 査読有り

    Alton Cao, Mami Ueta, Manae Uchibori, Michio Murakami, Hiroyuki Kunishima, Rauniyar Santosh Kumar, Prapichaya Prommas, Hana Tomoi, Stuart Gilmour, Haruka Sakamoto, Masahiro Hashizume, Wataru Naito, Tetsuo Yasutaka, Keiko Maruyama-Sakurai, Hiroaki Miyata, Shuhei Nomura

    2024年5月

    出版者・発行元:

    DOI: 10.1016/j.vaccine.2024.04.081  

    ISSN:0264-410X

  83. Global, regional, and national age-specific progress towards the 2020 milestones of the WHO End TB Strategy: a systematic analysis for the Global Burden of Disease Study 2021 査読有り

    GBD 2021 Tuberculosis Collaborators

    The Lancet Infectious Diseases 2024年3月19日

    出版者・発行元:

    DOI: 10.1016/s1473-3099(24)00007-0  

    ISSN:1473-3099

  84. Comparing the risks of environmental carcinogenic chemicals in Japan using the loss of happy life expectancy indicator 査読有り

    Michio Murakami, Kyoko Ono, Yoshitake Takebayashi, Masaharu Tsubokura, Shuhei Nomura

    118637-118637 2024年3月8日

    出版者・発行元:

    DOI: 10.1016/j.envres.2024.118637  

    ISSN:0013-9351

  85. A comprehensive assessment of deworming coverage among pregnant women in low- and middle-income countries, 2000–30 査読有り

    Miho Sassa, Daisuke Yoneoka, Chris Fook Sheng Ng, Alton Quan Cao, Ganan Devanathan, Masahiro Hashizume, Shuhei Nomura

    Journal of Global Health 14 2024年3月1日

    出版者・発行元:

    DOI: 10.7189/jogh.14.04002  

    ISSN:2047-2978

    eISSN:2047-2986

  86. Prioritizing Strategies for Building the Resilience of Public Health Systems to Disasters Across Multiple Communities and Countries 査読有り

    Benjamin J. Ryan, Mayumi Kako, Shelby Garner, Rok Fink, Ismail Tayfur, Jonathan Abrahams, Sanjaya Bhatia, Adriana Campelo, Matthew Fend, Alicia Fonteno, Nahuel Arenas Garcia, Tim Hatch, Ryoma Kayano, LaShonda Malrey-Horne, Makiko MacDermo, Md Moshiur Rahman, Chaverle Noel, Shuhei Nomura, Jeremy P. Novak, Maria Opazo, Kendell Oliver, Luciana Peters, Sohel Rahman, Perihan Şimşek, Andrew Stricklin, Raymond Swienton, Bryan W. Brooks

    International Journal of Disaster Risk Science 15 (1) 1-17 2024年2月29日

    出版者・発行元:

    DOI: 10.1007/s13753-024-00537-x  

    ISSN:2095-0055

    eISSN:2192-6395

  87. Changes in Place of Death Among Patients With Dementia During the COVID-19 Pandemic in Japan: A Time-series Analysis

    Harada, N., Koda, M., Eguchi, A., Hashizume, M., Suzuki, M., Nomura, S.

    Journal of Epidemiology 34 (10) 2024年2月24日

    DOI: 10.2188/jea.JE20230279  

    ISSN:0917-5040 1349-9092

  88. Excess suicides in Japan: a three-year post-pandemic assessment of gender and age disparities 査読有り

    Haruka Sakamoto, Masahide Koda, Akifumi Eguchi, Kaori Endo, Takahiro Arai, Nahoko Harada, Takashi Nishio, Shuhei Nomura

    115806-115806 2024年2月18日

    出版者・発行元:

    DOI: 10.1016/j.psychres.2024.115806  

    ISSN:0165-1781

  89. Factors associated with barriers to healthcare access among ever-married women of reproductive age in Bangladesh: Analysis from the 2017–2018 Bangladesh Demographic and Health Survey 査読有り

    Hitomi Hinata, Kaung Suu Lwin, Akifumi Eguchi, Cyrus Ghaznavi, Masahiro Hashizume, Shuhei Nomura

    19 (1) e0289324-e0289324 2024年1月5日

    出版者・発行元:

    DOI: 10.1371/journal.pone.0289324  

    ISSN:1932-6203

    eISSN:1932-6203

  90. Active and passive smoking and breast cancer in Japan: a pooled analysis of nine population-based cohort studies

    Wada, K., Nagata, C., Utada, M., Sakata, R., Kimura, T., Tamakoshi, A., Sugawara, Y., Tsuji, I., Sato, R., Sawada, N., Tsugane, S., Oze, I., Ito, H., Kitamura, T., Koyanagi, Y.N., Lin, Y., Matsuo, K., Abe, S.K., Inoue, M., Tanaka, S., Kimura, T., Sugawara, Y., Mizoue, T., Nomura, S., Takimoto, H., Tanaka, K., Charvat, H., Hidaka, A., Hirabayashi, M., Iwasaki, M., Kitamura, Y., Mori, N., Muto, M., Naito, M., Nakayama, T., Nishino, Y., Sadakane, A., Saito, E., Sasazuki, S., Shimazu, T., Shimizu, H., Sugiyama, K., Suzuki, H., Tsubono, Y., Wakai, K., Yamagiwa, Y., Yamaji, T.

    International Journal of Epidemiology 53 (3) 2024年

    DOI: 10.1093/ije/dyae047  

    ISSN:0300-5771 1464-3685

  91. Insights from the COVID-19 pandemic: trends in development assistance committee countries’ aid allocation, 2011–2021 査読有り

    Shuhei Nomura, Cyrus Ghaznavi, Kazuki Shimizu, Alton Cao, Miho Sassa, Manae Uchibori, Rauniyar Santosh Kumar, Lisa Yamasaki, Hana Tomoi, Haruka Sakamoto

    Global Health Action 16 (1) 2258707 2023年12月31日

    DOI: 10.1080/16549716.2023.2258707  

    ISSN:1654-9880

  92. Global Burden of Cardiovascular Diseases and Risks, 1990-2022 査読有り

    Global Burden of Cardiovascular Diseases and Risks Collaborators

    Journal of the American College of Cardiology 82 (25) 2350-2473 2023年12月19日

    出版者・発行元:

    DOI: 10.1016/j.jacc.2023.11.007  

    ISSN:0735-1097

  93. Early Outcomes of Changes to Collection of Suicide Data in Japan 査読有り

    Nahoko Harada, Masahide Koda, Shuhei Nomura

    JAMA Network Open 6 (12) e2347543-e2347543 2023年12月14日

    出版者・発行元: American Medical Association (AMA)

    DOI: 10.1001/jamanetworkopen.2023.47543  

    eISSN:2574-3805

    詳細を見る 詳細を閉じる

    This cross-sectional study examines implications of updated categorizations for suicide data collection in Japan.

  94. The Efficacy of an mHealth App in Facilitating Weight Loss Among Japanese Fitness Center Members: Regression Analysis Study

    Akifumi Eguchi, Yumi Kawamura, Takayuki Kawashima, Cyrus Ghaznavi, Keiko Ishimura, Shun Kohsaka, Satoru Matsuo, Shinichiro Mizuno, Yuki Sasaki, Arata Takahashi, Yuta Tanoue, Daisuke Yoneoka, Hiroaki Miyata, Shuhei Nomura

    JMIR Formative Research 7 e48435-e48435 2023年11月8日

    出版者・発行元: JMIR Publications Inc.

    DOI: 10.2196/48435  

    eISSN:2561-326X

    詳細を見る 詳細を閉じる

    Background Self-tracking smartphone apps have emerged as promising tools to encourage healthy behaviors. In this longitudinal study, we used gym use data from members of a major fitness club that operates gyms throughout Japan from January 2014 to December 2019. Objective Our objective was to assess the extent to which a health and fitness self-tracking mobile app introduced to gym members on January 1, 2018, contributed to their weight loss. The app allows users to input information regarding diet, sleep, weight, and gym exercise so that they can receive personalized feedback from an artificial intelligence chatbot to improve their health behaviors. Methods We used linear regression to quantify the association between app use and weight loss. The primary outcome of the study was the weight loss achieved by each gym user, which was calculated as the difference between their initial and final weights in kilograms, as recorded in the app. Individuals who did not attend the gym or failed to use the mobile app at least twice during the study period were excluded from the analysis. The model accounted for age, gender, distance between the gym and the member’s residence, average weekly number of times a member used the gym, user’s gym membership length in weeks, average weekly number of times a member input information into the app, and the number of weeks that the app was used at least once. Results Data from 26,589 participants were analyzed. Statistically significant associations were detected between weight loss and 2 metrics related to app use: the average weekly frequency of use and the total number of weeks in which the app was used at least once. One input per week was found to be associated with a loss of 62.1 (95% CI 53.8-70.5) g, and 1 week of app use was associated with 21.7 (95% CI 20.5-22.9) g of weight loss from the day of the first input to that of the final input to the app. Furthermore, the average number of times that a member used the gym weekly was also shown to be statistically significantly associated with weight loss: 1 use per week was associated with 255.5 (95% CI 228.5-282.6) g of weight loss. Conclusions This empirical study demonstrated a significant association between weight loss among gym members and not only the frequency of weekly gym use but also the use of a health and fitness self-tracking app. However, further work is needed to examine the mechanisms through which mobile apps affect health behaviors and to identify the specific app features that are most effective in promoting weight loss.

  95. Impact of the COVID-19 pandemic on cancer death locations in Japan: an analysis up to February 2023 on excess mortality 査読有り

    Shuhei Nomura, Marisa Nishio, Sarah Krull Abe, Akifumi Eguchi, Manami Inoue, Motoi Suzuki, Masahiro Hashizume

    Journal of Epidemiology 2023年10月21日

    出版者・発行元: Japan Epidemiological Association

    DOI: 10.2188/jea.je20230235  

    ISSN:0917-5040

    eISSN:1349-9092

  96. Understanding factors related to healthcare avoidance for menstrual disorders and menopausal symptoms: a cross-sectional study among women in Japan

    Manae Uchibori, Akifumi Eguchi, Cyrus Ghaznavi, Yuta Tanoue, Mami Ueta, Miho Sassa, Shu Suzuki, Sayaka Honda, Yukiko Kawata, Miho Iida, Haruka Sakamoto, Shuhei Nomura

    Preventive Medicine Reports 102467-102467 2023年10月11日

    出版者・発行元: Elsevier BV

    DOI: 10.1016/j.pmedr.2023.102467  

    ISSN:2211-3355

  97. Strategies for Strengthening the Resilience of Public Health Systems for Pandemics, Disasters, and Other Emergencies 査読有り

    Benjamin Ryan, Mayumi Kako, Rok Fink, Perihan Şimşek, Paul Barach, Jose Acosta, Sanjaya Bhatia, Mark Brickhouse, Matthew Fendt, Alicia Fontenot, Nahuel Arenas Garcia, Shelby Garner, Abdülkadir Gunduz, D. Mike, Hardin Jr, Tim Hatch, LaShonda Malrey-Horne, Makiko MacDermot, Ryoma Kayano, Joshua McKone, Chaverle Noel, Shuhei Nomura, Jeremy Novak, Andrew Stricklin, Raymond Swienton, Ismail Tayfur, Bryan Brooks

    Disaster Medicine and Public Health Preparedness 17 (5) e479 2023年9月5日

    DOI: 10.1017/dmp.2023.136  

    ISSN:1935-7893

    eISSN:1938-744X

  98. Estimation of the time of exposure based on interval and censored data using the ε‐accelerated EM algorithm 査読有り

    Daisuke Yoneoka, Takayuki Kawashima, Yuta Tanoue, Shuhei Nomura, Akifumi Eguchi

    Statistics in Medicine 42 (25) 4542-4555 2023年8月22日

    出版者・発行元: Wiley

    DOI: 10.1002/sim.9874  

    ISSN:0277-6715

    eISSN:1097-0258

    詳細を見る 詳細を閉じる

    Accurately estimating the timing of pathogen exposure plays a crucial role in outbreak control for emerging infectious diseases, including the source identification, contact tracing, and vaccine research and development. However, since surveillance activities often collect data retrospectively after symptoms have appeared, obtaining accurate data on the timing of disease onset is difficult in practice and can involve “coarse” observations, such as interval or censored data. To address this challenge, we propose a novel likelihood function, tailored to coarsely observed data in rapid outbreak surveillance, along with an optimization method based on an ‐accelerated EM algorithm for faster convergence to find maximum likelihood estimates (MLEs). The covariance matrix of MLEs is also discussed using a nonparametric bootstrap approach. In terms of bias and mean‐squared error, the performance of our proposed method is evaluated through extensive numerical experiments, as well as its application to a series of epidemiological surveillance focused on cases of mass food poisoning. The experiments show that our method exhibits less bias than conventional methods, providing greater efficiency across all scenarios.

  99. Estimating global changes in routine childhood vaccination coverage during the COVID-19 pandemic, 2020-2021 査読有り

    Cyrus Ghaznavi, Akifumi Eguchi, Kaung Suu Lwin, Daisuke Yoneoka, Yuta Tanoue, Rauniyar Santosh Kumar, Sayaka Horiuchi, Masahiro Hashizume, Shuhei Nomura

    Vaccine 2023年5月22日

    出版者・発行元: Elsevier BV

    DOI: 10.1016/j.vaccine.2023.05.034  

    ISSN:0264-410X

  100. Projection of morbidity and mortality due to breast cancer between 2020 and 2050 across 42 low- and middle-income countries 査読有り

    Santosh Kumar Rauniyar, Masahiro Hashizume, Daisuke Yoneoka, Shuhei Nomura

    Heliyon e16427-e16427 2023年5月19日

    出版者・発行元: Elsevier BV

    DOI: 10.1016/j.heliyon.2023.e16427  

    ISSN:2405-8440

  101. Promote global solidarity to advance health-system resilience: proposals for the G7 meetings in Japan 査読有り

    Hiroshima Global Health Task Force (in alphabetical order: Keishi Abe, Sarah Krull Abe, Takanori Fujita, Yoshiaki Gu, Masahiro Hashizume, Chieko Ikeda, Masaki Inaba, Kazuaki Jindai, Naoki Kondo, Osamu Kunii, Makiko Matsuo, Hiroki Nakatani, Yoshitaka Nishino, Shuhei Nomura, Haruka Sakamoto, Hideaki Shiroyama, Tomoko Suzuki, Ayako Takemi, Kayo Takuma)

    The Lancet 401 (10385) 1319-1321 2023年4月5日

    DOI: 10.1016/S0140-6736(23)00690-6  

    ISSN:0140-6736

    eISSN:1474-547X

  102. Modelling of salt intake reduction by incorporation of umami substances into Japanese foods: a cross-sectional study 国際誌 査読有り

    Shiori Tanaka, Daisuke Yoneoka, Aya Ishizuka, Megumi Adachi, Hitomi Hayabuchi, Toshihide Nishimura, Yukari Takemi, Hisayuki Uneyama, Haruyo Nakamura, Kaung Suu Lwin, Kenji Shibuya, Shuhei Nomura

    BMC Public Health 23 (516) 516-516 2023年3月19日

    DOI: 10.1186/s12889-023-15322-6  

  103. Changes in cerebrovascular disease-related deaths and their location during the COVID-19 pandemic in Japan 査読有り

    Shuhei Nomura, Akifumi Eguchi, Cyrus Ghaznavi, Lisa Yamasaki, Santosh Kumar Rauniyar, Yuta Tanoue, Takayuki Kawashima, Daisuke Yoneoka, Shun Kohsaka, Motoi Suzuki, Masahiro Hashizume

    Public Health (218) 176-179 2023年3月14日

    出版者・発行元: Elsevier BV

    DOI: 10.1016/j.puhe.2023.03.006  

    ISSN:0033-3506

  104. Comparing the risks of diabetes, psychological distress, and radiation-induced cancer exposure after the Fukushima disaster using the loss of happy life expectancy 査読有り

    Michio Murakami, Akihiko Ozaki, Kyoko Ono, Shuhei Nomura, Yoshitake Takebayashi, Masaharu Tsubokura

    Acta Psychologica 264 106563 2023年3月7日

    出版者・発行元:

    DOI: 10.1101/2023.05.01.23289327  

  105. The impact of social isolation from COVID-19-related public health measures on cognitive function and mental health among older adults: A systematic review and meta-analysis 査読有り

    Prapichaya Prommas, Kaung Suu Lwin, Yi Chi Chen, Misa Hyakutake, Cyrus Ghaznavi, Haruka Sakamoto, Hiroaki Miyata, Shuhei Nomura

    Ageing Research Reviews 85 101839-101839 2023年3月

    出版者・発行元: Elsevier {BV}

    DOI: 10.1016/j.arr.2022.101839  

    ISSN:1568-1637

  106. Public transportation network scan for rapid surveillance 査読有り

    Tanoue, Y., Yoneoka, D., Kawashima, T., Uryu, S., Nomura, S., Eguchi, A., Makiyama, K., Matsuura, K.

    Biostatistics and Epidemiology 7 (1) 2023年1月2日

    DOI: 10.1080/24709360.2022.2065628  

    ISSN:2470-9360 2470-9379

  107. Response to antiviral therapy for chronic hepatitis C and risk of hepatocellular carcinoma occurrence in Japan: a systematic review and meta-analysis of observational studies

    Yamagiwa, Y., Tanaka, K., Matsuo, K., Wada, K., Lin, Y., Sugawara, Y., Mizoue, T., Sawada, N., Takimoto, H., Ito, H., Kitamura, T., Sakata, R., Kimura, T., Tanaka, S., Inoue, M., Abe, S.K., Nomura, S.

    Scientific Reports 13 (1) 2023年

    DOI: 10.1038/s41598-023-30467-5  

    ISSN:2045-2322

  108. Rights-based global health security through all-hazard risk management

    Huda, Q., Downey, E.L., Ardalan, A., Nomura, S., Rakesh, A.

    Modernizing Global Health Security to Prevent Detect and Respond 2023年

    DOI: 10.1016/B978-0-323-90945-7.00007-5  

  109. Body mass index and esophageal and gastric cancer: A pooled analysis of 10 population-based cohort studies in Japan

    Koyanagi, Y.N., Matsuo, K., Ito, H., Wang, C., Tamakoshi, A., Sugawara, Y., Tsuji, I., Ono, A., Tsugane, S., Sawada, N., Wada, K., Nagata, C., Takeuchi, T., Kitamura, T., Utada, M., Sakata, R., Mizoue, T., Abe, S.K., Inoue, M., Kimura, T., Sugawara, Y., Nomura, S., Takimoto, H., Oze, I., Lin, Y., Hidaka, A., Hirabayashi, M., Iwasaki, M., Kitamura, Y., Mori, N., Muto, M., Naito, M., Nakayama, T., Nishino, Y., Sadakane, A., Saito, E., Sasazuki, S., Shimazu, T., Shimizu, H., Sugiyama, K., Suzuki, H., Tamakoshi, A., Tanaka, K., Tanaka, S., Tsubono, Y., Wakai, K., Yamagiwa, Y., Yamaji, T.

    Cancer Science 114 (7) 2023年

    DOI: 10.1111/cas.15805  

    ISSN:1347-9032 1349-7006

  110. Global, regional and national burden of dietary iron deficiency from 1990 to 2021: a Global Burden of Disease study

    Lee, S., Son, Y., Hwang, J., Kim, M.S., Shin, J.I., Yon, D.K., Kassebaum, N.J., Abate, S.M., Abate, Y.H., Elhafeez, S.A., Abd-Elsalam, S., Abdoun, M., Abdulkader, R.S., Abdullahi, A., Abebe, M., Abedi, A., Abie, A., Abiodun, O., Aboagye, R.G., Abolhassani, H., Abouzid, M., Abreu, L.G., Abualruz, H., Abukhadijah, H.J., Aburuz, S., Abu-Zaid, A., Adamu, L.H., Adane, M.M., Addo, I.Y., Adegboye, O.A., Adekanmbi, V., Adetunji, C.O., Adeyeoluwa, T.E., Adnani, Q.E.S., Adzigbli, L.A., Afzal, S., Agampodi, S.B., Agyemang-Duah, W., Ahmad, A., Ahmad, M.M., Ahmad, S., Ahmad, T., Ahmed, A., Ahmed, A., Ahmed, H., Ahmed, M.S., Ahmed, S.A., Ajami, M., Akinosoglou, K., Akter, E., Al Awaidy, S., Al Hasan, S.M., Al Omari, O., Alajlani, M.M., Al-Aly, Z., Al-Amer, R.M., Albashtawy, M., Aldhaleei, W.A., Algammal, A.M., Alhalaiqa, F.N., Ali, A., Ali, A., Ali, L., Ali, M.U., Ali, S.S., Ali, W., Samakkhah, S.A., Alif, S.M., Al-Marwani, S., Al-Mekhlafi, H.M., Almustanyir, S., Alqahtani, J.S., Al-Raddadi, R.M.M., Alsabri, M.A., Altaany, Z., Altaf, A., Al-Tammemi, A.B., Altirkawi, K.A., Aly, H., Alzoubi, K.H., Amani, R., Amiri, S., Amu, H., Amusa, G.A., Ancuceanu, R., Andrei, T., Anuoluwa, B.S., Anuoluwa, I.A., Anvari, S., Anwar, S.L., Anyasodor, A.E., Arabloo, J., Arafat, M., Aravkin, A.Y., Areda, D., Aregawi, B.B., Aremu, A., Ariffin, H., Arkew, M., Ni, K.A., Ashemo, M.Y., Atata, J.A., Athari, S.S., Atout, M.M.W., Atreya, A., Aweke, A.M., Awoke, M.A., Quintanilla, B.P.A., Azhar, G.S., Azzam, A.Y., Babu, G.R., Baghcheghi, N., Bagheri, N., Bahramian, S., Baig, A.A., Bakkannavar, S.M., Balakrishnan, S., Balcha, W.F., Banik, P.C., Bansal, H., Bante, S.A., Basiru, A., Bastan, M.-M., Batra, K., Begum, T., Bello, M.B., Belo, L., Bensenor, I.M., Beressa, G., Berhie, A.Y., Bhagat, D.S., Bhala, N., Bhardwaj, N., Bhardwaj, P., Bhardwaj, P.V., Bhaskar, S., Bhat, A.N., Bhatti, J.S., Biswas, B., Bodhare, T., Bodunrin, A.O., Boloor, A., Bora, K., Borhany, H., Bouaoud, S., Bustanji, Y., Barsbay, M., Calina, D., C{\'a}mera, L.A., Cao, F., Cattafesta, M., Cegolon, L., Cembranel, F., Cenderadewi, M., Cercy, K.M., Chakraborty, C., Chakraborty, S., Chandika, R.M., Chattu, V.K., Chaurasia, A., Chen, H., Chi, G., Ching, P.R., Chirinos-Caceres, J.L., Cho, W.C.S., Chong, B., Chopra, H., Choudhari, S.G., Chu, D.-T., Chukwu, I.S., Concina, F., Criqui, M.H., Cruz-Martins, N., da Silva, A.G., Dadras, O., D?amico, E., Darcho, S.D., Das, S., Dash, N.R., Debopadhaya, S., Bo, C.D., Delgado-Enciso, I., Desai, H.D., Desta, F., Devegowda, D., Dhane, A.S., Dhulipala, V.R., Do, T.C., Do, T.H.P., Doaei, S., Dohare, S., D?oria, M., Doshi, O.P., Dowou, R.K., Dsouza, A.C., Dsouza, H.L., Duraisamy, S., Dutta, S., Edinur, H.A., Efendi, F., Eftekharimehrabad, A., Eghbali, F., Ekholuenetale, M., Bayoumy, I.F.E., Elbarazi, I., Elgohary, G.M.T., Elhadi, M., El-Huneidi, W., Elshaer, M., Elsohaby, I., Emeto, T.I., Fagbamigbe, A.F., Fahim, A., Fakhradiyev, I.R., Faris, M.E.M., Fauk, N.K., Fazeli, P., Feizkhah, A., Fekadu, G., Ferreira, N., Fischer, F., Florin, B.T., Folayan, M.O.O., Fomenkov, A.A., Fukumoto, T., Fux, B., Sridevi, G., Gadanya, M.A., Gaidhane, A.M., Galali, Y., Gandhi, A.P., Gardner, W.M., Gautam, R.K., Gebregergis, M.W., Gebrehiwot, M., Gebremariam, T.B., B, Geremew, H., Getacher, L., Getahun, G.K., Getie, M., Getie, S.A., Ghadimi, D.J., Ghailan, K.Y., Ghazy, R.M., Gholamalizadeh, M., Gholamrezanezhad, A., Gil, A.U., Giri, B.R., Girmay, A.A., Goulart, A.C., Gubari, M.I.M., Gunawardane, D.A., Gupta, A.K., Gupta, I., Gupta, R.D., Gupta, S., Gupta, V.K., Habibzadeh, F., Habibzadeh, P., Hadi, N.R., Hagins, H., Halim, S.A., Hamdy, N.M., Hamidi, S., Handal, A.J., Handiso, D.W., Hasaballah, A.I., Hasan, M.K., Hasani, H., Md, S.H., Hassan, I.I., Hassankhani, H., Hay, S.I., Hayat, K., Heidari, G., Hemmati, M., Hezam, K., Hiraike, Y., Hoan, N.Q., Holla, R., Md, M.H., Hosseinzadeh, M., Hostiuc, M., Hostiuc, S., Huang, J., Hundie, T.G., Hussain, J., Huynh, H.-H., Hwang, B.-F., Ibitoye, S.E., Ikeda, N., Ilesanmi, O.S., Ilic, I.M., Ilic, M.D., Immurana, M., Inbaraj, L.R., Inok, A., Iqhrammullah, M., Irham, L.M., Islam, M.R., Islam, S.M.S., Ismail, N.E., Isola, G., Iwu, C.D., Iyasu, A.N., Iyer, M., Vinothini, J., Jafarzadeh, A., Jahankhani, K., Jain, A., Jairoun, A.A., Jakovljevic, M., Yengejeh, R.J., Jamil, S., Jawaid, T., Jayanna, K., Jayaram, S., Jena, B.H., Jeswani, B.M., Jokar, M., Jonas, J.B., Jose, J., Joseph, N., Joshua, C.E., Joukar, F., Jozwiak, J.J., Kabir, A., Kabir, Z., Kadir, D.H.H., Kahe, F., Kalankesh, L.R., Kamireddy, A., Kanmodi, K.K., Kantar, R.S., Karami, J., Behnagh, A.K., Kauppila, J.H., Kaur, N., Kayode, G.A., Kayola, K.K., Kebede, A.D., Keikavoosi-Arani, L., Keiyoro, P.N., Khajuria, H., Khalaji, A., Khalid, N., Khalilian, A., Khan, M., Khanal, V., Khatatbeh, H., Khatatbeh, M.M., Kheirallah, K.A., Khidri, F.F., Khokhar, M., Khosla, A.A., Khosravi, M., Khusun, H., Kim, Y.J., Kimokoti, R.W., Kisa, A., Kisa, S., Shivakumar, S.K.M., Kolahi, A.-A., Kompani, F., Koohestani, H.R., Kosen, S., Krishan, K., Kuddus, M., Kulimbet, M., Kumar, D., Kumar, N., Kumar, V., Kundu, S., Om, P.K., Kyei-Arthur, F., Lahariya, C., Lal, D.K., Landires, I., Latief, K. and Le, N.H.H., and Le, T.T.T., Lee, M., Lee, S.W., Lee, W.-C., An, L., Li, M.-C., Lim, S.S., Lin, J., Liu, X., Lonimath, A., Francisco L{\'o}pez-Gil, J., Lopukhov, P.D., Lorenzovici, L., Lotufo, P.A., Lubinda, J., Amin, H.I.M., Ma, Z.F., Rad, E.M., Malik, A.A., Malta, D.C., Manla, Y., Manu, E., Marino, M., Martorell, M., Marzo, R.R., Mathangasinghe, Y., Mathews, E., Mathur, M., Maugeri, A., Mazidi, M., McHugh, T.A., Mehmood, A., Mehra, R., Mehta, K.M., Meto, T.M., Mekonnen, B.D., Meles, H.N., Melese, E.B., Mendez-Lopez, M.A., Mendoza, W., Mestrovic, T., Mettananda, C.D.K., Mettananda, S., Miazgowski, T., Michalek, I.M., Le, H.N.M., Mini, G.K., Mirghafourvand, M., Misganaw, A., Mittal, M., Mohamed, A.I., Mohamed, J., Mohamed, N.S., Mohammad, A.M., Mohammad-Alizadeh-Charandabi, S., Mohammadi, S., Mohammed, S., Mokdad, A.H., Vardanjani, H.M., Monasta, L., Moni, M.A., Ghalibaf, A.M., Moradi, M., Mosapour, A., Motappa, R., Khaneghah, A.M., Mubarik, S., Mukherjee, S., Mulita, F., Munjal, K., Munkhsaikhan, Y., Murray, C.J.L., Musina, A.-M., Mustafa, G., Muthu, S., Muzaffar, M., Nagarajan, A.J., Naghavi, P., Naik, G., Najdaghi, S., Najmuldeen, H.H.R., Nandu, K.T.K., Swamy, S.N., Davani, D.N., Nashwan, A.J., Natto, Z.S., Nauman, J., Naveed, M., Nayak, B.P., Nazri-Panjaki, A., Takop Nchanji, G., Nega, A.T., Nega, M.H., Negoi, I., Negoi, R.I., Nejadghaderi, S.A., Netsere, H.B., Nguefack-Tsague, G., Ngunjiri, J.W., Nguyen, D.H., Nguyen, H.T.H., Nguyen, N., Nguyen, N.N.Y., Nguyen, P.T., Van Thanh Nguyen, Niazi, R.K., Nikoobar, A., Noman, E.A., Nomura, S., Noor, S.T.A., Nawsherwan, N.A., Nouri, M., Nozari, M., Nri-Ezedi, C.A., Nurrika, D., Nzoputam, C.I., Nzoputam, O.J., Oguta, J.O., Ojo-Akosile, T.R., Okeke, S.R., Okekunle, A.P., Okonji, O.C., Olagunju, A.T., Olatubi, M.I., Bali, A.O., Ordak, M., Ortiz, A., Ortiz-Prado, E., Osuagwu, U.L., Ouyahia, A., Owolabi, M.O., Mahesh Padukudru, P.A., Padron-Monedero, A., Padubidri, J.R., Panda-Jonas, S., Pani, P., Papadopoulou, P., Pardhan, S., Parija, P.P., Parikh, R.R., Park, S., Passera, R., Patel, J., Pati, S., Patil, S., Patoulias, D., Pawar, S., Peng, M., Peprah, P., Pereira, G., Perianayagam, A., Perico, N., Philip, A.K., Piracha, Z.Z., Poddighe, D., Poluru, R., Pourtaheri, N., Pradhan, P.M.S., Pradhan, J., Prasad, M., Purohit, B.M., Puvvula, J., Qasim, N.H., Qattea, I., Qazi, A.S., Deepthi, R., Radhakrishnan, V., Raghav, P., Rahim, F., Rahimi-Movaghar, V., Rahman, M.M., Rahman, M.H., U, Rahman, M., Rahman, M.A., Rahmani, A.M., Rahmanian, M., Rahmanian, V., Rahmawaty, S., Raja, A., Raja, S., Rajendran, V., Rajput, P., Ramachandra, K., Ramadan, M.M., Ramasamy, S.K., Rana, K., Rana, R.K., Rane, A., Rao, C.R., Rao, M., Rao, S.J., Rashidi, M.-M., Rasouli-Saravani, A., Rathish, D., Rawaf, S., Raza, R.Z., Razo, C., Redwan, E.M.M.M., Remuzzi, G., Rengasamy, K.R.R., Rezaei, N., Rezaeian, M., Riaz, M., Rickard, J., Rocha, H.A.L., Roever, L., Rohilla, R., Ronfani, L., Rony, M.K.K., Rout, H.S., Roy, B., de Andrade Ruela, G., Rwegerera, G.M., Saad, A.M.A., Sabet, C.J., Sabour, S., Dhingra, M.S., Saddik, B.A., Saeed, U., Sharif-Askari, F.S., Sharif-Askari, N.S., Sahebkar, A., Sahoo, P.M., Sahoo, S.S., Mohammad Sajadi, S., Salami, A.A., Salaroli, L.B., Saleem, S., Salem, M.R., Samodra, Y.L., Samuel, V.P., Samy, A.M., Sanjeev, R.K., Santos, I.S., Saraswathy, S.Y.I., Saravanan, A., Sarkar, T., Sarode, G.S., Sarode, S.C., Sathian, B., Sathyanarayan, A., Satpathy, M., Sawhney, M., Sayeed, A., Schuermans, A., Selvaraj, S., Semreen, M.H., Sengupta, P., Sepanlou, S.G., Sethi, Y., Setiawan, C.H., Shafie, M., Shahid, S., Shahid, W., Shahwan, M.J., Shaikh, M.A., Shakeri, A., Sham, S., Shamim, M.A., Shams-Beyranvand, M., Shamsi, A., Shamsutdinova, A., Shanawaz, M., Shannawaz, M., Sharath, M., Sharifan, A., Rad, J.S., Sharma, A., Sharma, V., Shayan, M., Sheikhi, R.A., Shenoy, R.R., Shetty, M., Shetty, P.H., Shetty, P.K., Shetty, S., Shiri, R., Shittu, A., Shivarov, V., Shrestha, S., Siddig, E.E., Silva, L.M.L.R., Singh, B., Singh, H., Singh, J., Singh, J.A., Singh, N.P., Singh, P., Singh, P., Singh, S., Sobia, F., Solanki, R., Solanki, S., Soraneh, S., Sorensen, R.J.D., Srinivasamurthy, S.K., Subramaniyan, V., Susianti, H., Swain, C.K., Szarpak, L., Szeto, M.D., Sree Sudha, T.Y., Tabatabaei, S.M., Tabatabaeizadeh, S.-A., Tabche, C., Taiba, J., Talaat, I.M., Tampa, M., Tamuzi, J.L., Tarigan, I.U., Tariqujjaman, M., Tat, N.Y., Taye, B.T., Tefera, Y.M., Temsah, M.-H., Thapar, R., Tharwat, S., Thirunavukkarasu, S., Thomas, N.K., Ticoalu, J.H.V., Titova, M.V., Tiwari, K., Tovani-Palone, M.R., Tran, N.M., Tran, N.H., Tran, T.H., Trico, D., Truyen, T.T.T.T., Tualeka, A.R., Tumurkhuu, M., Udoakang, A.J., Ullah, S., Ullah, S., Umar, M., Unnikrishnan, B., Ushula, T.W., Vahabi, S.M., Vahdati, S., Vaithinathan, A.G., Valizadeh, R., Van den Eynde, J., Varghese, J., Vasankari, T.J., Vellingiri, B., Verras, G.-I., Vervoort, D., Vinayak, M., Volovat, S.R., Waheed, Y., Wang, Y., Weerakoon, K.G., Wild, H., Willeit, P., Woday, A.T., Wubie, Y.M., Xiaoyue, X., Yadav, V., Yarahmadi, A., Yaya, S., Yesuf, S.A., Yigezu, M., Yin, D., Yonemoto, N., Chuanhua, Y., Zaman, B.A., Zamora, N., Zare, I., Zeariya, M.G.M., Zeru, N.G., Zhang, H., Zhang, L., Zhong, C.C., Zhumagaliuly, A., Zia, H., Zoghi, G., Zyoud, S.H., Perumal, N., Zoeckler, L., Vilchis-Tella, V., McLaughlin, S.A.

    Cancer Research and Treatment 55 (1) 2023年

    DOI: 10.4143/crt.2022.073  

    ISSN:1598-2998 2005-9256

  111. Annual prevalence of non-communicable diseases and identification of vulnerable populations following the Fukushima disaster and COVID-19 pandemic 査読有り

    Murakami, M., Nomura, S.

    International Journal of Disaster Risk Reduction 84 2023年

    DOI: 10.1016/j.ijdrr.2022.103471  

    ISSN:2212-4209

  112. Salt intake reduction using umami substance-incorporated food: a secondary analysis of NHANES 2017-2018 data 国際誌 査読有り

    Shuhei Nomura, Shiori Tanaka, Akifumi Eguchi, Takayuki Kawashima, Haruyo Nakamura, Kaung Suu Lwin, Lisa Yamasaki, Daisuke Yoneoka, Yuta Tanoe, Megumi Adachi, Hitomi Hayabuchi, Shosei Koganemaru, Toshihide Nishimura, Byron Sigel, Hisayuki Uneyama, Kenji Shibuya

    Public Health Nutrition 1-25 2022年12月1日

    出版者・発行元: Cambridge University Press (CUP)

    DOI: 10.1017/s136898002200249x  

    ISSN:1368-9800

    eISSN:1475-2727

    詳細を見る 詳細を閉じる

    Abstract Objective: Excessive salt intake raises blood pressure and increases the risk of non-communicable diseases (NCDs), such as cardiovascular disease, chronic kidney disease, and stomach cancer. Reducing the sodium content of food is an important public health measure to control the NCDs. This study quantifies the amount of salt reduced by using umami substances, i.e., glutamate, inosinate, and guanylate, for adults in the United States (US). Design: The secondary data analysis was performed using data of the US nationally representative cross-sectional dietary survey, the National Health and Nutrition Examination Survey (NHANES) 2017-2018. Per capita daily salt intake corresponding to the NHANES food groups was calculated in the four hypothetical scenarios of 0%, 30%, 60%, and 90% market share of low-sodium foods in the country. The salt reduction rates by using umami substances were estimated based on the previous study results. Setting: The United States Participants: 4,139 individuals aged 20 years and older in the US Results: Replacing salt with umami substances could help the US adults reduce salt intake by 7.31–13.53% (7.50–13.61% for women; 7.18–13.53% for men), which is equivalent to 0.61–1.13g/day (0.54–0.98g/day for women; 0.69–1.30g/day for men) without compromising the taste. Approximately, 21.21–26.04% of the US adults could keep their salt intake below 5 g/day, the World Health Organization’s recommendation in the scenario where there is no low-sodium product on the market. Conclusions: This study provides essential information that the use of umami substances as a substitute for salt may help reduce the US adults’ salt intake.

  113. Green tea and coffee consumption and risk of kidney cancer in Japanese adults 国際誌 査読有り

    Yichi Chen, Sarah K. Abe, Manami Inoue, Taiki Yamaji, Motoki Iwasaki, Shuhei Nomura, Masahiro Hashizume, Shoichiro Tsugane, Norie Sawada, N. Sawada, S. Tsugane, M. Iwasaki, M. Inoue, T. Yamaji, R. Katagiri, Y. Miyamoto, H. Ihira, S. K. Abe, S. Tanaka, T. moriya, T. Minamizono, Y. Shirai, H. Kuniyoshi, T. Yoshimi, H. Sonoda, T. Tagami, T. Ando, T. Kimura, Y. Kokubo, K. Yamagishi, T. Mizoue, K. Nakamura, R. Takachi, J. Ishihara, H. Iso, T. Kitamura, I. Saito, N. Yasuda, M. Mimura, K. Sakata, M. Noda, A. Goto, H. Yatsuya, M. Mimura, T. Hanaoka, A. Hidaka, S. Sasazuki, H. Charvat, T. Shimazu, S. Budhathoki, M. Muto, T. Imatoh, J. Ogata, S. Baba, T. Mannami, A. Okayama, K. Miyakawa, F. Saito, A. Koizumi, Y. Sano, I. Hashimoto, T. Ikuta, Y. Tanaba, H. Sato, Y. Roppongi, T. Takashima, H. Suzuki, T. Sugie, Y. Miyajima, N. Suzuki, S. Nagasawa, Y. Furusugi, N. Nagai, Y. Ito, S. Komatsu, H. Sanada, Y. Hatayama, F. Kobayashi, H. Uchino, Y. Shirai, T. Kondo, R. Sasaki, Y. Watanabe, Y. Miyagawa, Y. Kobayashi, M. Machida, K. Kobayashi, M. Tsukada, Y. Kishimoto, E. Takara, T. Fukuyama, M. Kinjo, M. Irei, H. Sakiyama, H. Sakiyama, K. Imoto, H. Yazawa, T. Seo, A. Seiko, F. Ito, F. Shoji, R. Saito, A. Murata, K. Minato, K. Motegi, T. Fujieda, S. Yamato, K. Matsui, T. Abe, M. Katagiri, M. Suzuki, M. Doi, A. Terao, Y. Ishikawa, H. Sueta, H. Doi, M. Urata, N. Okamoto, F. Ide, H. Goto, R. Fujita, Y. Sou, H. Sakiyama, N. Onga, H. Takaesu, M. Uehara, T. Nakasone, M. Yamakawa, Y. Miyasato, F. Horii, I. Asano, H. Yamaguchi, K. Aoki, S. Maruyama, M. Ichii, M. Takano, Y. Tsubono, K. Suzuki, Y. Honda, S. Sakurai, N. Tsuchiya, M. Kabuto, M. Yamaguchi, Y. Matsumura, S. Sasaki, S. Watanabe, M. Akabane, T. Kadowaki, Y. Takashima, Y. Yoshida, S. Matsushima, S. Natsukawa, H. Sugimura, S. Tominaga, M. Iida, W. Ajiki, A. Ioka, S. Sato, M. Konishi, K. Okada, T. Sobue, Y. Kawaguchi, N. Hamajima, S. Akiba, T. Isobe, Y. Sato, T. Sobue, H. Shimizu, S. Kono, T. Sobue, E. Maruyama

    Scientific Reports 12 (1) 20274-20274 2022年11月24日

    出版者・発行元: Springer Science and Business Media LLC

    DOI: 10.1038/s41598-022-24090-z  

    eISSN:2045-2322

    詳細を見る 詳細を閉じる

    Abstract The study aimed to evaluate the association between green tea and coffee consumption and the risk of kidney cancer using data from a large prospective cohort study in Japan (the Japan Public Health Center-based Prospective Study: JPHC Study). A total of 102,463 participants aged 40–69 were followed during 1,916,421 person-years (mean follow-up period, 19 years). A total of 286 cases of kidney cancer (199 in men, 87 in women) were identified. Cox proportional hazards regression models were used to estimate hazard ratios (HRs) and 95% confidence intervals (95% CIs) while adjusting for potential confounders. No statistically significant association between green tea intake and kidney cancer risk was found in the total population. Among women who consumed more than five cups of green tea per day, a statistically significant decreased risk was shown with a HR of 0.45 (95% CI: 0.23–0.89), compared to women who rarely consumed green tea. For coffee consumption, the association of kidney cancer risk was not statistically significant. This large prospective cohort study indicated green tea intake may be inversely associated with kidney cancer risk in Japanese adults, particularly in Japanese women.

  114. Reducing salt intake with umami: A secondary analysis of data in the UK National Diet and Nutrition Survey

    Haruyo Nakamura, Takayuki Kawashima, Lisa Yamasaki, Kaung Suu Lwin, Akifumi Eguchi, Hitomi Hayabuchi, Yuta Tanoe, Shiori Tanaka, Daisuke Yoneoka, Cyrus Ghaznavi, Hisayuki Uneyama, Kenji Shibuya, Shuhei Nomura

    Food Science & Nutrition 0 1-11 2022年11月12日

    出版者・発行元:

    DOI: 10.1002/fsn3.3121  

    ISSN:2048-7177

    eISSN:2048-7177

  115. Preventive Behaviors and Information Sources during COVID-19 Pandemic: A Cross-Sectional Study in Japan 国際誌 査読有り

    Manae Uchibori, Cyrus Ghaznavi, Michio Murakami, Akifumi Eguchi, Hiroyuki Kunishima, Satoshi Kaneko, Keiko Maruyama-Sakurai, Hiroaki Miyata, Shuhei Nomura

    International Journal of Environmental Research and Public Health 19 (21) 14511 2022年11月4日

    DOI: 10.3390/ijerph192114511  

  116. Estimated Global Proportions of Individuals With Persistent Fatigue, Cognitive, and Respiratory Symptom Clusters Following Symptomatic COVID-19 in 2020 and 2021 査読有り

    Sarah Wulf Hanson, Cristiana Abbafati, Joachim G. Aerts, Ziyad Al-Aly, Charlie Ashbaugh, Tala Ballouz, Oleg Blyuss, Polina Bobkova, Gouke Bonsel, Svetlana Borzakova, Danilo Buonsenso, Denis Butnaru, Austin Carter, Helen Chu, Cristina De Rose, Mohamed Mustafa Diab, Emil Ekbom, Maha El Tantawi, Victor Fomin, Robert Frithiof, Aysylu Gamirova, Petr V. Glybochko, Juanita A. Haagsma, Shaghayegh Haghjooy Javanmard, Erin B. Hamilton, Gabrielle Harris, Majanka H. Heijenbrok-Kal, Raimund Helbok, Merel E. Hellemons, David Hillus, Susanne M. Huijts, Michael Hultström, Waasila Jassat, Florian Kurth, Ing-Marie Larsson, Miklós Lipcsey, Chelsea Liu, Callan D. Loflin, Andrei Malinovschi, Wenhui Mao, Lyudmila Mazankova, Denise McCulloch, Dominik Menges, Noushin Mohammadifard, Daniel Munblit, Nikita A. Nekliudov, Osondu Ogbuoji, Ismail M. Osmanov, José L. Peñalvo, Maria Skaalum Petersen, Milo A. Puhan, Mujibur Rahman, Verena Rass, Nickolas Reinig, Gerard M. Ribbers, Antonia Ricchiuto, Sten Rubertsson, Elmira Samitova, Nizal Sarrafzadegan, Anastasia Shikhaleva, Kyle E. Simpson, Dario Sinatti, Joan B. Soriano, Ekaterina Spiridonova, Fridolin Steinbeis, Andrey A. Svistunov, Piero Valentini, Brittney J. van de Water, Rita van den Berg-Emons, Ewa Wallin, Martin Witzenrath, Yifan Wu, Hanzhang Xu, Thomas Zoller, Christopher Adolph, James Albright, Joanne O. Amlag, Aleksandr Y. Aravkin, Bree L. Bang-Jensen, Catherine Bisignano, Rachel Castellano, Emma Castro, Suman Chakrabarti, James K. Collins, Xiaochen Dai, Farah Daoud, Carolyn Dapper, Amanda Deen, Bruce B. Duncan, Megan Erickson, Samuel B. Ewald, Alize J. Ferrari, Abraham D. Flaxman, Nancy Fullman, Amiran Gamkrelidze, John R. Giles, Gaorui Guo, Simon I. Hay, Jiawei He, Monika Helak, Erin N. Hulland, Maia Kereselidze, Kris J. Krohn, Alice Lazzar-Atwood, Akiaja Lindstrom, Rafael Lozano, Deborah Carvalho Malta, Johan Månsson, Ana M. Mantilla Herrera, Ali H. Mokdad, Lorenzo Monasta, Shuhei Nomura, Maja Pasovic, David M. Pigott, Robert C. Reiner, Grace Reinke, Antonio Luiz P. Ribeiro, Damian Francesco Santomauro, Aleksei Sholokhov, Emma Elizabeth Spurlock, Rebecca Walcott, Ally Walker, Charles Shey Wiysonge, Peng Zheng, Janet Prvu Bettger, Christopher J. L. Murray, Theo Vos

    JAMA 2022年10月10日

    出版者・発行元: American Medical Association (AMA)

    DOI: 10.1001/jama.2022.18931  

    ISSN:0098-7484

    詳細を見る 詳細を閉じる

    Importance Some individuals experience persistent symptoms after initial symptomatic SARS-CoV-2 infection (often referred to as Long COVID). Objective To estimate the proportion of males and females with COVID-19, younger or older than 20 years of age, who had Long COVID symptoms in 2020 and 2021 and their Long COVID symptom duration. Design, Setting, and Participants Bayesian meta-regression and pooling of 54 studies and 2 medical record databases with data for 1.2 million individuals (from 22 countries) who had symptomatic SARS-CoV-2 infection. Of the 54 studies, 44 were published and 10 were collaborating cohorts (conducted in Austria, the Faroe Islands, Germany, Iran, Italy, the Netherlands, Russia, Sweden, Switzerland, and the US). The participant data were derived from the 44 published studies (10 501 hospitalized individuals and 42 891 nonhospitalized individuals), the 10 collaborating cohort studies (10 526 and 1906), and the 2 US electronic medical record databases (250 928 and 846 046). Data collection spanned March 2020 to January 2022. Exposures Symptomatic SARS-CoV-2 infection. Main Outcomes and Measures Proportion of individuals with at least 1 of the 3 self-reported Long COVID symptom clusters (persistent fatigue with bodily pain or mood swings; cognitive problems; or ongoing respiratory problems) 3 months after SARS-CoV-2 infection in 2020 and 2021, estimated separately for hospitalized and nonhospitalized individuals aged 20 years or older by sex and for both sexes of nonhospitalized individuals younger than 20 years of age. Results A total of 1.2 million individuals who had symptomatic SARS-CoV-2 infection were included (mean age, 4-66 years; males, 26%-88%). In the modeled estimates, 6.2% (95% uncertainty interval [UI], 2.4%-13.3%) of individuals who had symptomatic SARS-CoV-2 infection experienced at least 1 of the 3 Long COVID symptom clusters in 2020 and 2021, including 3.2% (95% UI, 0.6%-10.0%) for persistent fatigue with bodily pain or mood swings, 3.7% (95% UI, 0.9%-9.6%) for ongoing respiratory problems, and 2.2% (95% UI, 0.3%-7.6%) for cognitive problems after adjusting for health status before COVID-19, comprising an estimated 51.0% (95% UI, 16.9%-92.4%), 60.4% (95% UI, 18.9%-89.1%), and 35.4% (95% UI, 9.4%-75.1%), respectively, of Long COVID cases. The Long COVID symptom clusters were more common in women aged 20 years or older (10.6% [95% UI, 4.3%-22.2%]) 3 months after symptomatic SARS-CoV-2 infection than in men aged 20 years or older (5.4% [95% UI, 2.2%-11.7%]). Both sexes younger than 20 years of age were estimated to be affected in 2.8% (95% UI, 0.9%-7.0%) of symptomatic SARS-CoV-2 infections. The estimated mean Long COVID symptom cluster duration was 9.0 months (95% UI, 7.0-12.0 months) among hospitalized individuals and 4.0 months (95% UI, 3.6-4.6 months) among nonhospitalized individuals. Among individuals with Long COVID symptoms 3 months after symptomatic SARS-CoV-2 infection, an estimated 15.1% (95% UI, 10.3%-21.1%) continued to experience symptoms at 12 months. Conclusions and Relevance This study presents modeled estimates of the proportion of individuals with at least 1 of 3 self-reported Long COVID symptom clusters (persistent fatigue with bodily pain or mood swings; cognitive problems; or ongoing respiratory problems) 3 months after symptomatic SARS-CoV-2 infection.

  117. Effect of the Tokyo 2020 Summer Olympic Games on COVID-19 incidence in Japan: a synthetic control approach 国際誌 査読有り

    Daisuke Yoneoka, Akifumi Eguchi, Kentato Fukumoto, Takayuki Kawashima, Yuta Tanoue, Takahiro Tabuchi, Hiroaki Miyata, Cyrus Ghaznavi, Kenji Shibuya, Shuhei Nomura

    BMJ Open 12 (9) e061444 2022年9月21日

    DOI: 10.1136/bmjopen-2022-061444  

  118. Effect of the COVID-19 pandemic and state of emergency declarations on the relative incidence of legionellosis and invasive pneumococcal disease in Japan. 国際誌 査読有り

    Cyrus Ghaznavi, Masahiro Ishikane, Daisuke Yoneoka, Yuta Tanoue, Takayuki Kawashima, Akifumi Eguchi, Shuhei Nomura

    29 (1) 90-94 2022年9月16日

    出版者・発行元:

    DOI: 10.1016/j.jiac.2022.08.016  

    ISSN:1341-321X

  119. Myanmar’s coup risks a flood of vaccinepreventable disease 査読有り

    Lwin, K.S., Ghaznavi, C., Win, K.L., Gilmour, S., Hashizume, M., Nomura, S.

    Journal of Global Health 12 2022年9月3日

    出版者・発行元: International Global Health Society

    DOI: 10.7189/jogh.12.03060  

    ISSN:2047-2978 2047-2986

    eISSN:2047-2986

  120. Excess deaths from non-COVID-19-related causes in Japan and 47 prefectures from January 2020 through May 2021 by place of death 国際誌

    Shuhei Nomura, Akifumi Eguchi, Cyrus Ghaznavi, Yuta Tanoue, Takayuki Kawashima, Daisuke Yoneoka, Lisa Yamasaki, Motoi Suzuki, Masahiro Hashizume

    SSM - Population Health 19 101196-101196 2022年8月6日

    出版者・発行元: Elsevier BV

    DOI: 10.1016/j.ssmph.2022.101196  

    ISSN:2352-8273

    詳細を見る 詳細を閉じる

    Excess deaths, including all-causes mortality, were confirmed for the first time in Japan in April 2021. However, little is known about the indirect effects of COVID-19 on the number of non-COVID-19-related deaths. We then estimated the excess deaths from non-COVID-19-related causes in Japan and its 47 prefectures from January 2020 through May 2021 by place of death. Vital statistical data on deaths were obtained from the Ministry of Health, Labour and Welfare. Using quasi-Poisson regression models, we estimated the expected weekly number of deaths due to all-causes excluding COVID-19 (non-COVID-19) and due to respiratory disease, circulatory disease, malignant neoplasms, and senility. Estimates were made separately for deaths in all locations, as well as for deaths in hospitals and clinics, in nursing homes and elderly care facilities, and at home. We defined a week with excess deaths as one in which the observed number of deaths exceeded the upper bound of the two-sided 95% prediction interval. Excess death was expressed as a range of differences between the observed and expected number of deaths and the 95% upper bound of the two-sided predictive interval. The excess percentage was calculated as the number of excess deaths divided by the expected number of deaths. At the national level, excess deaths from non-COVID-19-related all-causes were observed during April 19 to May 16, 2021. The largest excess percentage was 2.73-8.58% (excess deaths 689-2161) in the week of May 3-9. Similar trends were observed for all four cause categories. The cause-of-death categories which contributed to the excesses showed heterogeneity among prefectures. When stratified by place of death, excess mortality tended to be observed in nursing homes and elderly care facilities for all categories, in hospitals and clinics for circulatory disease, and at home for respiratory disease, malignant neoplasms, and senility. A caution is necessary that for the lastest three months (March-May 2021), adjusted data were used to account for possible reporting delays.

  121. Eliciting national and subnational sets of disability weights in mainland China: Findings from the Chinese disability weight measurement study 査読有り

    Xiaoxue Liu, Fang Wang, Chuanhua Yu, Maigeng Zhou, Yong Yu, Jinlei Qi, Peng Yin, Shicheng Yu, Yuchang Zhou, Lin Lin, Yunning Liu, Qiqi Wang, Wenling Zhong, Shaofen Huang, Yanxia Li, Li Liu, Yuan Liu, Fang Ma, Yine Zhang, Yuan Tian, Qiuli Yu, Jing Zeng, Jingju Pan, Mengge Zhou, Weiwei Kang, Jin-Yi Zhou, Hao Yu, Yuehua Liu, Shaofang Li, Huiting Yu, Chunfang Wang, Tian Xia, Jinen Xi, Xiaolan Ren, Xiuya Xing, Qianyao Cheng, Fangrong Fei, Dezheng Wang, Shuang Zhang, Yuling He, Haoyu Wen, Yan Liu, Fang Shi, Yafeng Wang, Panglin Sun, Jianjun Bai, Xuyan Wang, Hui Shen, Yudiyang Ma, Donghui Yang, Sumaira Mubarik, Jinhong Cao, Runtang Meng, Yunquan Zhang, Yan Guo, Yaqiong Yan, Wei Zhang, Sisi Ke, Runhua Zhang, Dingyi Wang, Tingting Zhang, Shuhei Nomura, Simon I. Hay, Joshua A. Salomon, Juanita A. Haagsma, Christopher J.L. Murray, Theo Vos

    The Lancet Regional Health - Western Pacific 26 100520-100520 2022年7月26日

    出版者・発行元: Elsevier {BV}

    DOI: 10.1016/j.lanwpc.2022.100520  

    ISSN:2666-6065

  122. Distributed lag interrupted time series model for unclear intervention timing: efect of a statement of emergency during COVID-19 pandemic 国際誌

    Daisuke Yoneoka, Takayuki Kawashima, Yuta Tanoue, Shuhei Nomura, Akifumi Eguchi

    BMC Medical Research Methodology 22 (202) 202-202 2022年7月25日

    DOI: 10.1186/s12874-022-01662-1  

  123. Factors associated with reversals of COVID-19 vaccination willingness: Results from two longitudinal, national surveys in Japan 2021-2022 査読有り

    Cyrus Ghaznavi, Daisuke Yoneoka, Takayuki Kawashima, Akifumi Eguchi, Michio Murakami, Stuart Gilmour, Satoshi Kaneko, Hiroyuki Kunishima, Wataru Naito, Haruka Sakamoto, Keiko Maruyama-Sakurai, Arata Takahashi, Yoshihiro Takayama, Yuta Tanoue, Yoshiko Yamamoto, Tetsuo Yasutaka, Hiroaki Miyata, Shuhei Nomura

    The Lancet Regional Health - Western Pacific 100540-100540 2022年7月22日

    出版者・発行元:

    DOI: 10.1016/j.lanwpc.2022.100540  

    ISSN:2666-6065

  124. Characterising reasons for reversals of COVID-19 vaccination hesitancy among Japanese people: One-year follow-up survey 査読有り

    Shuhei Nomura, Akifumi Eguchi, Daisuke Yoneoka, Michio Murakami, Cyrus Ghaznavi, Stuart Gilmour, Satoshi Kaneko, Takayuki Kawashima, Hiroyuki Kunishima, Wataru Naito, Haruka Sakamoto, Keiko Maruyama-Sakurai, Arata Takahashi, Yoshihiro Takayama, Yuta Tanoue, Yoshiko Yamamoto, Tetsuo Yasutaka, Hiroaki Miyata

    The Lancet Regional Health - Western Pacific 100541-100541 2022年7月22日

    出版者・発行元:

    DOI: 10.1016/j.lanwpc.2022.100541  

    ISSN:2666-6065

  125. Changes in Health Care Access during the COVID-19 Pandemic: Estimates of National Japanese Data, June 2020–October 2021 国際誌

    Yuta Tanoue, Cyrus Ghaznavi, Takayuki Kawashima, Akifumi Eguchi, Daisuke Yoneoka, Shuhei Nomura

    International Journal of Environmental Research and Public Health 19 (14) 8810-8810 2022年7月20日

    出版者・発行元: MDPI AG

    DOI: 10.3390/ijerph19148810  

    eISSN:1660-4601

    詳細を見る 詳細を閉じる

    The COVID-19 pandemic has disrupted health care access around the world, both for inpatients and outpatients. We applied a quasi-Poisson regression to national, monthly data on the number of outpatients, number of inpatients, length of average hospital stay, and the number of new hospitalizations from March 2015 to October 2021 to assess how these outcomes changed between June 2020 to October 2021. The number of outpatient visits were lower-than-predicted during the early phases of the pandemic but normalized by the fall of 2021. The number of inpatients and new hospitalizations were lower-than-predicted throughout the pandemic, and deficits in reporting continued to be observed in late 2021. The length of hospital stays was within the predicted range for all beds, but when stratified by bed type, was higher than predicted for psychiatric beds, lower-than-predicted for tuberculosis beds, and showed variable changes in long-term care insurance beds. Health care access in Japan was impacted by the COVID-19 pandemic.

  126. Inter-Prefectural Travel and Network Connectedness During the COVID-19 Pandemic in Japan 査読有り

    Cyrus Ghaznavi, Daisuke Yoneoka, Yuta Tanoue, Stuart Gilmour, Takayuki Kawashima, Akifumi Eguchi, Yumi Kawamura, Hiroaki Miyata, Shuhei Nomura

    Journal of Epidemiology 32 (11) 510-518 2022年7月

    出版者・発行元: Japan Epidemiological Association

    DOI: 10.2188/jea.je20220064  

    ISSN:0917-5040

    eISSN:1349-9092

    詳細を見る 詳細を閉じる

    BackgroundIncreases in human mobility have been linked to rises in COVID-19 transmission. The pandemic era in Japan has been characterized by changes in inter-prefectural mobility across state of emergency declarations (SOE) and travel campaigns, but they have yet to be characterized.MethodsUsing Yahoo Japan mobility data extracted from the smartphones of more than 10 million Japanese residents, we calculated the monthly number of inter-prefectural travel instances, stratified by residential prefecture and destination prefecture. We then used this adjacency matrix to calculate two network connectedness metrics, closeness centrality and effective distance, that reliably predict disease transmission.ResultsInter-prefectural mobility and network connectedness decreased most considerably during the first SOE, but this decrease dampened with each successive SOE. Mobility and network connectedness increased during the Go To Travel campaign. Travel volume between distant prefectures decreased more than travel between prefectures with geographic proximity. Closeness centrality was found to be negatively correlated with the rate of COVID-19 infection across prefectures, with the strength of this association increasing in tandem with the infection rate. Changes in effective distance were more visible among geographically isolated prefectures (Hokkaido and Okinawa) than among metropolitan, central prefectures (Tokyo, Aichi, Osaka, and Fukuoka).ConclusionsThe magnitude of reductions in human mobility decreased with each subsequent state of emergency, consistent with pandemic fatigue. The association between network connectedness and rates of COVID-19 infection remained visible throughout the entirety of the pandemic period, suggesting that inter-prefectural mobility may have contributed to disease spread.

  127. Public transportation network scan for rapid surveillance

    Yuta Tanoue, Daisuke Yoneoka, Takayuki Kawashima, Shinya Uryu, Shuhei Nomura, Akifumi Eguchi, Koji Makiyama, Kentaro Matsuura

    Biostatistics & Epidemiology 1-15 2022年6月2日

    出版者・発行元: Informa UK Limited

    DOI: 10.1080/24709360.2022.2069458  

    ISSN:2470-9360

    eISSN:2470-9379

  128. Attributable risk of household solid fuel use and second-hand smoke associated with under-5 mortality in 46 low- and lower-middle-income countries, 2010–2020 国際誌 査読有り

    Kaung Suu Lwin, Shuhei Nomura, Khin Thet Swe, Stuart Gilmour, Md Ashraful Alam, Masahiro Hashizume

    International Journal of Hygiene and Environmental Health 243 113986-113986 2022年6月

    出版者・発行元: Elsevier BV

    DOI: 10.1016/j.ijheh.2022.113986  

    ISSN:1438-4639

    詳細を見る 詳細を閉じる

    BACKGROUND: Household solid fuel use (including indoor and outdoor) and second-hand smoke (SHS) are considered to be major contributors of under-5 mortality (U5M) in low- and lower-middle-income countries (LMICs). This study provides a comprehensive assessment of their odds ratios and attributable mortality in LMICs. METHODS: We used the Demographic Health Surveys data for under-5 children in 46 LMICs (n = 778,532) from 2010 to 2020. Mixed effect multilevel logistic regressions were conducted to estimate the pooled adjusted odds ratio (aOR) for U5M due to solid fuel use, SHS and their combination compared to no exposure to them in 46 LMICs. The attributable mortality of solid fuel use, SHS, and their combination were assessed for each LMIC. FINDINGS: The pooled aOR of solid fuel use and SHS for U5M was estimated to be 1.27 (95% Confidence Interval (CI): 1.19-1.36) and 1.13 (95%CI: 1.06-1.25), respectively, whereas those of their combination was 1.40 (95%CI: 1.31-1.50). U5M attributable to indoor and outdoor solid fuel use was the highest in Myanmar (18.0%) and the Gambia (16.5%), respectively, while those attributable to SHS was the highest in Indonesia (9.8%). U5M attributable to the combination of solid fuel use and SHS was the highest in Timor-Leste (22.7%). INTERPRETATION: The combined effect of exposure to solid fuel and SHS had a higher risk of U5M than the individual risk. The use of clean fuel and tobacco control measures should be integrated with other child health promotion policies. FUNDING: This research was partially supported by a research grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan (21H03203).

  129. Decreased incidence followed by comeback of pediatric infections during the COVID-19 pandemic in Japan 国際誌 査読有り

    Cyrus Ghaznavi, Haruka Sakamoto, Takayuki Kawashima, Sayaka Horiuchi, Masahiro Ishikane, Sarah Krull Abe, Daisuke Yoneoka, Akifumi Eguchi, Yuta Tanoue, Masahiro Hashizume, Shuhei Nomura

    World Journal of Pediatrics 18 (8) 564-567 2022年5月31日

    DOI: 10.1007/s12519-022-00575-9  

  130. Changes in marriage, divorce and births during the COVID-19 pandemic in Japan 国際誌 査読有り

    Cyrus Ghaznavi, Takayuki Kawashima, Yuta Tanoue, Daisuke Yoneoka, Koji Makiyama, Haruka Sakamoto, Peter Ueda, Akifumi Eguchi, Shuhei Nomura

    BMJ Global Health 7 (5) e007866 2022年5月16日

    DOI: 10.1136/bmjgh-2021-007866  

  131. Assessment of Traffic Accidents in Japan during the COVID-19 Pandemic vs. Previous Years: A Preliminary Report 査読有り

    Kazuki Shimizu, Peter Ueda, Cyrus Ghaznavi, Haruka Sakamoto, Shuhei Nomura

    Healthcare 10 (5) 860-860 2022年5月6日

    出版者・発行元: {MDPI} {AG}

    DOI: 10.3390/healthcare10050860  

    eISSN:2227-9032

    詳細を見る 詳細を閉じる

    Beginning in April 2020, social distancing measures were implemented to mitigate the COVID-19 pandemic in Japan. We assessed whether traffic accident rates had decreased from April 2020 to December 2021 as compared with previous years. The analysis included 2,934,477 traffic accidents, and the trend of decreasing rates of traffic accidents in recent years and seasonal fluctuations in traffic accidents were considered. The yearly change in the traffic accident rate between 2015 and 2019 was estimated, and the traffic accident rate in 2020 and 2021 was predicted. This was followed by the comparison of observed vs. predicted traffic accident rate. In 2020, the observed vs. expected rates of traffic accidents were lower in April to December 2020, and the rate of traffic accidents in Japan was 30–40% lower in April–May 2020 than would be expected based on trends from previous years. In 2021, rates of traffic accidents remained lower than expected between January and November, but the magnitude of decrease was not as pronounced. These findings could be explained by social distancing policies, including the declaration of the state of emergency, and the relaxation of public health and social measures over time.

  132. Pre- and post-COVID-19 all-cause mortality of Japanese citizens versus foreign residents living in Japan, 2015–2021 国際誌 査読有り

    Cyrus Ghaznavi, Akifumi Eguchi, Yuta Tanoue, Daisuke Yoneoka, Takayuki Kawashima, Motoi Suzuki, Masahiro Hashizume, Shuhei Nomura

    SSM - Population Health 18 101114-101114 2022年5月

    出版者・発行元: Elsevier BV

    DOI: 10.1016/j.ssmph.2022.101114  

    ISSN:2352-8273

    詳細を見る 詳細を閉じる

    Immigrants in Japan face multiple health care challenges. There is limited research addressing how all-cause mortality differs between foreign residents and Japanese citizens, including the impact of the COVID-19 pandemic. We assessed whether all-cause mortality rates between Japanese citizens and foreign residents living in Japan differ, and whether these differentials changed after the start of the COVID-19 pandemic. We conducted a cross-sectional analysis using vital statistical data of all deaths among citizens and foreign residents that occurred within Japanese borders aggregated every 6 months between January 1, 2015 and June 30, 2021. Data were used to calculate sex-, region-, and 20-year age group-specific standardized mortality rates using the direct method based on the population distribution of Japanese citizens in 2021 by sex, region, and 20-year age groups. Chi-squared tests and linear regression were used to assess whether the pandemic was associated with changes in mortality rates among groups and changes in the mortality differentials between citizens and non-citizens, respectively. All-cause mortality increased monotonically with age for men and women. Men had higher mortality than women, regardless of age or nationality. All-cause mortality is lower among immigrants than Japanese citizens between the ages of 20-59, but higher under the age of 20 and over the age of 59. The pandemic was associated with significant changes in mortality in most groups, but no statistically significant changes in the mortality differentials between immigrants and Japanese citizens were detected. Young immigrants are generally healthier than their Japanese counterparts, in line with the healthy migrant hypothesis. Younger migrants are at higher risk of mortality, possibly due to increased vulnerability to psychologic stress. Older migrant mortality converged with citizen mortality, consistent with acculturation that occurs with longer duration of residence. The pandemic did not exacerbate health inequities for foreign residents with respect to mortality.

  133. Japan's development assistance for health: Historical trends and prospects for a new era

    Shuhei Nomura, Lisa Yamasaki, Kazuki Shimizu, Cyrus Ghaznavi, Haruka Sakamoto

    The Lancet Regional Health - Western Pacific 22 100403-100403 2022年5月

    出版者・発行元: Elsevier BV

    DOI: 10.1016/j.lanwpc.2022.100403  

    ISSN:2666-6065

  134. Salaries, degrees, and babies: Trends in fertility by income and education among Japanese men and women born 1943–1975—Analysis of national surveys 国際誌 査読有り

    Cyrus Ghaznavi, Haruka Sakamoto, Lisa Yamasaki, Shuhei Nomura, Daisuke Yoneoka, Kenji Shibuya, Peter Ueda

    PLoS ONE 17 (4) e0266835 2022年4月28日

    DOI: 10.1371/journal.pone.0266835  

  135. Factors associated with the risk perception of COVID-19 infection and severe illness: A cross-sectional study in Japan 国際誌 査読有り

    Megumi Adachi, Michio Murakami, Daisuke Yoneoka, Takayuki Kawashima, Masahiro Hashizume, Haruka Sakamoto, Akifumi Eguchi, Cyrus Ghaznavi, Stuart Gilmour, Satoshi Kaneko, Hiroyuki Kunishima, Keiko Maruyama-Sakurai, Yuta Tanoue, Yoshiko Yamamoto, Hiroaki Miyata, Shuhei Nomura

    SSM - Population Health 18 101105-101105 2022年4月26日

    出版者・発行元: Elsevier BV

    DOI: 10.1016/j.ssmph.2022.101105  

    ISSN:2352-8273

    詳細を見る 詳細を閉じる

    Understanding COVID-19 risk perception may help inform public health messaging aimed at encouraging preventive measures and improving countermeasures against the pandemic. We conducted an online survey of 29,708 Japanese adults in February 2021 and estimated the associations between COVID-19 risk perception and a broad array of individual factors. Two logistic regressions were constructed to estimate factors associated with the risk perception of COVID-19 (defined as responding that one might become infected within the next 6 months), and of severe illness among those who responded that they might become infected (defined as responding that one would become severely ill). After adjusting for covariates, those with a higher perceived risk of the COVID-19 vaccine had higher odds of risk perception for both infection and severe illness. Interestingly, those with higher odds of risk perception of being infected were more likely to report obtaining their information from healthcare workers whereas those with lower odds were more likely to report obtaining their information from the Internet or the government; those with lower odds of risk perception of being severely ill were more likely to report obtaining their information from the Internet. The higher the trust level in the government as a COVID-19 information source, the lower the odds of both risk perception of being infected and becoming severely ill. The higher the trust levels in social networking services as a COVID-19 information source, the higher the odds of risk perception of becoming severely ill. Public health messaging should address the factors identified in our study.

  136. Recent changes in the reporting of STIs in Japan during the COVID-19 pandemic. 国際誌 査読有り

    Cyrus Ghaznavi, Yuta Tanoue, Takayuki Kawashima, Akifumi Eguchi, Daisuke Yoneoka, Haruka Sakamoto, Peter Ueda, Masahiro Ishikane, Naokatsu Ando, Yusuke Miyazato, Shuhei Nomura

    Sexually transmitted infections 99 (2) 124-127 2022年4月22日

    DOI: 10.1136/sextrans-2021-055378  

    詳細を見る 詳細を閉じる

    OBJECTIVES: The COVID-19 pandemic has had variable effects on the rates of STIs reported across the globe. This study sought to assess how the number of STI reports changed during the pandemic in Japan. METHODS: We used national infectious disease surveillance data from the National Institute of Infectious Diseases (Tokyo, Japan) for the period between January 2013 and December 2021. We compared reported rates of chlamydia, gonorrhoea, condyloma acuminata and genital herpes, as well as total notifications for HIV/AIDS and syphilis during the pandemic versus previous years in Japan. We used a quasi-Poisson regression to determine whether any given week or month between January 2018 and December 2021 had a significant excess or deficit of STIs. Notification values above or below the 95% upper and lower prediction thresholds were considered as statistically significant. The start of the pandemic was defined as January 2020. RESULTS: Chlamydia generally remained within predicted range during the pandemic period. Reporting of gonorrhoea was significantly higher than expected throughout early-to-mid 2021 but otherwise generally remained within predicted range prior to 2021. Condyloma, herpes and HIV/AIDS reporting were transiently significantly lower than expected throughout the pandemic period, but no significant periods of higher-than-expected reporting were detected. Syphilis showed widespread evidence of significantly lower-than-predicted reporting throughout 2020 but eventually reversed, showing significantly higher-than-predicted reporting in mid-to-late 2021. CONCLUSIONS: The COVID-19 pandemic was associated with variable changes in the reporting of STIs in Japan. Higher-than-predicted reporting was more likely to be observed in the later phases of the pandemic. These changes may have been attributable to pandemic-related changes in sexual behaviour and decreased STI clinic attendance and testing, but further research on the long-term impact of the pandemic on STIs is necessary.

  137. Estimating global, regional, and national daily and cumulative infections with SARS-CoV-2 through Nov 14, 2021: a statistical analysis 査読有り

    Ryan M Barber, Reed J D Sorensen, David M Pigott, Catherine Bisignano, Austin Carter, Joanne O Amlag, James K Collins, Cristiana Abbafati, Christopher Adolph, Adrien Allorant, Aleksandr Y Aravkin, Bree L Bang-Jensen, Emma Castro, Suman Chakrabarti, Rebecca M Cogen, Emily Combs, Haley Comfort, Kimberly Cooperrider, Xiaochen Dai, Farah Daoud, Amanda Deen, Lucas Earl, Megan Erickson, Samuel B Ewald, Alize J Ferrari, Abraham D Flaxman, Joseph Jon Frostad, Nancy Fullman, John R Giles, Gaorui Guo, Jiawei He, Monika Helak, Erin N Hulland, Bethany M Huntley, Alice Lazzar-Atwood, Kate E LeGrand, Stephen S Lim, Akiaja Lindstrom, Emily Linebarger, Rafael Lozano, Beatrice Magistro, Deborah Carvalho Malta, Johan Månsson, Ana M Mantilla Herrera, Ali H Mokdad, Lorenzo Monasta, Mohsen Naghavi, Shuhei Nomura, Christopher M Odell, Latera Tesfaye Olana, Samuel M Ostroff, Maja Pasovic, Spencer A Pease, Robert C Reiner Jr, Grace Reinke, Antonio Luiz P Ribeiro, Damian F Santomauro, Aleksei Sholokhov, Emma E Spurlock, Ruri Syailendrawati, Roman Topor-Madry, Anh Truc Vo, Theo Vos, Rebecca Walcott, Ally Walker, Kirsten E Wiens, Charles Shey Wiysonge, Nahom Alemseged Worku, Peng Zheng, Simon I Hay, Emmanuela Gakidou, Christopher J L Murray

    The Lancet 2022年4月

    出版者・発行元: Elsevier BV

    DOI: 10.1016/s0140-6736(22)00484-6  

    ISSN:0140-6736

  138. Toward a third term of Health Japan 21 – implications from the rise in non-communicable disease burden and highly preventable risk factors 査読有り

    Nomura, S., Sakamoto, H., Ghaznavi, C., Inoue, M.

    Lancet Regional Health Western Pacific 21 100377-100377 2022年4月

    出版者・発行元: Elsevier BV

    DOI: 10.1016/j.lanwpc.2021.100377  

    ISSN:2666-6065

  139. Long-Term Mental Health Support after Natural Hazard Events: A Report from an Online Survey among Experts in Japan 査読有り

    Kayano, R., Lin, M., Shinozaki, Y., Nomura, S., Kim, Y.

    International Journal of Environmental Research and Public Health 19 (5) 3022-3022 2022年3月4日

    出版者・発行元: {MDPI} {AG}

    DOI: 10.3390/ijerph19053022  

    ISSN:1661-7827 1660-4601

    eISSN:1660-4601

  140. Global, regional, and national burden of diseases and injuries for adults 70 years and older: systematic analysis for the Global Burden of Disease 2019 Study 査読有り

    GBD 2019 Ageing Collaborators

    BMJ 2022年3月

  141. Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020–21 査読有り

    Haidong Wang, Katherine R Paulson, Spencer A Pease, Stefanie Watson, Haley Comfort, Peng Zheng, Aleks, r Y Aravkin, Catherine Bisignano, Ryan M Barber, Tahiya Alam, John E Fuller, Erin A May, Darwin Phan Jones, Meghan E Frisch, Cristiana Abbafati, Christopher Adolph, Adrien Allorant, Joanne O Amlag, Bree Bang-Jensen, Gregory J Bertolacci, Sabina S Bloom, Austin Carter, Emma Castro, Suman Chakrabarti, Jhilik Chattopadhyay, Rebecca M Cogen, James K Collins, Kimberly Cooperrider, Xiaochen Dai, William James Dangel, Farah Daoud, Carolyn Dapper, Am, a Deen, Bruce B Duncan, Megan Erickson, Samuel B Ewald, Tatiana Fedosseeva, Alize J Ferrari, Joseph Jon Frostad, Nancy Fullman, John Gallagher, Amiran Gamkrelidze, Gaorui Guo, Jiawei He, Monika Helak, Nathaniel J Henry, Erin N Hull, Bethany M Huntley, Maia Kereselidze, Alice Lazzar-Atwood, Kate E LeGr, Akiaja Lindstrom, Emily Linebarger, Paulo A Lotufo, Rafael Lozano, Beatrice Magistro, Deborah Carvalho Malta, Johan M{\aa}nsson, Ana M Mantilla Herrera, Fatima Marinho, Alemnesh H Mirkuzie, Awoke Temesgen Misganaw, Lorenzo Monasta, Paulami Naik, Shuhei Nomura, Edward G O{\textquotesingle}Brien, James Kevin O{\textquotesingle}Halloran, Latera Tesfaye Olana, Samuel M Ostroff, Louise Penberthy, Robert C Reiner Jr, Grace Reinke, Antonio Luiz P Ribeiro, Damian Francesco Santomauro, Maria In{\^{e } }s Schmidt, David H Shaw, Brittney S Sheena, Aleksei Sholokhov, Natia Skhvitaridze, Reed J D Sorensen, Emma Elizabeth Spurlock, Ruri Syailendrawati, Roman Topor-Madry, Christopher E Troeger, Rebecca Walcott, Ally Walker, Charles Shey Wiysonge, Nahom Alemseged Worku, Bethany Zigler, David M Pigott, Mohsen Naghavi, Ali H Mokdad, Stephen S Lim, Simon I Hay, Emmanuela Gakidou, Christopher J L Murray

    The Lancet 2022年3月

    出版者・発行元: Elsevier {BV}

    DOI: 10.1016/s0140-6736(21)02796-3  

    ISSN:0140-6736

  142. Global warming and the Summer Olympic and Paralympic games: a perspective from the Tokyo 2020 Games 査読有り

    Yamasaki, L., Nomura, S.

    Environmental Health and Preventive Medicine 27 (1) 7-7 2022年3月

    出版者・発行元: Japanese Society for Hygiene

    DOI: 10.1265/ehpm.21-00024  

    ISSN:1342-078X 1347-4715

    eISSN:1347-4715

  143. Reduced mortality during the COVID-19 outbreak in Japan, 2020: a two-stage interrupted time-series design 国際誌

    Daisuke Onozuka, Yuta Tanoue, Shuhei Nomura, Takayuki Kawashima, Daisuke Yoneoka, Akifumi Eguchi, Chris Fook Sheng Ng, Kentaro Matsuura, Shoi Shi, Koji Makiyama, Shinya Uryu, Yumi Kawamura, Shinichi Takayanagi, Stuart Gilmour, Takehiko I Hayashi, Hiroaki Miyata, Francesco Sera, Tomimasa Sunagawa, Takuri Takahashi, Yuuki Tsuchihashi, Yusuke Kobayashi, Yuzo Arima, Kazuhiko Kanou, Motoi Suzuki, Masahiro Hashizume

    International Journal of Epidemiology 51 (1) 75-84 2022年2月18日

    出版者・発行元: Oxford University Press (OUP)

    DOI: 10.1093/ije/dyab216  

    ISSN:0300-5771

    eISSN:1464-3685

    詳細を見る 詳細を閉じる

    <title>Abstract</title> <sec> <title>Background</title> Coronavirus disease 2019 (COVID-19) continues to be a major global health burden. This study aims to estimate the all-cause excess mortality occurring in the COVID-19 outbreak in Japan, 2020, by sex and age group. </sec> <sec> <title>Methods</title> Daily time series of mortality for the period January 2015–December 2020 in all 47 prefectures of Japan were obtained from the Ministry of Health, Labour and Welfare, Japan. A two-stage interrupted time-series design was used to calculate excess mortality. In the first stage, we estimated excess mortality by prefecture using quasi-Poisson regression models in combination with distributed lag non-linear models, adjusting for seasonal and long-term variations, weather conditions and influenza activity. In the second stage, we used a random-effects multivariate meta-analysis to synthesize prefecture-specific estimates at the nationwide level. </sec> <sec> <title>Results</title> In 2020, we estimated an all-cause excess mortality of −20 982 deaths [95% empirical confidence intervals (eCI): −38 367 to −5472] in Japan, which corresponded to a percentage excess of −1.7% (95% eCI: −3.1 to −0.5) relative to the expected value. Reduced deaths were observed for both sexes and in all age groups except those aged &amp;lt;60 and 70–79 years. </sec> <sec> <title>Conclusions</title> All-cause mortality during the COVID-19 outbreak in Japan in 2020 was decreased compared with a historical baseline. Further evaluation of cause-specific excess mortality is warranted. </sec>

  144. Variation in the COVID-19 infection–fatality ratio by age, time, and geography during the pre-vaccine era: a systematic analysis 査読有り

    Reed J D Sorensen, Ryan M Barber, David M Pigott, Austin Carter, Cory N Spencer, Samuel M Ostroff, Robert C Reiner Jr, Cristiana Abbafati, Christopher Adolph, Adrien Allorant, Joanne O Amlag, Aleksandr Y Aravkin, Steven D Bachmeier, Bree L Bang-Jensen, Catherine Bisignano, Sabina S Bloom, Rachel Castellano, Emma Castro, James K Collins, Haley Comfort, Xiaochen Dai, William James Dangel, Carolyn Dapper, Amanda Deen, Lucas Earl, Megan Erickson, Samuel B Ewald, Alize J Ferrari, Abraham D Flaxman, Joseph Jon Frostad, Nancy Fullman, Amiran Gamkrelidze, John R Giles, Gaorui Guo, Jiawei He, Monika Helak, Erin N Hulland, Bethany M Huntley, Maia Kereselidze, Alice Lazzar-Atwood, Kate E LeGrand, Akiaja Lindstrom, Emily Linebarger, Rafael Lozano, Beatrice Magistro, Deborah Carvalho Malta, Johan Månsson, Ana M Mantilla Herrera, Fatima Marinho, Alemnesh H Mirkuzie, Ali H Mokdad, Lorenzo Monasta, Mohsen Naghavi, Hasan Nassereldine, Shuhei Nomura, Christopher M Odell, Latera Tesfaye Olana, Maja Pasovic, Spencer A Pease, Louise Penberthy, Grace Reinke, Antonio Luiz, P Ribeiro, Damian Francesco Santomauro, Aleksei Sholokhov, Natia Skhvitaridze, Emma Elizabeth Spurlock, Ruri Syailendrawati, Roman Topor-Madry, Anh Truc Vo, Theo Vos, Rebecca Walcott, Ally Walker, Stefanie Watson, Charles Shey Wiysonge, Nahom Alemseged Worku, Peng Zheng, Simon I Hay, Emmanuela Gakidou, Christopher J L Murray

    The Lancet 2022年2月

    出版者・発行元:

    DOI: 10.1016/s0140-6736(21)02867-1  

    ISSN:0140-6736

  145. Fish in the sea: Number, characteristics, and partner preferences of unmarried Japanese adults - analysis of a national survey 国際誌 査読有り

    Cyrus Ghaznavi, Haruka Sakamoto, Shuhei Nomura, Anna Kubota, Daisuke Yoneoka, Kenji Shibuya, Peter Ueda

    Plos One 17 (2) e0262528 2022年2月

    DOI: 10.1371/journal.pone.0262528  

  146. Pandemic preparedness and COVID-19: an exploratory analysis of infection and fatality rates, and contextual factors associated with preparedness in 177 countries, from Jan 1, 2020, to Sept 30, 2021 査読有り

    Thomas J Bollyky, Erin N Hull, Ryan M Barber, James K Collins, Samantha Kiernan, Mark Moses, David M Pigott, Robert C Reiner Jr, Reed J D Sorensen, Cristiana Abbafati, Christopher Adolph, Adrien Allorant, Joanne O Amlag, Aleks, r Y Aravkin, Bree Bang-Jensen, Austin Carter, Rachel Castellano, Emma Castro, Suman Chakrabarti, Emily Combs, Xiaochen Dai, William James Dangel, Carolyn Dapper, Am, a Deen, Bruce B Duncan, Lucas Earl, Megan Erickson, Samuel B Ewald, Tatiana Fedosseeva, Alize J Ferrari, Abraham D Flaxman, Nancy Fullman, Emmanuela Gakidou, Bayan Galal, John Gallagher, John R Giles, Gaorui Guo, Jiawei He, Monika Helak, Bethany M Huntley, Bulat Idrisov, Casey Johanns, Kate E LeGr, Ian D Letourneau, Akiaja Lindstrom, Emily Linebarger, Paulo A Lotufo, Rafael Lozano, Beatrice Magistro, Deborah Carvalho Malta, Johan M{\aa}nsson, Ana M Mantilla Herrera, Fatima Marinho, Alemnesh H Mirkuzie, Ali H Mokdad, Lorenzo Monasta, Paulami Naik, Shuhei Nomura, James Kevin O{\textquotesingle}Halloran, Christopher M Odell, Latera Tesfaye Olana, Samuel M Ostroff, Maja Pasovic, Valeria Maria de Azeredo Passos, Louise Penberthy, Grace Reinke, Damian Francesco Santomauro, Maria In{\^{e } }s Schmidt, Aleksei Sholokhov, Emma Spurlock, Christopher E Troeger, Elena Varavikova, Anh T Vo, Theo Vos, Rebecca Walcott, Ally Walker, Simon D Wigley, Charles Shey Wiysonge, Nahom Alemseged Worku, Yifan Wu, Sarah Wulf Hanson, Peng Zheng, Simon I Hay, Christopher J L Murray, Joseph L Dieleman

    The Lancet 2022年2月1日

    出版者・発行元: Elsevier {BV}

    DOI: 10.1016/s0140-6736(22)00172-6  

    ISSN:0140-6736

  147. Excess deaths from COVID-19 in Japan and 47 prefectures from January through June 2021

    Nomura, S., Eguchi, A., Tanoue, Y., Yoneoka, D., Kawashima, T., Suzuki, M., Hashizume, M.

    Public Health 203 15-18 2022年2月

    出版者・発行元: Elsevier BV

    DOI: 10.1016/j.puhe.2021.11.023  

    ISSN:0033-3506 1476-5616

  148. Reasons for Suicide During the COVID-19 Pandemic in Japan 国際誌 査読有り

    Masahide Koda, Nahoko Harada, Akifumi Eguchi, Shuhei Nomura, Yasushi Ishida

    JAMA Network Open 5 (1) e2145870-e2145870 2022年1月31日

    出版者・発行元: American Medical Association (AMA)

    DOI: 10.1001/jamanetworkopen.2021.45870  

    eISSN:2574-3805

    詳細を見る 詳細を閉じる

    Importance: Although the suicide rate in Japan increased during the COVID-19 pandemic, the reasons for suicide have yet to be comprehensively investigated. Objective: To assess which reasons for suicide had rates that exceeded the expected number of suicide deaths for that reason during the COVID-19 pandemic. Design, Setting, and Participants: This national, population-based cross-sectional study of data on suicides gathered by the Ministry of Health, Labor, and Welfare from January 2020 to May 2021 used a times-series analysis on the numbers of reason-identified suicides. Data of decedents were recorded by the National Police Agency and compiled by the Ministry of Health, Labor, and Welfare. Exposure: For category analysis, we compared data from January 2020 to May 2021 with data from December 2014 to June 2020. For subcategory analysis, data from January 2020 to May 2021 were compared with data from January 2019 to June 2020. Main Outcomes and Measures: The main outcome was the monthly excess suicide rate, ie, the difference between the observed number of monthly suicide deaths and the upper bound of the 1-sided 95% CI for the expected number of suicide deaths in that month. Reasons for suicide were categorized into family, health, economy, work, relationships, school, and others, which were further divided into 52 subcategories. A quasi-Poisson regression model was used to estimate the expected number of monthly suicides. Individual regression models were used for each of the 7 categories, 52 subcategories, men, women, and both genders. Results: From the 29 938 suicides (9984 [33.3%] women; 1093 [3.7%] aged <20 years; 3147 [10.5%] aged >80 years), there were 21 027 reason-identified suicides (7415 [35.3%] women). For both genders, all categories indicated monthly excess suicide rates, except for school in men. October 2020 had the highest excess suicide rates for all cases (observed, 1577; upper bound of 95% CI for expected number of suicides, 1254; 25.8% greater). In men, the highest monthly excess suicide rate was 24.3% for the other category in August 2020 (observed, 87; upper bound of 95% CI for expected number, 70); in women, it was 85.7% for school in August 2020 (observed, 26; upper bound of 95% CI for expected number, 14). Conclusions and Relevance: In this study, observed suicides corresponding to all 7 categories of reasons exceeded the monthly estimates (based on data from before or during the COVID-19 pandemic), except for school-related reasons in men. This study can be used as a basis for developing intervention programs for suicide prevention.

  149. Identification of optimum combinations of media channels for approaching COVID-19 vaccine unsure and unwilling groups in Japan 国際誌 査読有り

    Daisuke Yoneoka, Akifumi Eguchi, Shuhei Nomura, Takayuki Kawashima, Yuta Tanoue, Michio Murakami, Haruka Sakamoto, Keiko Maruyama-Sakurai, Stuart Gilmour, Shoi Shi, Hiroyuki Kunishima, Satoshi Kaneko, Megumi Adachi, Koki Shimada, Yoshiko Yamamoto, Hiroaki Miyata

    The Lancet Regional Health - Western Pacific 18 100330-100330 2022年1月

    出版者・発行元: Elsevier BV

    DOI: 10.1016/j.lanwpc.2021.100330  

    ISSN:2666-6065

    詳細を見る 詳細を閉じる

    BACKGROUND: Optimizing media campaigns for those who were unsure or unwilling to take coronavirus disease (COVID-19) vaccines is required urgently to effectively present public health messages aimed at increasing vaccination coverage. We propose a novel framework for selecting tailor-made media channels and their combinations for this task. METHODS: An online survey was conducted in Japan during February to March, 2021, with 30,053 participants. In addition to their sociodemographic characteristics, it asked the attitude toward vaccination and information sources (i.e., media channels) for COVID-19 issues. Multinomial logic regression was fitted to estimate the combinations of the media channels and their odds ratio (OR) associated with vaccination attitudes. FINDINGS: The proportion of respondents who were unsure or unwilling to take the vaccination was skewed toward younger generation: 58.1% were aged under 35, while 28.1% were 65 years or older. Media channels such as "Non-medical and Non-TV" and "Non-medical and Non-government" were associated with the unsure group: OR (95% Confidence intervals, (CI)) = 1.75 (1.62, 1.89) and 1.53 (1.44, 1.62), respectively. In addition, media channels such as "Newspapers or the Novel Coronavirus Expert Meeting", "Medical or Local government", and "Non-TV" were associated with the unwilling group: OR (95% CI) were 2.00 (1.47, 2.75), 3.13 (2.58, 3.81), and 2.25 (1.84, 2.77), respectively. INTERPRETATION: To effectively approach COVID-19 vaccine unsure and unwilling groups, generation-specific online and offline media campaigns should be optimized to the type of vaccine attitude. FUNDING: Funded by the Ministry of Health, Labour and Welfare of Japan (H29-Gantaisaku-ippan-009) and the Japan Agency for Medical Research and Development (AMED) (JP20fk0108535).

  150. A prospective evaluation of AI-augmented epidemiology to forecast COVID-19 in the USA and Japan 国際誌 査読有り

    Sercan Ö. Arık, Joel Shor, Rajarishi Sinha, Jinsung Yoon, Joseph R. Ledsam, Long T. Le, Michael W. Dusenberry, Nathanael C. Yoder, Kris Popendorf, Arkady Epshteyn, Johan Euphrosine, Elli Kanal, Isaac Jones, Chun-Liang Li, Beth Luan, Joe Mckenna, Vikas Menon, Shashank Singh, Mimi Sun, Ashwin Sura Ravi, Leyou Zhang, Dario Sava, Kane Cunningham, Hiroki Kayama, Thomas Tsai, Daisuke Yoneoka, Shuhei Nomura, Hiroaki Miyata, Tomas Pfister

    npj Digital Medicine 4 (1) 146-146 2021年12月

    出版者・発行元: Springer Science and Business Media LLC

    DOI: 10.1038/s41746-021-00511-7  

    eISSN:2398-6352

    詳細を見る 詳細を閉じる

    <title>Abstract</title>The COVID-19 pandemic has highlighted the global need for reliable models of disease spread. We propose an AI-augmented forecast modeling framework that provides daily predictions of the expected number of confirmed COVID-19 deaths, cases, and hospitalizations during the following 4 weeks. We present an international, prospective evaluation of our models’ performance across all states and counties in the USA and prefectures in Japan. Nationally, incident mean absolute percentage error (MAPE) for predicting COVID-19 associated deaths during prospective deployment remained consistently &lt;8% (US) and &lt;29% (Japan), while cumulative MAPE remained &lt;2% (US) and &lt;10% (Japan). We show that our models perform well even during periods of considerable change in population behavior, and are robust to demographic differences across different geographic locations. We further demonstrate that our framework provides meaningful explanatory insights with the models accurately adapting to local and national policy interventions. Our framework enables counterfactual simulations, which indicate continuing Non-Pharmaceutical Interventions alongside vaccinations is essential for faster recovery from the pandemic, delaying the application of interventions has a detrimental effect, and allow exploration of the consequences of different vaccination strategies. The COVID-19 pandemic remains a global emergency. In the face of substantial challenges ahead, the approach presented here has the potential to inform critical decisions.

  151. Alcohol intake and stomach cancer risk in Japan: A pooled analysis of six cohort studies

    Takashi Tamura, Kenji Wakai, Yingsong Lin, Akiko Tamakoshi, Mai Utada, Kotaro Ozasa, Yumi Sugawara, Ichiro Tsuji, Ayami Ono, Norie Sawada, Shoichiro Tsugane, Hidemi Ito, Chisato Nagata, Tetsuhisa Kitamura, Mariko Naito, Keitaro Tanaka, Taichi Shimazu, Tetsuya Mizoue, Keitaro Matsuo, Manami Inoue, Sarah K. Abe, Motoki Iwasaki, Michihiro Muto, Eiko Saito, Shiori Tanaka, Taiki Yamaji, Hadrien Charvat, Tetsuya Otani, Shizuka Sasazuki, Yoshikazu Nishino, Yoshitaka Tsubono, Shuhei Nomura, Hidekazu Suzuki, Isao Oze, Keiko Wada, Yuri Kitamura, Tomio Nakayama, Atsuko Sadakane

    Cancer Science 113 (1) 261-276 2021年11月28日

    出版者・発行元: Wiley

    DOI: 10.1111/cas.15172  

    ISSN:1347-9032

    eISSN:1349-7006

  152. Age-appropriate vaccination coverage and its determinants in children aged 12–36 months in Nepal: a national and subnational assessment 国際誌 査読有り

    Santosh Kumar Rauniyar, Yoko Iwaki, Daisuke Yoneoka, Masahiro Hashizume, Shuhei Nomura

    BMC Public Health 21 (1) 2063-2063 2021年11月

    出版者・発行元: Springer Science and Business Media LLC

    DOI: 10.1186/s12889-021-11841-2  

    eISSN:1471-2458

    詳細を見る 詳細を閉じる

    <title>Abstract</title><sec> <title>Background</title> Vaccination is one of the effective ways to develop immunity against potential life-threatening diseases in children in early age. This study is focused on analysing the age-appropriate vaccination coverage at national and subnational levels and identify the factors associated with age-appropriate coverage in Nepal. </sec><sec> <title>Methods</title> 460 children aged 12–36 months were included in the study. The data was obtained from Nepal Demographic and Health Survey (NDHS) 2016–17. Age-appropriate coverage of Bacillus Calmette-Guerin vaccine (BCG), oral polio vaccine (OPV) doses 1–3, pentavalent vaccine (PE) doses 1–3, and first dose of measles, mumps, and rubella vaccine (MMR) were estimated using Kaplan Meier method. Multilevel logistic regression with random intercept was used to identify the factors associated with age-appropriate vaccination. </sec><sec> <title>Results</title> The crude coverage of the vaccines included in the study ranged from 91.5% (95% CI, 88.5–93.7) for PE3 to 97.8% (95.8–98.7) for BCG. Although the crude coverage of all the vaccines was above 90%, the age-appropriate coverage was significantly low, ranging from 41.5% (36.5–46.6) for PE3 to 73.9% (69.2–78.1) for PE1. Furthermore, high disparity in timely vaccination coverage was observed at regional level. Compared to the age-appropriate vaccination coverage in other provinces, Province 2 had the lowest coverage of all, followed by that in Province 6. The timeliness of vaccination was significantly associated with subnational regions i.e., provinces and the season of childbirth. </sec><sec> <title>Conclusion</title> Although the immunization program in Nepal has achieved the target of 90% crude coverage of all the childhood vaccines, the age-appropriate coverage is significantly low which undermines the effectiveness of the vaccines administered. Thus, along with crude coverage, timeliness of the vaccines administered should be taken into consideration and thoroughly monitored at national and subnational levels. Provincial government should formulate tailored strategies to ensure the timely administration of the childhood vaccines. </sec>

  153. Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic

    Santomauro, D.F., Mantilla Herrera, A.M., Shadid, J., Zheng, P., Ashbaugh, C., Pigott, D.M., Abbafati, C., Adolph, C., Amlag, J.O., Aravkin, A.Y., Bang-Jensen, B.L., Bertolacci, G.J., Bloom, S.S., Castellano, R., Castro, E., Chakrabarti, S., Chattopadhyay, J., Cogen, R.M., Collins, J.K., Dai, X., Dangel, W.J., Dapper, C., Deen, A., Erickson, M., Ewald, S.B., Flaxman, A.D., Frostad, J.J., Fullman, N., Giles, J.R., Giref, A.Z., Guo, G., He, J., Helak, M., Hulland, E.N., Idrisov, B., L, rom, A., Linebarger, E., Lotufo, P.A., Lozano, R., Magistro, B., Malta, D.C., M?nsson, J.C., Marinho, F., Mokdad, A.H., Monasta, L., Naik, P., Nomura, S., O{'}Halloran, J.K., Ostroff, S.M., Pasovic, M., Penberthy, L., Reiner Jr, R.C., Reinke, G., Ribeiro, A.L.P., Sholokhov, A., Sorensen, R.J.D., Varavikova, E., Vo, A.T., Walcott, R., Watson, S., Wiysonge, C.S., Zigler, B., Hay, S.I., Vos, T., Murray, C.J.L., Whiteford, H.A., Ferrari, A.J.

    Lancet 398 (10312) 1700-1712 2021年11月

    出版者・発行元: Elsevier BV

    DOI: 10.1016/S0140-6736(21)02143-7  

    ISSN:0140-6736 1474-547X

  154. Salt intake reduction using umami substance-incorporated food in the United States

    Shuhei Nomura, Shiori Tanaka, Akifumi Eguchi, Takayuki Kawashima, Daisuke Yoneoka, Yuta Tanoe, Megumi Adachi, Hitomi Hayabuchi, Shosei Koganemaru, Toshihide Nishimura, Byron Sigel, Hisayuki Uneyama, Kenji Shibuya

    2021年10月19日

    DOI: 10.21203/rs.3.rs-966864/v1  

  155. Global, regional, and national mortality among young people aged 10–24 years, 1950–2019: a systematic analysis for the Global Burden of Disease Study 2019 査読有り

    GBD 2019 Adolescent Mortality Collaborators

    The Lancet 398 (10311) 1593-1618 2021年10月

    出版者・発行元: Elsevier BV

    DOI: 10.1016/s0140-6736(21)01546-4  

    ISSN:0140-6736

    eISSN:1474-547X

  156. Analysis of the relationship between the HbA1c screening results and the development and worsening of diabetes among adults aged over 40 years: a 4-year follow-up study of 140,000 people in Japan – the Shizuoka study 国際誌 査読有り

    Shuhei Nomura, Haruka Sakamoto, Santosh Kumar Rauniyar, Koki Shimada, Hiroyuki Yamamoto, Shun Kohsaka, Nao Ichihara, Hiraku Kumamaru, Hiroaki Miyata

    BMC Public Health 21 (1) 1880-1880 2021年10月

    出版者・発行元: Springer Science and Business Media LLC

    DOI: 10.1186/s12889-021-11933-z  

    eISSN:1471-2458

    詳細を見る 詳細を閉じる

    <title>Abstract</title><sec> <title>Background</title> Hemoglobin A1c (HbA1c) levels are routinely measured during health check-ups and are used as an indicator of glycemic control in Japan. However, only a few studies have followed up individuals to assess the risk of diabetes development and worsening based on HbA1c screening results. This study evaluated the relationship between HbA1c screening results and the risk of diabetes development and worsening. </sec><sec> <title>Methods</title> Data were collected from the Shizuoka Kokuho Database, a Japanese administrative claims database of insured individuals aged &gt; 40 years. We included individuals available for follow-up from April 2012 to March 2018 who had not received any diabetes treatment before March 2014. HbA1c screening results were categorized into 4 groups based on the HbA1c levels at the 2012 and 2013 health check-ups: group A, those whose HbA1c levels were &lt; 6.5% in 2012 and 2013; group B, those whose HbA1c levels &gt; 6.5% in 2012 but &lt; 6.5% in 2013; group C, those whose HbA1c levels were &gt; 6.5% in 2012 and 2013; and group D, those whose HbA1c levels were &lt; 6.5% in 2012 and &gt; 6.5% in 2013. Logistic regression models were used to analyze diabetes development and worsening, defined as the initiation of diabetes treatment by March 2018 and the use of injection drugs by participants who initiated diabetes treatment by March 2018. </sec><sec> <title>Results</title> Overall, 137,852 individuals were analyzed. After adjusting for covariates, compared with group A, group B was more likely to initiate treatment within 4 years (odds ratio: 22.64; 95% confidence interval: 14.66–34.99). In patients who initiated diabetes treatment by March 2018, injection drugs were less likely used by group D than by group A (odds ratio: 0.28; 95% confidence interval: 0.12–0.61). </sec><sec> <title>Conclusions</title> Our study suggests that although HbA1c levels measured during health check-ups were correlated with the risk of diabetes development and worsening, HbA1c levels in a single year may not necessarily provide sufficient information to consider these future risks. </sec>

  157. Tracking development assistance for health and for COVID-19: a review of development assistance, government, out-of-pocket, and other private spending on health for 204 countries and territories, 1990–2050

    Angela E Micah, Ian E Cogswell, Brandon Cunningham, Satoshi Ezoe, Anton C Harle, Emilie R Maddison, Darrah McCracken, Shuhei Nomura, Kyle E Simpson, Hayley N Stutzman, Golsum Tsakalos, Lindsey E Wallace, Yingxi Zhao, Rahul R Zende, Cristiana Abbafati, Michael Abdelmasseh, Aidin Abedi, Kedir Hussein Abegaz, E S Abhilash, Hassan Abolhassani, Michael R M Abrigo, Tara Ballav Adhikari, Saira Afzal, Bright Opoku Ahinkorah, Sepideh Ahmadi, Haroon Ahmed, Muktar Beshir Ahmed, Tarik Ahmed Rashid, Marjan Ajami, Budi Aji, Yonas Akalu, Chisom Joyqueenet Akunna, Hanadi Al Hamad, Khurshid Alam, Fahad Mashhour Alanezi, Turki M Alanzi, Yosef Alemayehu, Robert Kaba Alhassan, Cyrus Alinia, Syed Mohamed Aljunid, Sami Almustanyir Almustanyir, Nelson Alvis-Guzman, Nelson J Alvis-Zakzuk, Saeed Amini, Mostafa Amini-Rarani, Hubert Amu, Robert Ancuceanu, Catalina Liliana Andrei, Tudorel Andrei, Blake Angell, Mina Anjomshoa, Carl Abelardo T Antonio, Catherine M Antony, Muhammad Aqeel, Jalal Arabloo, Morteza Arab-Zozani, Timur Aripov, Alessandro Arrigo, Tahira Ashraf, Desta Debalkie Atnafu, Marcel Ausloos, Leticia Avila-Burgos, Asma Tahir Awan, Getinet Ayano, Martin Amogre Ayanore, Samad Azari, Gulrez Shah Azhar, Tesleem Kayode Babalola, Mohammad Amin Bahrami, Atif Amin Baig, Maciej Banach, Nastaran Barati, Till Winfried Bärnighausen, Amadou Barrow, Sanjay Basu, Bernhard T Baune, Mohsen Bayati, Habib Benzian, Adam E Berman, Akshaya Srikanth Bhagavathula, Nikha Bhardwaj, Pankaj Bhardwaj, Sonu Bhaskar, Sadia Bibi, Ali Bijani, Virginia Bodolica, Nicola Luigi Bragazzi, Dejana Braithwaite, Nicholas J K Breitborde, Alexey V Breusov, Nikolay Ivanovich Briko, Reinhard Busse, Lucero Cahuana-Hurtado, Emily Joy Callander, Luis Alberto Cámera, Carlos A Castañeda-Orjuela, Ferrán Catalá-López, Jaykaran Charan, Souranshu Chatterjee, Soosanna Kumary Chattu, Vijay Kumar Chattu, Simiao Chen, Arrigo Francesco Giuseppe Cicero, Omid Dadras, Saad M A Dahlawi, Xiaochen Dai, Koustuv Dalal, Lalit Dandona, Rakhi Dandona, Dragos Virgil Davitoiu, Jan-Walter De Neve, Antonio Reis de Sá-Junior, Edgar Denova-Gutiérrez, Deepak Dhamnetiya, Samath Dhamminda Dharmaratne, Leila Doshmangir, John Dube, Elham Ehsani-Chimeh, Maysaa El Sayed Zaki, Maha El Tantawi, Sharareh Eskandarieh, Farshad Farzadfar, Tomas Y Ferede, Florian Fischer, Nataliya A Foigt, Alberto Freitas, Sara D Friedman, Takeshi Fukumoto, Nancy Fullman, Peter Andras Gaal, Mohamed M Gad, MA Garcia-Gordillo, Tushar Garg, Mansour Ghafourifard, Ahmad Ghashghaee, Asadollah Gholamian, Ali Gholamrezanezhad, Ghozali Ghozali, Syed Amir Gilani, Ionela-Roxana Glăvan, Ekaterina Vladimirovna Glushkova, Salime Goharinezhad, Mahaveer Golechha, Srinivas Goli, Avirup Guha, Veer Bala Gupta, Vivek Kumar Gupta, Annie Haakenstad, Mohammad Rifat Haider, Alemayehu Hailu, Samer Hamidi, Asif Hanif, Harapan Harapan, Risky Kusuma Hartono, Ahmed I Hasaballah, Shoaib Hassan, Mohamed H Hassanein, Khezar Hayat, Mohamed I Hegazy, Golnaz Heidari, Delia Hendrie, Ileana Heredia-Pi, Claudiu Herteliu, Kamal Hezam, Ramesh Holla, Sheikh Jamal Hossain, Mehdi Hosseinzadeh, Sorin Hostiuc, Tanvir M Huda, Bing-Fang Hwang, Ivo Iavicoli, Bulat Idrisov, Olayinka Stephen Ilesanmi, Seyed Sina Naghibi Irvani, Sheikh Mohammed Shariful Islam, Nahlah Elkudssiah Ismail, Gaetano Isola, Mohammad Ali Jahani, Nader Jahanmehr, Mihajlo Jakovljevic, Manthan Dilipkumar Janodia, Tahereh Javaheri, Sathish Kumar Jayapal, Ranil Jayawardena, Seyed Behzad Jazayeri, Ravi Prakash Jha, Jost B Jonas, Tamas Joo, Farahnaz Joukar, Mikk Jürisson, Billingsley Kaambwa, Rohollah Kalhor, Tanuj Kanchan, Himal Kandel, Behzad Karami Matin, Salah Eddin Karimi, Getinet Kassahun, Gbenga A Kayode, Ali Kazemi Karyani, Leila Keikavoosi-Arani, Yousef Saleh Khader, Himanshu Khajuria, Rovshan Khalilov, Mohammad Khammarnia, Junaid Khan, Jagdish Khubchandani, Neda Kianipour, Gyu Ri Kim, Yun Jin Kim, Adnan Kisa, Sezer Kisa, Stefan Kohler, Soewarta Kosen, Rajasekaran Koteeswaran, Sindhura Lakshmi Koulmane Laxminarayana, Ai Koyanagi, Kewal Krishan, G Anil Kumar, Dian Kusuma, Demetris Lamnisos, Van Charles Lansingh, Anders O Larsson, Savita Lasrado, Long Khanh Dao Le, Shaun Wen Huey Lee, Yeong Yeh Lee, Stephen S Lim, Stany W Lobo, Rafael Lozano, Hassan Magdy Abd El Razek, Muhammed Magdy Abd El Razek, Mokhtar Mahdavi Mahdavi, Azeem Majeed, Alaa Makki, Afshin Maleki, Reza Malekzadeh, Ana Laura Manda, Fariborz Mansour-Ghanaei, Mohammad Ali Mansournia, Carlos Alberto Marrugo Arnedo, Adolfo Martinez-Valle, Seyedeh Zahra Masoumi, Richard James Maude, Martin McKee, Carlo Eduardo Medina-Solís, Ritesh G Menezes, Atte Meretoja, Tuomo J Meretoja, Mohamed Kamal Mesregah, Tomislav Mestrovic, Neda Milevska Kostova, Ted R Miller, GK Mini, Andreea Mirica, Erkin M Mirrakhimov, Bahram Mohajer, Teroj Abdulrahman Mohamed, Mokhtar Mohammadi, Abdollah Mohammadian-Hafshejani, Shafiu Mohammed, Modhurima Moitra, Ali H Mokdad, Mariam Molokhia, Mohammad Ali Moni, Yousef Moradi, Jakub Morze, Seyyed Meysam Mousavi, Christine Mpundu-Kaambwa, Moses K Muriithi, Saravanan Muthupandian, Ahamarshan Jayaraman Nagarajan, Mukhammad David Naimzada, Vinay Nangia, Atta Abbas Naqvi, Aparna Ichalangod Narayana, Bruno Ramos Nascimento, Muhammad Naveed, Biswa Prakash Nayak, Javad Nazari, Rawlance Ndejjo, Ionut Negoi, Sandhya Neupane Kandel, Trang Huyen Nguyen, Justice Nonvignon, Jean Jacques Noubiap, Vincent Ebuka Nwatah, Bogdan Oancea, Foluke Adetola Ogunyemi Ojelabi, Andrew T Olagunju, Babayemi Oluwaseun Olakunde, Stefano Olgiati, Jacob Olusegun Olusanya, Obinna E Onwujekwe, Adrian Otoiu, Nikita Otstavnov, Stanislav S Otstavnov, Mayowa O Owolabi, Jagadish Rao Padubidri, Raffaele Palladino, Songhomitra Panda-Jonas, Eun-Cheol Park, Fatemeh Pashazadeh Kan, Shrikant Pawar, Hamidreza Pazoki Toroudi, David M Pereira, Arokiasamy Perianayagam, Konrad Pesudovs, Cristiano Piccinelli, Maarten J Postma, Sergio I Prada, Mohammad Rabiee, Navid Rabiee, Fakher Rahim, Vafa Rahimi-Movaghar, Mohammad Hifz Ur Rahman, Mosiur Rahman, Amir Masoud Rahmani, Usha Ram, Chhabi Lal Ranabhat, Priyanga Ranasinghe, Chythra R Rao, Priya Rathi, David Laith Rawaf, Salman Rawaf, Lal Rawal, Reza Rawassizadeh, Robert C Reiner Jr, Andre M N Renzaho, Bhageerathy Reshmi, Mavra A Riaz, Rezaul Karim Ripon, Anas M Saad, Mohammad Ali Sahraian, Maitreyi Sahu, Joseph S Salama, Sana Salehi, Abdallah M Samy, Juan Sanabria, Francesco Sanmarchi, João Vasco Santos, Milena M Santric-Milicevic, Brijesh Sathian, Miloje Savic, Deepak Saxena, Mehdi Sayyah, Falk Schwendicke, Subramanian Senthilkumaran, Sadaf G Sepanlou, Allen Seylani, Saeed Shahabi, Masood Ali Shaikh, Aziz Sheikh, Adithi Shetty, Pavanchand H Shetty, Kenji Shibuya, Mark G Shrime, Kanwar Hamza Shuja, Jasvinder A Singh, Valentin Yurievich Skryabin, Anna Aleksandrovna Skryabina, Shahin Soltani, Moslem Soofi, Emma Elizabeth Spurlock, Simona Cătălina Stefan, Viktória Szerencsés, Miklós Szócska, Rafael Tabarés-Seisdedos, Biruk Wogayehu Taddele, Yonas Getaye Tefera, Aravind Thavamani, Ruoyan Tobe-Gai, Roman Topor-Madry, Marcos Roberto Tovani-Palone, Bach Xuan Tran, Lorainne Tudor Car, Anayat Ullah, Saif Ullah, Nasir Umar, Eduardo A Undurraga, Pascual R Valdez, Tommi Juhani Vasankari, Jorge Hugo Villafañe, Francesco S Violante, Vasily Vlassov, Bay Vo, Sebastian Vollmer, Theo Vos, Giang Thu Vu, Linh Gia Vu, Richard G Wamai, Andrea Werdecker, Mesfin Agachew Woldekidan, Befikadu Legesse Wubishet, Gelin Xu, Sanni Yaya, Vahid Yazdi-Feyzabadi, Vahit Yiğit, Paul Yip, Birhanu Wubale Yirdaw, Naohiro Yonemoto, Mustafa Z Younis, Chuanhua Yu, Ismaeel Yunusa, Telma Zahirian Moghadam, Hamed Zandian, Mikhail Sergeevich Zastrozhin, Anasthasia Zastrozhina, Zhi-Jiang Zhang, Arash Ziapour, Yves Miel H Zuniga, Simon I Hay, Christopher J L Murray, Joseph L Dieleman

    The Lancet 398 (10308) 1317-1343 2021年10月

    出版者・発行元: Elsevier BV

    DOI: 10.1016/s0140-6736(21)01258-7  

    ISSN:0140-6736

    eISSN:1474-547X

  158. Geographically weighted generalized Farrington algorithm for rapid outbreak detection over short data accumulation periods 査読有り

    Daisuke Yoneoka, Takayuki Kawashima, Koji Makiyama, Yuta Tanoue, Shuhei Nomura, Akifumi Eguchi

    Statistics in Medicine 40 (28) 6277-6294 2021年9月7日

    DOI: 10.1002/sim.9182  

    ISSN:0277-6715

    eISSN:1097-0258

  159. Profiling of Androgen-Dependent Enhancer RNAs Expression in Human Prostate Tumors: Search for Malignancy Transition Markers 国際誌 査読有り

    Koichi Nishimura, Jinichi Mori, Takahiro Sawada, Shuhei Nomura, Alexander Kouzmenko, Kaori Yamashita, Yoshiaki Kanemoto, Tomohiro Kurokawa, Akira Hayakawa, Suguru Tokiwa, Michihisa Ochi, Hiroaki Shimmura, Shigeaki Kato

    Research and Reports in Urology 13 705-713 2021年9月

    出版者・発行元: Informa UK Limited

    DOI: 10.2147/rru.s328661  

    eISSN:2253-2447

    詳細を見る 詳細を閉じる

    INTRODUCTION: Although the ability of androgens to promote prostate cancer development has been known for decades, the molecular mechanisms of androgen receptor (AR) signaling in the tumorigenesis remain unclear. Enhancer RNAs (eRNAs) transcribed from strong enhancers, or super-enhancers (SEs), have recently emerged as a novel class of regulatory non-coding RNAs (ncRNAs) that facilitate transcription, including that of androgen target genes, through chromatin looping to position enhancers proximate to the promoters. The aim of this study was to assess androgen-dependent transcription in prostate tumors of eRNAs (designated as KLK3eRNAs) from the SE of the KLK3 gene encoding the prostate-specific antigen (PSA) protein, a clinical marker of prostate carcinogenesis. MATERIALS AND METHODS: The androgen-induced KLK3eRNAs were identified in the LNCaP human prostate cancer cell line. The expressions of these KLK3eRNAs together with KLK3 and AR mRNA transcripts were assessed by qRT-PCR in prostate tumor samples from five prostate cancer patients. RESULTS: Androgen-induced KLK3eRNAs have been identified in the LNCaP cells, and their expression was further analyzed in tumors of prostate cancer patients. Transcripts of the tested KLK3eRNAs have been detected in all clinical samples, but their expression patterns differed between individual tumor specimens. We found a statistically significant correlation between the levels of the KLK3 and AR mRNAs with those of the previously reported KLK3eRNAs, while such correlation was not observed for novel KLK3eRNAs described in our recent report. CONCLUSION: Presented data suggest that prostate tumor development may associate with epigenetic reorganization in the KLK3 genomic regulatory elements reflected by changes of the KLK3eRNA expression. Our findings support a potential of eRNAs profiling to be used as diagnostic marker.

  160. Reasons for being unsure or unwilling regarding intention to take COVID-19 vaccine among Japanese people: A large cross-sectional national survey 国際誌 査読有り

    Shuhei Nomura, Akifumi Eguchi, Daisuke Yoneoka, Takayuki Kawashima, Yuta Tanoue, Michio Murakami, Haruka Sakamoto, Keiko Maruyama-Sakurai, Stuart Gilmour, Shoi Shi, Hiroyuki Kunishima, Satoshi Kaneko, Megumi Adachi, Koki Shimada, Yoshiko Yamamoto, Hiroaki Miyata

    The Lancet Regional Health - Western Pacific 14 100223-100223 2021年9月

    出版者・発行元: Elsevier BV

    DOI: 10.1016/j.lanwpc.2021.100223  

    ISSN:2666-6065

    詳細を見る 詳細を閉じる

    BACKGROUND: Identifying and understanding reasons for being unsure or unwilling regarding intention to be vaccinated against coronavirus disease (COVID-19) may help to inform future public health messages aimed at increasing vaccination coverage. We analyzed a broad array of individual's psychological dispositions with regard to decision-making about COVID-19 vaccination in Japan. METHODS: A nationally representative cross-sectional web survey was conducted with 30053 Japanese adults aged 20 years or older at the end of February 2021. In addition to the question on the individual's intention to be vaccinated against COVID-19, respondents were asked about their sociodemographic, health-related, and psychological characteristics as well as information sources about COVID-19 and their levels of trust. Also, those who responded 'not sure' or 'no' regarding intention to take COVID-19 vaccine were asked why. Multinomial logistic regression with sparse group Lasso (Least Absolute Shrinkage and Selection Operator) penalty was used to compute adjusted odds ratios for factors associated with the intention (not sure/no versus yes). FINDINGS: The percentages of respondents who answered 'not sure' or 'no' regarding intention to be vaccinated against COVID-19 vaccine were 32.9% and 11.0%, respectively. After adjusting for covariates, the perceived risks of COVID-19, perceived risk of a COVID-19 vaccine, perceived benefits of a COVID-19 vaccine, trust in scientists and public authorities, and the belief that healthcare workers should be vaccinated were significantly associated with vaccination intention. Several sources of information about COVID-19 were also significantly associated with vaccination intention, including physicians, nurses, and television, medical information sites with lower odds of being unsure or unwilling, and internet news sites, YouTube, family members, and scientists and researchers with higher odds. The higher the level of trust in television as a source of COVID-19 information, the higher the odds of responding 'not sure' (odds ratio 1.11, 95% confidence interval 1.01-1.21). We also demonstrated that many respondents presented concerns about the side effects and safety of a COVID-19 vaccine as a major reason for being unsure or unwilling. To decide whether or not to get the vaccine, many respondents requested more information about the compatibilities between the vaccine and their personal health conditions, whether other people had been vaccinated, the effectiveness of vaccines against variants, and doctors' recommendations. INTERPRETATION: Our findings suggest that public health messaging based on the sociodemographic and psychological characteristics of those who are unsure or unwilling regarding intention to be vaccinated against COVID-19 vaccine may help to increase vaccine uptake amongst this population. FUNDING: The present work was supported in part by a grant from the Ministry of Health, Labour and Welfare of Japan (H29-Gantaisaku-ippan-009).

  161. Tracking development assistance for health: A comparative study of the 29 development assistance committee countries, 2011–2019 査読有り

    Nomura, S., Sakamoto, H., Ishizuka, A., Shibuya, K.

    International Journal of Environmental Research and Public Health 18 (16) 8519-8519 2021年8月12日

    出版者・発行元: MDPI AG

    DOI: 10.3390/ijerph18168519  

    ISSN:1661-7827 1660-4601

    eISSN:1660-4601

  162. Mobility Patterns in Different Age Groups in Japan during the COVID-19 Pandemic: a Small Area Time Series Analysis through March 2021 査読有り

    Shuhei Nomura, Yuta Tanoue, Daisuke Yoneoka, Stuart Gilmour, Takayuki Kawashima, Akifumi Eguchi, Hiroaki Miyata

    Journal of Urban Health 98 (5) 635-641 2021年8月11日

    DOI: 10.1007/s11524-021-00566-7  

    ISSN:1099-3460

    eISSN:1468-2869

  163. Effect of emergency declaration on mental health during the COVID-19 pandemic in Japan: A social network service-based difference-in-differences approach

    Akifumi Eguchi, Daisuke Yoneoka, Shoi Shi, Yuta Tanoue, Takayuki Kawashima, Shuhei Nomura, Koji Makiyama, Shinya Uryu, Masayuki Sawada, Yumi Kawamura, Shinichi Takayanagi, Stuart Gilmour, Hiroaki Miyata

    Science Progress 104 (3) 003685042110297-003685042110297 2021年8月

    DOI: 10.1177/00368504211029793  

    ISSN:0036-8504

    eISSN:2047-7163

  164. Suicide by gender and 10-year age groups during the COVID-19 pandemic vs previous five years in Japan: an analysis of national vital statistics 国際誌 査読有り

    Akifumi Eguchi, Shuhei Nomura, Stuart Gilmour, Nahoko Harada, Haruka Sakamoto, Peter Ueda, Daisuke Yoneoka, Yuta Tanoue, Takayuki Kawashima, Takehiko I. Hayashi, Yuzo Arima, Motoi Suzuki, Masahiro Hashizume

    Psychiatry Research 305 114173-114173 2021年8月

    出版者・発行元: Elsevier BV

    DOI: 10.1016/j.psychres.2021.114173  

    ISSN:0165-1781

    詳細を見る 詳細を閉じる

    Using daily vital statistics data from the Japanese Ministry of Health, Labour and Welfare, we provide the first weekly and age-group-specific estimates of the additional suicide burden during the COVID-19 pandemic in Japan by gender, from January through November 2020. Our results indicate that compared with the previous five years, suicide cases in 2020 in Japan have increased from late July to November for women in all age groups and for men in the 20-29 and 80+ years age group. Targeted interventions based on age and gender might be more effective in reducing suicide during the COVID-19 pandemic in Japan.

  165. Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global Burden of Disease Study 2019 査読有り

    GBD 2019 Under-5 Mortality Collaborators

    The Lancet 398 (10303) 870-905 2021年8月

    出版者・発行元: Elsevier BV

    DOI: 10.1016/s0140-6736(21)01207-1  

    ISSN:0140-6736

    eISSN:1474-547X

  166. Hospital admission for type 2 diabetes mellitus under the Universal Coverage Scheme in Thailand: A time- and geographical-trend analysis, 2009–2016 国際誌 査読有り

    Tanapat Laowahutanon, Haruyo Nakamura, Hisateru Tachimori, Shuhei Nomura, Tippawan Liabsuetrakul, Apiradee Lim, Petch Rawdaree, Netnapis Suchonwanich, Hiroyuki Yamamoto, Aya Ishizuka, Kenji Shibuya, Hiroaki Miyata, Virasakdi Chongsuvivatwong

    PLOS ONE 16 (7) e0253434-e0253434 2021年7月1日

    出版者・発行元: Public Library of Science (PLoS)

    DOI: 10.1371/journal.pone.0253434  

    eISSN:1932-6203

    詳細を見る 詳細を閉じる

    <sec id="sec001"> <title>Background</title> Descriptive analyses of 2009–2016 were performed using the data of the Universal Coverage Scheme (UCS) which covers nearly 70 percent of the Thai population. The analyses described the time and geographical trends of nationwide admission rates of type 2 diabetes mellitus (T2DM) and its complications, including chronic kidney disease (CKD), myocardial infarction, cerebrovascular diseases, retinopathy, cataract, and diabetic foot amputation. </sec> <sec id="sec002"> <title>Methods and findings</title> The database of T2DM patients aged 15–100 years who were admitted between 2009 and 2016 under the UCS and that of the UCS population were retrieved for the analyses. The admitted cases of T2DM were extracted from the database using disease codes of principal and secondary diagnoses defined by the International Classification of Diseases 9th and 10th Revisions. The T2DM admission rates in 2009–2016 were the number of admissions divided by the number of the UCS population. The standardized admission rates (SARs)were further estimated in contrast to the expected number of admissions considering age and sex composition of the UCS population in each region. A linearly increased trend was found in T2DM admission rates from 2009 to 2016. Female admission rates were persistently higher than that of males. In 2016, an increase in the T2DM admission rates was observed among the older ages relative to that in 2009. Although the SARs of T2DM were generally higher in Bangkok and central regions in 2009, except that with CKD and foot amputation which had higher trends in northeastern regions, the geographical inequalities were fairly reduced by 2016. </sec> <sec id="sec003"> <title>Conclusion</title> Admission rates of T2DM and its major complications increased in Thailand from 2009 to 2016. Although the overall geographical inequalities in the SARs of T2DM were reduced in the country, further efforts are required to improve the health system and policies focusing on risk factors and regions to manage the increasing T2DM. </sec>

  167. Developing and validating regression models for predicting household consumption to introduce an equitable and sustainable health insurance system in Cambodia 査読有り

    Haruyo Nakamura, Floriano Amimo, Siyan Yi, Sovannary Tuot, Tomoya Yoshida, Makoto Tobe, Md. Mizanur Rahman, Daisuke Yoneoka, Aya Ishizuka, Shuhei Nomura

    International Journal of Health Planning and Management 36 (6) 1-12 2021年7月

    DOI: 10.1002/hpm.3269  

    ISSN:0749-6753

    eISSN:1099-1751

  168. Umami: An Alternative Japanese Approach to Reducing Sodium While Enhancing Taste Desirability 査読有り

    Shuhei Nomura, Aya Ishizuka, Shiori Tanaka, Daisuke Yoneoka, Hisayuki Uneyama, Kenji Shibuya

    Health 13 (06) 629-636 2021年6月5日

    出版者・発行元: Scientific Research Publishing, Inc.

    DOI: 10.4236/health.2021.136047  

    ISSN:1949-4998 1949-5005

    eISSN:1949-5005

  169. Comparative risk assessment of non-communicable diseases by evacuation scenario– a retrospective study in the 7 years following the Fukushima Daiichi nuclear power plant accident 国際誌 査読有り

    Shuhei Nomura, Michio Murakami, Akihiko Ozaki, Toyoaki Sawano, Claire Leppold, Yoshitaka Nishikawa, Hiroaki Saito, Tomoyoshi Oikawa, Masaharu Tsubokura

    Global Health Action 14 (1) 1918886-1918886 2021年6月1日

    出版者・発行元: Informa UK Limited

    DOI: 10.1080/16549716.2021.1918886  

    ISSN:1654-9716

    eISSN:1654-9880

    詳細を見る 詳細を閉じる

    Background: As a result of the Fukushima Daiichi nuclear power plant accident, many residents evacuated and were exposed to changes in their living environment and socioeconomic status, and to persistent stressors. Past studies have suggested the potential for these circumstances to contribute to long-term changes to population health.Objective: The objective of this study was to gain a better understanding of long-term health effects of evacuation, by evaluating the risk of non-communicable diseases among evacuees from Minamisoma City (one of the closest municipalities to the power plant) until 2017.Methods: The study evaluated data from annual health check-ups for residents aged 40-74 years covered by National Health Insurance (who are largely self-employed) from 2010 to 2017 administered by Minamisoma City. Diabetes, hyperlipidemia, and hypertension were defined from the results of blood sampling. Annual changes in age-adjusted prevalence were estimated by evacuation scenario. We also performed an inverse-probability weighting (IPW) analysis to adjust for baseline covariates in 2010 and estimated the differences in the risk of diabetes, hyperlipidemia, and hypertension by evacuation scenario as of the 2017 health check-up in reference to the no-evacuation group.Results: A total of 1,837 individuals were considered in this study. Regardless of evacuation scenario, there was statistical evidence suggesting an upward and a downward trend in diabetes and hypertension from 2010 to 2017, respectively, while hyperlipidemia showed no remarkable change. IPW analyses demonstrated that disease risks in 2017 did not differ significantly among people with different evacuation scenarios.Conclusions: Region-specific factors played an important role in the health effects of the evacuation. Our findings have important implications for the need of an assessment of the health effects of evacuations in more localized manner. Further research in this area will strengthen the communities' preparedness for future disasters that require mass evacuation.

  170. Assessing factors associated with tb awareness in nepal: A national and subnational study 査読有り

    Iwaki, Y., Rauniyar, S.K., Nomura, S., Huang, M.

    International Journal of Environmental Research and Public Health 18 (10) 5124-5124 2021年5月12日

    出版者・発行元: {MDPI} {AG}

    DOI: 10.3390/ijerph18105124  

    ISSN:1661-7827 1660-4601

    eISSN:1660-4601

  171. Progress towards the development of research agenda and the launch of knowledge hub: The who thematic platform for health emergency and disaster risk management research network (health edrm rn) 査読有り

    Kayano, R., Nomura, S., Abrahams, J., Huda, Q., Chan, E.Y.Y., Murray, V.

    International Journal of Environmental Research and Public Health 18 (9) 4959 2021年5月7日

    DOI: 10.3390/ijerph18094959  

    ISSN:1661-7827 1660-4601

  172. Association between Daily Living Walking Speed and Lifestyle and Physiological Factors in Older, Female Pokémon GO Players 査読有り

    Shuhei Nomura, Akifumi Eguchi, Daisuke Yoneoka, Takayuki Kawashima, Norimichi Hirahara, Yuta Tanoue, Stuart Gilmour, Hisateru Tachimori, Hiroaki Miyata

    Health 13 (05) 564-573 2021年5月

    出版者・発行元: Scientific Research Publishing, Inc.

    DOI: 10.4236/health.2021.135042  

    ISSN:1949-4998

    eISSN:1949-5005

  173. National genotype prevalence and age distribution of human papillomavirus from infection to cervical cancer in Japanese women: a systematic review and meta-analysis protocol 国際誌 査読有り

    Matthew Palmer, Kota Katanoda, Eiko Saito, Cecilia Acuti Martellucci, Shiori Ostuki, Shuhei Nomura, Erika Ota, Julia M. L. Brotherton, Jane Hocking

    Systematic Reviews 10 (135) 135-135 2021年5月

    出版者・発行元: Springer Science and Business Media LLC

    DOI: 10.1186/s13643-021-01686-6  

    eISSN:2046-4053

    詳細を見る 詳細を閉じる

    <title>Abstract</title><sec> <title>Background</title> Despite prophylactic human papillomavirus (HPV) vaccination being a safe, effective and cost-effective public health intervention for the prevention of cervical cancer, the HPV vaccine is not actively recommended or promoted by the Ministry of Health Labour and Welfare in Japan. With already very low levels of cervical screening below 30%, and vaccination levels that are below levels that award any population effect at 0.3% of the eligible population, cervical cancer mortality is higher than other similar high-income countries at 4.4/100,000 (2900) deaths per year in 2015. There is limited population-based or nationally representative data for HPV genotype distribution in Japan, thus making an assessment of the burden of vaccine-preventable cervical cancer difficult. Therefore, this systematic review and meta-analysis aims to determine the HPV genotype prevalence and age distribution of HPV infection in women with a cytological or histological diagnosis of normal through cervical cancer in Japan. We anticipate this information will guide and enhance programme interventions to reduce vaccine-preventable cervical cancer mortality in Japan. </sec><sec> <title>Methods</title> PubMed, Embase and the Japan Medical Abstract Society Database will be searched from the date of establishment to March 2021 to identify original research articles that report the prevalence of HPV genotypes in Japanese women with normal cervical cytology, low grade, high grade and cancerous cervical lesions. No exclusion criteria relating to language or publication date will be applied. The quality of the studies will be assessed using the Joanna Briggs checklist for prevalence studies. Randomised control trials, cohort studies, cross-sectional and prevalence studies will be considered eligible. Study findings will be combined using a traditional random-effects or fixed-effects meta-analysis to summarise pooled prevalence and 95% confidence intervals depending on heterogeneity. Subgroup analyses and meta-regression will be used to investigate heterogeneity, and sensitivity analyses will be conducted to assess the robustness of the findings. </sec><sec> <title>Discussion</title> To our knowledge, this is the first systematic review protocol that includes both Japanese and English peer-reviewed articles for the determination of genotype-specific HPV prevalence in cytological or histological confirmed normal cervical specimens, low- and high-grade intraepithelial lesions and cervical cancers by age in Japan. We anticipate this information will guide and enhance programme interventions to reduce vaccine-preventable cervical cancer mortality in Japan. </sec><sec> <title>Systematic review registration</title> PROSPERO CRD42018117596 </sec>

  174. Overall health information exposure, its barriers and impacts on attitude toward healthcare among cancer patients. The long-term aftermath of the 2011 triple disaster in Fukushima, Japan: A single institution cross-sectional study 国際誌 査読有り

    Akihiko Ozaki, Michio Murakami, Shuhei Nomura, Toyoaki Sawano, Masaharu Tsubokura, Kyoko Ono, Yoshitake Takebayashi, Manabu Tsukada, Kazue Yamaoka, Yoshinori Nakata, Hiromichi Ohira

    Health Informatics Journal 27 (2) 146045822199642-146045822199642 2021年4月

    出版者・発行元: SAGE Publications

    DOI: 10.1177/1460458221996420  

    ISSN:1460-4582

    eISSN:1741-2811

    詳細を見る 詳細を閉じる

    Disasters can hinder access to health information among cancer patients. However, little is known regarding overall health information exposure (HIE), its barriers and its impacts on attitudes toward healthcare among cancer patients in the long-term aftermath of disasters. The aims of this study were threefold: assess the extent of HIE; identify associations between family composition and a non-engagement with HIE; and examine the effects of HIE on attitudes toward healthcare among local cancer patients—5 years after the 2011 triple disaster (earthquake, tsunami, and nuclear disaster) in Fukushima, Japan. We conducted self-administered surveys with all cancer and non-cancer surgery department outpatients at Minamisoma Municipal General Hospital (MMGH), Minamisoma City, from October 2016 to January 2017. In total, 404 patients (263 cancer patients and 141 non-cancer patients) voluntarily participated in the study. The results revealed that a regular level of HIE occurred among 90.5% of the cancer patients. In cancer patients, family composition was not significantly associated with HIE, and HIE was not associated with attitude toward healthcare. In conclusion, most cancer patients visiting the MMGH surgical department were regularly engaged in HIE.

  175. Expected Scopes of Health Emergency and Disaster Risk Management (Health EDRM): Report on the Expert Workshop at the Annual Conference for the Japanese Association for Disaster Medicine 2020 査読有り

    Shuhei Nomura, Ryoma Kayano, Shinichi Egawa, Nahoko Harada, Yuichi Koido

    International Journal of Environmental Research and Public Health 18 (9) 4447-4447 2021年4月

    出版者・発行元: MDPI AG

    DOI: 10.3390/ijerph18094447  

    eISSN:1660-4601

    詳細を見る 詳細を閉じる

    The World Health Organization (WHO) and its partners established the WHO Thematic Platform for Health Emergency and Disaster Risk Management Research Network (HEALTH EDRM RN) in 2016 to respond to the increasing burden of recent health emergencies and disasters. The mission of the HEALTH EDRM RN, whose secretariat is located at the WHO Kobe Centre (WKC), is to promote global research collaboration and strengthen research activities to inform policies and programs by generating new evidence to manage health risks associated with all types of emergencies and disasters. With the strong support and involvement of all WHO regional offices, the HEALTH EDRM RN now works with more than 200 global experts and partners to pursue its mission. The first Core Group Meetings of the HEALTH EDRM RN were held on 17–18 October 2019, and concluded with the HEALTH EDRM RN-activity priorities to (1) promote operational research to better meet the needs of emergency- and disaster-exposed individuals and communities and efforts to translate science to policies and programs and (2) strengthen the research capacity of the Health EDRM community. In collaboration with the Japanese Association for Disaster Medicine, the WKC held a workshop on 21 February 2020, in which 20 Japanese experts from different research fields participated to further discuss these two points. This paper summarizes the discussion at the workshop.

  176. How do Japanese rate the severity of different diseases and injuries?—an assessment of disability weights for 231 health states by 37,318 Japanese respondents 国際誌 査読有り

    Shuhei Nomura, Yoshiko Yamamoto, Daisuke Yoneoka, Juanita A. Haagsma, Joshua A. Salomon, Peter Ueda, Rintaro Mori, Damian Santomauro, Theo Vos, Kenji Shibuya

    Population Health Metrics 19 (21) 21-21 2021年4月

    DOI: 10.1186/s12963-021-00253-4  

    詳細を見る 詳細を閉じる

    BACKGROUND: Disability weights (DWs) are weight factors that reflect the severity of health states for estimates of disability-adjusted life years. A new set of global DWs was published for the Global Burden of Diseases and Injuries (GBD) 2013 study, which relied on sampling from various world regions, but included little data for countries in East Asia. This study aimed to measure DWs in Japan using comparable methods, and compare the results with previous estimates from the GBD 2013 DW study. METHODS: We conducted a web-based survey in 2019 to estimate DWs for 231 health states for the Japanese population. The survey included five new health states but otherwise followed the method of the GBD DW measurement study. The survey consisted of 15 paired comparison (PC) questions and 3 population health equivalence questions (PHE) per respondent. We analyzed PC data using probit regression and rescaled results to DW units between 0 (equivalent to full health) and 1 (equivalent to death). FINDINGS: We considered 37,318 nationally representative respondents. The values of the resulting DWs ranged from 0.707 (95% uncertainty interval (UI) 0.527-0.842) for spinal cord injury at neck level (untreated) to 0.004 (UI 0.001-0.009) for mild anemia. High correlation between Japanese DW and GBD 2013 DW was observed, but there was considerable disagreement. Out of 226 comparable health states, 55 (24.3%) showed more than a factor-of-two difference, of which 41 (74.6%) had a higher value in Japanese DW. Many of the health states with higher DW in the Japan study were injuries, including amputation and fracture, and hearing and vision loss, while mental, behavioral, and substance use disorders generally tended to be lower. CONCLUSIONS: This study has created an empirical basis for assessment of Japanese DWs of health status. The findings from this study based on the Japanese population suggest that there might be contextual differences in rating the severity of health states compared to previous surveys conducted elsewhere.

  177. Projections of disability-adjusted life years for major diseases due to a change in vegetable intake in 2017–2040 in Japan 国際誌 査読有り

    Shiori Tanaka, Daisuke Yoneoka, Aya Ishizuka, Peter Ueda, Keiji Nakamura, Hisayuki Uneyama, Naoki Hayashi, Kenji Shibuya, Shuhei Nomura

    BMC Public Health 21 (770) 770-770 2021年4月

    DOI: 10.1186/s12889-021-10772-2  

    詳細を見る 詳細を閉じる

    BACKGROUND: Low vegetable intake is one of the key dietary risk factors known to be associated with a range of health problems, including cardiovascular diseases (CVDs), cancer, and diabetes and kidney diseases (DKDs). Using data from Japan's National Health and Nutrition Surveys and the Global Burden of Diseases study in 2017, this study aimed to forecast the impact of change in vegetable intake on disability-adjusted life years (DALYs) between 2017 and 2040 for three diseases. METHODS: We generated a three-component model of cause-specific DALYs, including changes in major behavioural and metabolic risk predictors, the socio-demographic index and an autoregressive integrated moving average model to project future DALY rates for 2017-2040 using the data between 1990 and 2016. Data on Vegetable consumption and risk predictors, and DALY rate were obtained from Japan's National Health and Nutrition Surveys and the Global Burden of Diseases Study in 2017. We also modelled three scenarios of better, moderate and worse cases to evaluate the impact of change in vegetable consumption on the DALY rates for three diseases (CVDs, cancer, and DKDs). RESULTS: Projected mean vegetable intake in the total population showed a decreasing trend through 2040 to 237.7 g/day. A significant difference between the reference scenario and the better case scenario was observed with un-overlapped 95% prediction intervals of DALY rates in females aged 20-49 years (- 8.0%) for CVDs, the total population for cancer (- 5.6%), and in males (- 8.2%) and females (- 13.7%) for DKDs. CONCLUSIONS: Our analysis indicates that increased vegetable consumption would have a significant reduction in the burdens of CVDs, cancer and DKDs in Japan. By estimating the disease burden attributable to low vegetable intake under different scenarios of future vegetable consumption, our study can inform the design of targeted interventions for public health challenges.

  178. Military coup during COVID-19 pandemic and health crisis in Myanmar 国際誌 査読有り

    Su Myat Han, Kaung Suu Lwin, Khin Thet Swe, Stuart Gilmour, Shuhei Nomura

    BMJ Global Health 6 (4) e005801-e005801 2021年4月

    出版者・発行元: BMJ

    DOI: 10.1136/bmjgh-2021-005801  

    eISSN:2059-7908

  179. Trends in suicide in Japan by gender during the COVID-19 pandemic, through December 2020 査読有り

    Shuhei Nomura, Takayuki Kawashima, Nahoko Harada, Daisuke Yoneoka, Yuta Tanoue, Akifumi Eguchi, Stuart Gilmour, Yumi Kawamura, Masahiro Hashizume

    Psychiatry Research 300 113913-113913 2021年4月

    出版者・発行元: Elsevier BV

    DOI: 10.1016/j.psychres.2021.113913  

    ISSN:0165-1781

    eISSN:1872-7123

  180. COVID-19 and Heat Illness in Tokyo, Japan: Implications for the Summer Olympic and Paralympic Games in 2021. 国際誌

    Kazuki Shimizu, Stuart Gilmour, Hiromi Mase, Phuong Mai Le, Ayaka Teshima, Haruka Sakamoto, Shuhei Nomura

    International journal of environmental research and public health 18 (7) 2021年3月31日

    DOI: 10.3390/ijerph18073620  

    詳細を見る 詳細を閉じる

    The 2020 summer Olympic and Paralympic Games in Tokyo were postponed to July-September 2021 due to the coronavirus disease 2019 (COVID-19) pandemic. While COVID-19 has emerged as a monumental health threat for mass gathering events, heat illness must be acknowledged as a potentially large health threat for maintaining health services. We examined the number of COVID-19 admissions and the Tokyo rule for emergency medical care, in Tokyo, from March to September 2020, and investigated the weekly number of emergency transportations due to heat illness and weekly averages of the daily maximum Wet Bulb Globe Temperature (WBGT) in Tokyo in the summer (2016-2020). The peak of emergency transportations due to heat illness overlapped the resurgence of COVID-19 in 2020, and an increase of heat illness patients and WBGT has been observed. Respect for robust science is critical for the decision-making process of mass gathering events during the pandemic, and science-based countermeasures and implementations for COVID-19 will be warranted. Without urgent reconsiderations and sufficient countermeasures, the double burden of COVID-19 and heat-related illnesses in Tokyo will overwhelm the healthcare provision system, and maintaining essential health services will be challenging during the 2021 summer Olympic and Paralympic Games.

  181. Trends in Healthcare Access in Japan during the First Wave of the COVID-19 Pandemic, up to June 2020 国際誌 査読有り

    Koji Makiyama, Takayuki Kawashima, Shuhei Nomura, Akifumi Eguchi, Daisuke Yoneoka, Yuta Tanoue, Yumi Kawamura, Haruka Sakamoto, Stuart Gilmour, Shoi Shi, Kentaro Matsuura, Shinya Uryu, Masahiro Hashizume

    International Journal of Environmental Research and Public Health 18 (6) 3271-3271 2021年3月22日

    出版者・発行元: MDPI AG

    DOI: 10.3390/ijerph18063271  

    eISSN:1660-4601

    詳細を見る 詳細を閉じる

    We evaluated the impact of the new coronavirus disease (COVID-19) on healthcare access in Japan in terms of the number of outpatients and hospitalized patients as well as the length of hospital stays, during the first wave of the pandemic, up to June 2020. This observational study evaluated the monthly average number of outpatients per day at hospitals, the average number of hospitalized patients per day, and the average length of hospital stays per patient, from December 2010 to June 2020, using the hospital reports data, which are open aggregated data on the utilization of hospitals from the Ministry of Health, Labour and Welfare. These numbers were compared with those from the same period of previous years, using a quasi-Poisson regression model. We found a nationwide decrease in the number of outpatients in general hospitals and hospitalized patients, particularly in long-term care beds in Japan, as well as the excess length of hospital stays among psychiatric care patients during the first wave of the COVID-19. This limited access to healthcare demonstrated the importance of the long-term health monitoring of vulnerable populations and the need for urgent management support to healthcare facilities in preparation for possible prolonged pandemics in the future.

  182. Excess All-Cause Deaths during Coronavirus Disease Pandemic, Japan, January–May 20201 国際誌 査読有り

    Takayuki Kawashima, Shuhei Nomura, Yuta Tanoue, Daisuke Yoneoka, Akifumi Eguchi, Chris Fook Sheng Ng, Kentaro Matsuura, Shoi Shi, Koji Makiyama, Shinya Uryu, Yumi Kawamura, Shinichi Takayanagi, Stuart Gilmour, Hiroaki Miyata, Tomimasa Sunagawa, Takuri Takahashi, Yuuki Tsuchihashi, Yusuke Kobayashi, Yuzo Arima, Kazuhiko Kanou, Motoi Suzuki, Masahiro Hashizume

    Emerging Infectious Diseases 27 (3) 789-795 2021年3月

    出版者・発行元: Centers for Disease Control and Prevention (CDC)

    DOI: 10.3201/eid2703.203925  

    ISSN:1080-6040

    eISSN:1080-6059

    詳細を見る 詳細を閉じる

    To provide insight into the mortality burden of coronavirus disease (COVID-19) in Japan, we estimated the excess all-cause deaths for each week during the pandemic, January-May 2020, by prefecture and age group. We applied quasi-Poisson regression models to vital statistics data. Excess deaths were expressed as the range of differences between the observed and expected number of all-cause deaths and the 95% upper bound of the 1-sided prediction interval. A total of 208-4,322 all-cause excess deaths at the national level indicated a 0.03%-0.72% excess in the observed number of deaths. Prefecture and age structure consistency between the reported COVID-19 deaths and our estimates was weak, suggesting the need to use cause-specific analyses to distinguish between direct and indirect consequences of COVID-19.

  183. Development and Worsening of Diabetes Among Adults Aged Over 40 Years: A 6-Year Follow-Up Study of 140,000 People in Japan – The Shizuoka Study

    Nomura S, Sakamoto H, Rauniyar SK, Shimada K, Yamamoto H, Kohsaka S, Ichihara N, Kumamaru H, Miyata H

    2021年2月

    DOI: 10.21203/rs.3.rs-242898/v1  

  184. Human papillomavirus vaccine effectiveness within a cervical cancer screening programme: cohort study

    C. Acuti Martellucci, S. Nomura, D. Yoneoka, P. Ueda, J. M.L. Brotherton, K. Canfell, M. Palmer, L. Manzoli, P. Giorgi Rossi, A. De Togni, C. Palmonari, A. Califano, E. Saito, M. Hashizume, K. Shibuya

    BJOG: An International Journal of Obstetrics and Gynaecology 128 (3) 532-539 2021年2月

    DOI: 10.1111/1471-0528.16429  

    ISSN:1470-0328

    eISSN:1471-0528

  185. Assessing the regional impact of Japan’s COVID-19 state of emergency declaration: a population-level observational study using social networking services 国際誌 査読有り

    Daisuke Yoneoka, Shoi Shi, Shuhei Nomura, Yuta Tanoue, Takayuki Kawashima, Akifumi Eguchi, Kentaro Matsuura, Koji Makiyama, Shinya Uryu, Keisuke Ejima, Haruka Sakamoto, Toshibumi Taniguchi, Hiroyuki Kunishima, Stuart Gilmour, Hiroshi Nishiura, Hiroaki Miyata

    BMJ Open 11 (2) e042002-e042002 2021年2月

    出版者・発行元: BMJ

    DOI: 10.1136/bmjopen-2020-042002  

    ISSN:2044-6055

    eISSN:2044-6055

    詳細を見る 詳細を閉じる

    <sec><title>Objective</title>On 7 April 2020, the Japanese government declared a state of emergency in response to the novel coronavirus outbreak. To estimate the impact of the declaration on regional cities with low numbers of COVID-19 cases, large-scale surveillance to capture the current epidemiological situation of COVID-19 was urgently conducted in this study. </sec><sec><title>Design</title>Cohort study. </sec><sec><title>Setting</title>Social networking service (SNS)-based online survey conducted in five prefectures of Japan: Tottori, Kagawa, Shimane, Tokushima and Okayama. </sec><sec><title>Participants</title>127 121 participants from the five prefectures surveyed between 24 March and 5 May 2020. </sec><sec><title>Interventions</title>An SNS-based healthcare system named COOPERA (COvid-19: Operation for Personalized Empowerment to Render smart prevention And care seeking) was launched. It asks questions regarding postcode, personal information, preventive actions, and current and past symptoms related to COVID-19. </sec><sec><title>Primary and secondary outcome measures</title>Empirical Bayes estimates of age-sex-standardised incidence rate (EBSIR) of symptoms and the spatial correlation between the number of those who reported having symptoms and the number of COVID-19 cases were examined to identify the geographical distribution of symptoms in the five prefectures. </sec><sec><title>Results</title>97.8% of participants had no subjective symptoms. We identified several geographical clusters of fever with significant spatial correlation (r=0.67) with the number of confirmed COVID-19 cases, especially in the urban centres of prefectural capital cities. </sec><sec><title>Conclusions</title>Given that there are still several high-risk areas measured by EBSIR, careful discussion on which areas should be reopened at the end of the state of emergency is urgently required using real-time SNS system to monitor the nationwide epidemic. </sec>

  186. Impact of domestic travel restrictions on transmission of COVID-19 infection using public transportation network approach 国際誌 査読有り

    Yayoi Murano, Ryo Ueno, Shoi Shi, Takayuki Kawashima, Yuta Tanoue, Shiori Tanaka, Shuhei Nomura, Hiromichi Shoji, Toshiaki Shimizu, Huy Nguyen, Hiroaki Miyata, Stuart Gilmour, Daisuke Yoneoka

    Scientific Reports 11 (1) 3109-3109 2021年2月

    出版者・発行元: Springer Science and Business Media LLC

    DOI: 10.1038/s41598-021-81806-3  

    eISSN:2045-2322

    詳細を見る 詳細を閉じる

    <title>Abstract</title>The international spread of COVID-19 infection has attracted global attention, but the impact of local or domestic travel restriction on public transportation network remains unclear. Passenger volume data for the domestic public transportation network in Japan and the time at which the first confirmed COVID-19 case was observed in each prefecture were extracted from public data sources. A survival approach in which a hazard was modeled as a function of the closeness centrality on the network was utilized to estimate the risk of importation of COVID-19 in each prefecture. A total of 46 prefectures with imported cases were identified. Hypothetical scenario analyses indicated that both strategies of locking down the metropolitan areas and restricting domestic airline travel would be equally effective in reducing the risk of importation of COVID-19. While caution is necessary that the data were limited to June 2020 when the pandemic was in its initial stage and that no other virus spreading routes have been considered, domestic travel restrictions were effective to prevent the spread of COVID-19 on public transportation network in Japan. Instead of lockdown that might seriously damage the economy, milder travel restrictions could have the similar impact on controlling the domestic transmission of COVID-19.

  187. Hypertensive disorders of pregnancy by oocyte donation pregnancy in Japanese women aged 40 years or older: a single-center retrospective cohort study 査読有り

    Gekka, Y., Adachi, T., Oi, R., Nakayama, S., Kawana, Y., Takeda, Y., Nomura, S., Ozaki, A., Tanimoto, T., Sakamoto, H., Yamashita, T.

    Hypertension in Pregnancy 40 (1) 36-44 2021年1月2日

    出版者・発行元: Informa UK Limited

    DOI: 10.1080/10641955.2020.1861461  

    ISSN:1064-1955 1525-6065

    eISSN:1525-6065

  188. Trends in emergency transportation due to heat illness under the new normal lifestyle in the COVID-19 era, in Japan and 47 prefectures 国際誌 査読有り

    Shinya Uryu, Yuta Tanoue, Shuhei Nomura, Kentaro Matsuura, Koji Makiyama, Takayuki Kawashima, Daisuke Yoneoka, Akifumi Eguchi, Yumi Kawamura, Stuart Gilmour, Haruka Sakamoto, Kazuki Shimizu, Chris Fook Sheng Ng, Masahiro Hashizume

    Science of The Total Environment 768 144723-144723 2021年1月

    出版者・発行元: Elsevier BV

    DOI: 10.1016/j.scitotenv.2020.144723  

    ISSN:0048-9697

    詳細を見る 詳細を閉じる

    In Japan, in response to the spread of the new coronavirus disease (COVID-19), a 'new normal' in the era of the COVID-19 was proposed by the government, which calls for thorough wearing of masks as an infection control measure in the era of the COVID-19, but related heat illness has been a great concern this summer. We applied quasi-Poisson regression models to the daily number of emergency transportations due to heat illness from 2008 to 2020 from the Fire and Disaster Management Agency, Ministry of Internal Affairs and Communications, Japan, to estimate the expected weekly number of emergency transportations from heat illness, with adjustment for their long-term trend and the weather conditions, including temperatures. We found that, at the national level, the number of heat illness emergency transports did not significantly increase or decrease from the annual trend in 2020. By prefecture, on the other hand, there were some prefectures in which the number of heat illness emergency transports was less than the average year, and most of them were in the week of August 10-16. By age group, the number of heat illness emergency transports in the 0-17 and 18-64 age groups was particularly low in some prefectures, and by severity, those in mild cases was particularly low. A caution is necessary that there is a possibility that a decrease in cases possibly associated with COVID-19 measures, such as, outdoor activity restrictions at schools/universities and cancellation of public events, may offset the possible increase in heat illness cases occurring elsewhere associated with wearing masks. Given that the end of the COVID-19 pandemic is not expected yet, continuous and appropriate awareness-raising activities to prevent heat-related illness remain important.

  189. Tracking sectoral allocation of official development assistance: a comparative study of the 29 Development Assistance Committee countries, 2011–2018 査読有り

    Nomura, S., Sakamoto, H., Ishizuka, A., Shimizu, K., Shibuya, K.

    Global Health Action 14 (1) 1903222-1903222 2021年1月1日

    出版者・発行元: Informa {UK} Limited

    DOI: 10.1080/16549716.2021.1903222  

    ISSN:1654-9880

    eISSN:1654-9880

  190. Trends in suicide in Japan by gender during the COVID-19 pandemic, up to September 2020 国際誌 査読有り

    Shuhei Nomura, Takayuki Kawashima, Daisuke Yoneoka, Yuta Tanoue, Akifumi Eguchi, Stuart Gilmour, Yumi Kawamura, Nahoko Harada, Masahiro Hashizume

    Psychiatry Research 295 113622-113622 2021年1月

    出版者・発行元: Elsevier BV

    DOI: 10.1016/j.psychres.2020.113622  

    ISSN:0165-1781

    詳細を見る 詳細を閉じる

    Suicide is an extreme consequence of the psychological burden associated with the coronavirus disease 2019 (COVID-19) counter-measures. A quasi-Poisson regression was applied to monthly suicide mortality data obtained from the National Police Agency to estimate the gender-specific excess/exiguous suicide deaths during the COVID-19 pandemic in Japan up to September 2020. We found excess suicide deaths among women in July, August and September, but not among men. Our results indicate the importance of COVID-19 related suicide prevention, especially for women. Timely access to mental health care and financial and social support is urgently needed, as is optimal treatment for mental illness.

  191. Ongoing debate on data governance principles for achieving Universal Health Coverage: a proposal to post-G20 Osaka Summit meetings 査読有り

    Nomura, S., Sakamoto, H., Ishizuka, A., Katsuma, Y., Akashi, H., Miyata, H.

    Global Health Action 13 (1) 1859822-1859822 2020年12月31日

    出版者・発行元: Informa {UK} Limited

    DOI: 10.1080/16549716.2020.1859822  

    ISSN:1654-9880

    eISSN:1654-9880

  192. Reduced burden from major diseases due to an increase in vegetable intake in Japan: projections of disability-adjusted life years, 2017-2040

    Tanaka S, Yoneoka D, Ishizuka A, Ueda P, Nakamura K, Uneyama H, Hayashi N, Shibuya K, Nomura S

    2020年12月

    DOI: 10.21203/rs.3.rs-122329/v1  

  193. Trends in deaths from road injuries during the COVID-19 pandemic in Japan, January to September 2020 国際誌 査読有り

    Shuhei Nomura, Takayuki Kawashima, Daisuke Yoneoka, Yuta Tanoue, Akifumi Eguchi, Stuart Gilmour, Masahiro Hashizume

    Injury Epidemiology 7 (66) 66-66 2020年12月

    出版者・発行元: Springer Science and Business Media LLC

    DOI: 10.1186/s40621-020-00294-7  

    eISSN:2197-1714

    詳細を見る 詳細を閉じる

    <title>Abstract</title><sec> <title>Background</title> In Japan, the latest estimates of excess all-cause deaths through January to July 2020 showed that the overall (direct and indirect) mortality burden from the Coronavirus Disease 2019 (COVID-19) in Japan was relatively low compared to Europe and the United States. However, consistency between the reported number of COVID-19 deaths and excess all-cause deaths was limited across prefectures, suggesting the necessity of distinguishing the direct and indirect consequences of COVID-19 by cause-specific analysis. To examine whether deaths from road injuries decreased during the COVID-19 pandemic in Japan, consistent with a possible reduction of road transport activity connected to Japan’s state of emergency declaration, we estimated the exiguous deaths from road injuries in each week from January to September 2020 by 47 prefectures. </sec><sec> <title>Methods</title> To estimate the expected weekly number of deaths from road injuries, a quasi-Poisson regression was applied to daily traffic fatalities data obtained from Traffic Accident Research and Data Analysis, Japan. We set two thresholds, point estimate and lower bound of the two-sided 95% prediction interval, for exiguous deaths, and report the range of differences between the observed number of deaths and each of these thresholds as exiguous deaths. </sec><sec> <title>Results</title> Since January 2020, in a few weeks the observed deaths from road injuries fell below the 95% lower bound, such as April 6–12 (exiguous deaths 5–21, percent deficit 2.82–38.14), May 4–10 (8–23, 21.05–43.01), July 20–26 (12–29, 30.77–51.53), and August 3–9 (3–20, 7.32–34.41). However, those less than the 95% lower bound were also observed in weeks in the previous years. </sec><sec> <title>Conclusions</title> The number of road traffic fatalities during the COVID-19 pandemic in Japan has decreased slightly, but not significantly, in several weeks compared with the average year. This suggests that the relatively small changes in excess all-cause mortality observed in Japan during the COVID-19 pandemic could not be explained simply by an offsetting reduction in traffic deaths. Considering a variety of other indirect effects, evaluating an independent, unbiased measure of COVID-19-related mortality burden could provide insight into the design of future broad-based infectious disease counter-measures and offer lessons to other countries. </sec>

  194. Digitization of the approach to food and nutrition respecting individual health values 査読有り

    Nomura, S., Miyata, H.

    Nutrition Reviews 78 (Supplement_3) 46-48 2020年11月30日

    出版者・発行元: Oxford University Press (OUP)

    DOI: 10.1093/nutrit/nuaa073  

    ISSN:0029-6643 1753-4887

    eISSN:1753-4887

  195. Prediction of disability-adjusted life years for diseases due to low fruit intake in 2017–2040 in Japan 国際誌 査読有り

    Daisuke Yoneoka, Shuhei Nomura, Shiori Tanaka, Aya Ishizuka, Ueda Peter, Santosh Kumar Rauniyar, Keiji Nakamura, Hisayuki Uneyama, Naoki Hayashi, Kenji Shibuya

    Public Health Nutrition 24 (10) 1-11 2020年11月13日

    出版者・発行元: Cambridge University Press (CUP)

    DOI: 10.1017/s1368980020004541  

    ISSN:1368-9800

    eISSN:1475-2727

    詳細を見る 詳細を閉じる

    <title>Abstract</title> <sec id="S1368980020004541_as1"> <title>Objective:</title> The current study aimed to predict disability-adjusted life years (DALY) rate in Japan through 2040 with plausible future scenarios of fruit intake for neoplasms, cardiovascular diseases (CVD) and diabetes and kidney diseases (DKD). </sec> <sec id="S1368980020004541_as2"> <title>Design:</title> Data from National Health and Nutrition Surveys and the Global Burden of Diseases study in 2017 were used. We developed an autoregressive integrated moving average model with four future scenarios. Reference scenario maintains the current trend. Best scenario assumes that the goal defined in Health Japan 21 is achieved in 2023 and is kept constant afterwards. Moderate scenario assumes that the goal is achieved in 2040. Constant scenario applies the same proportion of 2016 for the period between 2017 and 2040. </sec> <sec id="S1368980020004541_as3"> <title>Setting:</title> DALY rates in Japan were predicted for the period between 2017 and 2040. </sec> <sec id="S1368980020004541_as4"> <title>Participants:</title> Population aged more than than 20 years old. </sec> <sec id="S1368980020004541_as5"> <title>Results:</title> In our reference forecast, the DALY rates in all-ages group were projected to be stable for CVD and continue increasing for neoplasms and DKD. Age group-specific DALY rates for these three disease groups were forecasted to decrease, with some exceptions. Among men aged 20–49 years, DALY attributable to CVD differed substantially between the scenarios, implying that there is a significant potential for reducing the burden of CVD by increasing fruit intake at the population level. </sec> <sec id="S1368980020004541_as6"> <title>Conclusions:</title> Our scenario analysis shows that higher fruit intake is associated with lower disease burden in Japan. Further research is required to assess which policies and interventions can be used to achieve an increase in fruit intake as modelled in the scenarios of the current study. </sec>

  196. The herbivore’s dilemma: Trends in and factors associated with heterosexual relationship status and interest in romantic relationships among young adults in Japan—Analysis of national surveys, 1987–2015 国際誌 査読有り

    Cyrus Ghaznavi, Haruka Sakamoto, Shuhei Nomura, Anna Kubota, Daisuke Yoneoka, Kenji Shibuya, Peter Ueda

    PLOS ONE 15 (11) e0241571-e0241571 2020年11月9日

    出版者・発行元: Public Library of Science (PLoS)

    DOI: 10.1371/journal.pone.0241571  

    eISSN:1932-6203

    詳細を見る 詳細を閉じる

    <sec id="sec001"> <title>Background</title> It has been suggested that an increasing proportion of young adults in Japan have lost interest in romantic relationships, a phenomenon termed “herbivorization”. We assessed trends in heterosexual relationship status and self-reported interest in heterosexual romantic relationships in nationally representative data. </sec> <sec id="sec002"> <title>Methods</title> We used data from seven rounds of the National Fertility Survey (1987–2015) and included adults aged 18–39 years (18–34 years in the 1987 survey; sample size 11,683–17,675). Current heterosexual relationship status (married; unmarried but in a relationship; single) was estimated by sex, age group and survey year, with singles further categorized into those reporting interest vs. no interest in heterosexual romantic relationships. Information about same-sex relationships were not available. </sec> <sec id="sec003"> <title>Results</title> Between 1992 and 2015, the age-standardized proportion of 18-39-year-old Japanese adults who were single had increased steadily, from 27.4 to 40.7% among women and from 40.3 to 50.8% among men. This increase was largely driven by decreases in the proportion of married women aged 25–39 years and men aged 30–39 years, while those in a relationship had increased only slightly for women and remained stable for men. By 2015, the proportion of single women was 30.2% in those aged 30–34 years and 24.4% in those aged 35–39 years. The corresponding numbers for men were 39.3% and 32.4%. Around half of the singles (21.4% of all women and 25.1% of all men aged 18–39 years) reported that they had no interest in heterosexual romantic relationships. Single women and men who reported no interest in romantic relationships had lower income and educational levels and were less likely to have regular employment compared to those who reported such an interest. </sec> <sec id="sec004"> <title>Conclusions</title> In this analysis of heterosexual relationships in nationally representative data from Japan, singlehood among young adults had steadily increased over the last three decades. In 2015 around one in four women and one in three men in their thirties were unmarried and not in a heterosexual relationship. Half of the singles reported no interest in romantic relationships and these women and men had lower income and educational levels and were less likely to have regular employment. </sec>

  197. Trend change of the transmission route of COVID-19–related symptoms in Japan

    A. Eguchi, D. Yoneoka, S. Shi, Y. Tanoue, T. Kawashima, S. Nomura, K. Matsuura, K. Makiyama, K. Ejima, S. Gilmour, H. Nishiura, H. Miyata

    Public Health 187 157-160 2020年10月

    出版者・発行元: Elsevier BV

    DOI: 10.1016/j.puhe.2020.08.020  

    ISSN:0033-3506

  198. Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950–2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019 査読有り

    GBD 2019 Demographics Collaborators

    The Lancet 396 (10258) 1160-1203 2020年10月

    DOI: 10.1016/s0140-6736(20)30977-6  

    ISSN:0140-6736

    eISSN:1474-547X

  199. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 査読有り

    GBD 2019 Risk Factors Collaborators

    The Lancet 396 (10258) 1223-1249 2020年10月

    DOI: 10.1016/s0140-6736(20)30752-2  

    ISSN:0140-6736

    eISSN:1474-547X

  200. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 査読有り

    GBD 2019 Diseases and Injuries Collaborators

    The Lancet 396 (10258) 1204-1222 2020年10月

    DOI: 10.1016/s0140-6736(20)30925-9  

    ISSN:0140-6736

    eISSN:1474-547X

  201. Five insights from the Global Burden of Disease Study 2019 査読有り

    GBD 2019 Viewpoint Collaborators

    The Lancet 396 (10258) 1135-1159 2020年10月

    DOI: 10.1016/s0140-6736(20)31404-5  

    ISSN:0140-6736

    eISSN:1474-547X

  202. Large-scale epidemiological monitoring of the COVID-19 epidemic in Tokyo 査読有り

    Daisuke Yoneoka, Yuta Tanoue, Takayuki Kawashima, Shuhei Nomura, Shoi Shi, Akifumi Eguchi, Keisuke Ejima, Toshibumi Taniguchi, Haruka Sakamoto, Hiroyuki Kunishima, Stuart Gilmour, Hiroshi Nishiura, Hiroaki Miyata

    The Lancet Regional Health - Western Pacific 3 100016-100016 2020年10月

    出版者・発行元: Elsevier BV

    DOI: 10.1016/j.lanwpc.2020.100016  

    ISSN:2666-6065

  203. Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 査読有り

    GBD 2019 Universal Health Coverage Collaborators

    The Lancet 396 (10258) 1250-1284 2020年10月

    DOI: 10.1016/s0140-6736(20)30750-9  

    ISSN:0140-6736

    eISSN:1474-547X

  204. Effect and cost-effectiveness of national gastric cancer screening in Japan: a microsimulation modeling study. 国際誌 査読有り

    Hsi-Lan Huang, Chi Yan Leung, Eiko Saito, Kota Katanoda, Chin Hur, Chung Yin Kong, Shuhei Nomura, Kenji Shibuya

    BMC medicine 18 (1) 257-257 2020年9月14日

    DOI: 10.1186/s12916-020-01729-0  

    詳細を見る 詳細を閉じる

    BACKGROUND: A national endoscopic screening program for gastric cancer was rolled out in Japan in 2015. We used a microsimulation model to estimate the cost-effectiveness of current screening guidelines and alternative screening strategies in Japan. METHODS: We developed a microsimulation model that simulated a virtual population corresponding to the Japanese population in risk factor profile and life expectancy. We evaluated 15 endoscopic screening scenarios with various starting ages, stopping ages, and screening intervals. The primary outcomes were quality-adjusted life-years (QALYs), costs, and incremental cost-effectiveness ratio. Cost-effective screening strategies were determined using a willingness-to-pay threshold of $50,000 per QALY gained. One-way sensitivity and probabilistic sensitivity analyses were done to explore model uncertainty. RESULTS: Using the threshold of $50,000 per QALY, a triennial screening program for individuals aged 50 to 75 years was the cost-effective strategy, with an incremental cost-effectiveness ratio of $45,665. Compared with no endoscopic screening, this strategy is predicted to prevent 63% of gastric cancer mortality and confer 27.2 QALYs gained per 1000 individuals over a lifetime period. Current screening guidelines were not on the cost-effectiveness efficient frontier. The results were robust on one-way sensitivity analyses and probabilistic sensitivity analysis. CONCLUSIONS: This modeling study suggests that the endoscopic screening program in Japan would be cost-effective when implemented between age 50 and 75 years, with the screening repeated every 3 years. These findings underscore the need for further evaluation of the current gastric cancer screening recommendations.

  205. Inequalities and risk factors analysis in prevalence and management of hypertension in India and Nepal: a national and subnational study. 国際誌 査読有り

    Santosh Kumar Rauniyar, Md Mizanur Rahman, Md Shafiur Rahman, Sarah Krull Abe, Shuhei Nomura, Kenji Shibuya

    BMC public health 20 (1) 1341-1341 2020年9月3日

    DOI: 10.1186/s12889-020-09450-6  

    詳細を見る 詳細を閉じる

    BACKGROUND: Hypertension is one of the leading risk factors for cardiovascular diseases in India and Nepal. Socio-economic disparity in these two countries has created wide gap in management of hypertension. However, inequalities in prevalence and management (awareness, treatment, and control) of hypertension is poorly assessed. This study analyzes the risk factors associated with prevalence and management of hypertension in India and Nepal and assesses the wealth-and education-based inequalities in them. METHODS: This study used data from the Demographic and Health Survey; a cross-sectional survey conducted between January 2015 to December 2016 in India and June 2016 to January 2017 in Nepal. A total of 787,713 individuals in India and 14,454 individuals in Nepal aged between 15 and 49 years were included in the study. Respondents were classified as being hypertensive if their systolic blood pressure (SBP) readings were at least 140 mmHg or diastolic blood pressure (DBP) readings were at least 90 mmHg, or if they reported currently taking anti-hypertensive medication. Multilevel logistic regression models with random intercepts at household-and community-levels were used to identify the risk factors associated with prevalence and management of hypertension. For inequality assessment, slope index and relative index of inequalities in prevalence and management of hypertension were estimated. RESULTS: Overall prevalence of hypertension in India and Nepal were 11.4% (95% confidence interval (CI), 11.4-11.5) and 19.6% (95% CI, 18.9-20.2), respectively. Less than one-third of the hypertensive population received treatment and below 20% among them had their blood pressure controlled. In both countries, wealth-and education-based inequalities in awareness, treatment, and control of hypertension were significantly high in urban and rural areas. CONCLUSION: Wealth- and education-based inequalities in prevalence and management of hypertension were high among different socio-economic groups at national and sub-national levels. Tailored strategies are required to effectively manage hypertension in different regions by considering socio-economic and demographic factors.

  206. Forecasting disability-adjusted life years for chronic diseases: reference and alternative scenarios of salt intake for 2017–2040 in Japan 国際誌 査読有り

    Shuhei Nomura, Daisuke Yoneoka, Shiori Tanaka, Aya Ishizuka, Peter Ueda, Keiji Nakamura, Hisayuki Uneyama, Naoki Hayashi, Kenji Shibuya

    BMC Public Health 20 (1) 1475-1475 2020年9月

    出版者・発行元: Springer Science and Business Media LLC

    DOI: 10.1186/s12889-020-09596-3  

    eISSN:1471-2458

    詳細を見る 詳細を閉じる

    <title>Abstract</title> <sec> <title>Background</title> In Japan, a high-sodium diet is the most important dietary risk factor and is known to cause a range of health problems. This study aimed to forecast Japan’s disability-adjusted life year (DALYs) for chronic diseases that would be associated with high-sodium diet in different future scenarios of salt intake. We modelled DALY forecast and alternative future scenarios of salt intake for cardiovascular diseases (CVDs), chronic kidney diseases (CKDs), and stomach cancer (SC) from 2017 to 2040. </sec> <sec> <title>Methods</title> We developed a three-component model of disease-specific DALYs: a component on the changes in major behavioural and metabolic risk predictors including salt intake; a component on the income per person, educational attainment, and total fertility rate under 25 years; and an autoregressive integrated moving average model to capture the unexplained component correlated over time. Data on risk predictors were obtained from Japan’s National Health and Nutrition Surveys and from the Global Burden of Disease Study 2017. To generate a reference forecast of disease-specific DALY rates for 2017–2040, we modelled the three diseases using the data for 1990–2016. Additionally, we generated better, moderate, and worse scenarios to evaluate the impact of change in salt intake on the DALY rate for the diseases. </sec> <sec> <title>Results</title> In our reference forecast, the DALY rates across all ages were predicted to be stable for CVDs, continuously increasing for CKDs, and continuously decreasing for SC. Meanwhile, the age group-specific DALY rates for these three diseases were forecasted to decrease, with some exceptions. Except for the ≥70 age group, there were remarkable differences in DALY rates between scenarios, with the best scenario having the lowest DALY rates in 2040 for SC. This represents a wide scope of future trajectories by 2040 with a potential for tremendous decrease in SC burden. </sec> <sec> <title>Conclusions</title> The gap between scenarios provides some quantification of the range of policy impacts on future trajectories of salt intake. Even though we do not yet know the policy mix used to achieve these scenarios, the result that there can be differences between scenarios means that policies today can have a significant impact on the future DALYs. </sec>

  207. Timeliness of routine vaccination among children and determinants associated with age-appropriate vaccination in Mongolia 国際誌 査読有り

    Santosh Kumar Rauniyar, Enkhtuya Munkhbat, Peter Ueda, Daisuke Yoneoka, Kenji Shibuya, Shuhei Nomura

    Heliyon 6 (9) e04898 2020年9月

    出版者・発行元: Elsevier {BV}

    DOI: 10.1016/j.heliyon.2020.e04898  

    詳細を見る 詳細を閉じる

    Introduction: Routine vaccination at the recommended age is crucial to minimize the risk of acquiring vaccine preventable diseases. This study aimed to assess the proportion of children receiving routine immunization at the recommended age and determinants of timely (age-appropriate) vaccination in Mongolia. Material and method: A total of 879 eligible children aged 12-23 months were included in this study. We investigated age-appropriate administration of Bacillus Calmette-Guerin vaccine (BCG); hepatitis B vaccine (Hep B); oral polio vaccine (OPV); pentavalent vaccine; and measles, mumps, and rubella vaccine (MMR) using Kaplan-Meier method. Multilevel logistic regression with random intercept at cluster level was used to assess the determinants of age-appropriate vaccination. Results: Overall, the crude vaccination coverage for routine vaccinations were above 90% for all vaccines except MMR1 which was 86.0% (95% CI, 83.6-88.2). While the first dose of almost all the vaccines given at birth; BCG, Hep B, and OPV0, were administered in a timely manner, a substantial proportion of second and third doses of these vaccines were not given in a timely manner with age-appropriate vaccination coverage ranging from 35.9% (32.8-39.1%) for MMR1 to 67.7% (64.5-70.7%) for OPV1 respectively. Factors associated with age-appropriate administration of the investigated vaccines included socio-economic status of household, religion of household heads, area of residence, owning mobile phone, and season of childbirth. For instance, children belonging to households from richer wealth quintile had higher possibilities of getting age-appropriate OPV1-OPV3, PE1-PE3 and MMR1 vaccines compared to those from the poorest household wealth quintile. Conclusion: Our findings suggest that the commonly used indicator 'crude vaccination coverage' could be supplemented by 'age-appropriate vaccination' to help to identify gaps in timely vaccinations and stimulate interventions in Mongolia. Factors such as household wealth quintile, place of residence and religion associated with timely vaccination in our study could be considered to promote effective intervention aiming to improve adequate vaccination coverage.

  208. Early SNS-Based Monitoring System for the COVID-19 Outbreak in Japan: A Population-Level Observational Study. 査読有り

    Daisuke Yoneoka, Takayuki Kawashima, Yuta Tanoue, Shuhei Nomura, Keisuke Ejima, Shoi Shi, Akifumi Eguchi, Toshibumi Taniguchi, Haruka Sakamoto, Hiroyuki Kunishima, Stuart Gilmour, Hiroshi Nishiura, Hiroaki Miyata

    Journal of epidemiology 30 (8) 362-370 2020年8月5日

    DOI: 10.2188/jea.JE20200150  

    詳細を見る 詳細を閉じる

    BACKGROUND: The World Health Organization declared the novel coronavirus outbreak (COVID-19) to be a pandemic on March 11, 2020. Large-scale monitoring for capturing the current epidemiological situation of COVID-19 in Japan would improve preparation for and prevention of a massive outbreak. METHODS: A chatbot-based healthcare system named COOPERA (COvid-19: Operation for Personalized Empowerment to Render smart prevention And care seeking) was developed using the LINE app to evaluate the current Japanese epidemiological situation. LINE users could participate in the system either though a QR code page in the prefectures' websites or a banner at the top of the LINE app screen. COOPERA asked participants questions regarding personal information, preventive actions, and non-specific symptoms related to COVID-19 and their duration. We calculated daily cross correlation functions between the reported number of infected cases confirmed using polymerase chain reaction and the symptom-positive group captured by COOPERA. RESULTS: We analyzed 206,218 participants from three prefectures reported between March 5 and 30, 2020. The mean age of participants was 44.2 (standard deviation, 13.2) years. No symptoms were reported by 96.93% of participants, but there was a significantly positive correlation between the reported number of COVID-19 cases and self-reported fevers, suggesting that massive monitoring of fever might help to estimate the scale of the COVID-19 epidemic in real time. CONCLUSIONS: COOPERA is the first real-time system being used to monitor trends in COVID-19 in Japan and provides useful insights to assist political decisions to tackle the epidemic.

  209. An assessment of self-reported COVID-19 related symptoms of 227,898 users of a social networking service in Japan: Has the regional risk changed after the declaration of the state of emergency? 査読有り

    Shuhei Nomura, Daisuke Yoneoka, Shoi Shi, Yuta Tanoue, Takayuki Kawashima, Akifumi Eguchi, Kentaro Matsuura, Koji Makiyama, Keisuke Ejima, Toshibumi Taniguchi, Haruka Sakamoto, Hiroyuki Kunishima, Stuart Gilmour, Hiroshi Nishiura, Hiroaki Miyata

    The Lancet Regional Health - Western Pacific 1 100011-100011 2020年8月

    出版者・発行元: Elsevier BV

    DOI: 10.1016/j.lanwpc.2020.100011  

    ISSN:2666-6065

  210. Travel restrictions and sars-cov-2 transmission: An effective distance approach to estimate impact 査読有り

    Shoi Shi, Shiori Tanaka, Ryo Ueno, Stuart Gilmour, Yuta Tanoue, Takayuki Kawashima, Shuhei Nomura, Akifumi Eguchi, Hiroaki Miyata, Daisuke Yoneoka

    Bulletin of the World Health Organization 98 (8) 518-529 2020年8月

    DOI: 10.2471/BLT.20.255679  

    ISSN:0042-9686

    eISSN:1564-0604

  211. Time to Reconsider Diverse Ways of Working in Japan to Promote Social Distancing Measures against the COVID-19 査読有り

    Shuhei Nomura, Daisuke Yoneoka, Yuta Tanoue, Takayuki Kawashima, Shoi Shi, Akifumi Eguchi, Hiroaki Miyata

    Journal of Urban Health 97 (4) 457-460 2020年8月1日

    DOI: 10.1007/s11524-020-00464-4  

    ISSN:1099-3460

    eISSN:1468-2869

  212. Loss of working life years due to mortality, sickness absence, or ill-health retirement: A comprehensive approach to estimating disease burden in the workplace.

    Yosuke Inoue, Shuhei Nomura, Chihiro Nishiura, Ai Hori, Kenya Yamamoto, Tohru Nakagawa, Toru Honda, Shuichiro Yamamoto, Masafumi Eguchi, Takeshi Kochi, Toshiaki Miyamoto, Hiroko Okazaki, Teppei Imai, Akiko Nishihara, Takayuki Ogasawara, Naoko Sasaki, Akihiko Uehara, Makoto Yamamoto, Makiko Shimizu, Maki Konishi, Isamu Kabe, Tetsuya Mizoue, Seitaro Dohi

    Journal of epidemiology 2020年7月25日

    DOI: 10.2188/jea.JE20190332  

    詳細を見る 詳細を閉じる

    BACKGROUND: While much effort has focused on quantifying disease burden in occupational health, no study has simultaneously assessed disease burden in terms of mortality and morbidity. We aimed to propose a new comprehensive method of quantifying the disease burden in the workplace. METHOD: The data were obtained from the Japan Epidemiology Collaboration on Occupational Health (J-ECOH) Study, a large-scale prospective study of approximately 80,000 workers. We defined disease burden in the workplace as the number of working years lost among the working population during a 6-year period (April 2012 to March 2018). We calculated the disease burden according to consequences of health problems (i.e., mortality, sickness absence [SA], and ill-health retirement) and disease category. We also calculated the age-group- (20-39 and 40-59 years old) and sex-specific disease burden. RESULTS: The largest contributors to disease burden in the workplace were mental and behavioural disorders (47.0 person-years lost per 10,000 person-years of working years, i.e., per myriad [proportion]), followed by neoplasms (10.8 per myriad) and diseases of the circulatory system (7.1 per myriad). While mental and behavioural disorders made a greater contribution to SA and ill-health retirement compared to mortality, the latter two disorders were the largest contributors to the disease burden in the workplace due to mortality. The number of working years lost was greater among younger vs. older female participants, whereas the opposite trend was observed in males. CONCLUSIONS: Our approach is in contrast to those in previous studies that focused exclusively on mortality or morbidity.

  213. Contributions of information and communications technology to future health systems and Universal Health Coverage: application of Japan’s experiences

    Shuhei Nomura, Vera Siesjö, Göran Tomson, Wiebke Mohr, Eriko Fukuchi, Kenji Shibuya, Viroj Tangcharoensathien, Hiroaki Miyata

    Health Research Policy and Systems 18 (1) 2020年6月

    出版者・発行元: Springer Science and Business Media {LLC}

    DOI: 10.1186/s12961-020-00585-x  

    ISSN:1478-4505

  214. Cancer incidence attributable to tuberculosis in 2015: global, regional, and national estimates. 国際誌 査読有り

    Chi Yan Leung, Hsi-Lan Huang, Md Mizanur Rahman, Shuhei Nomura, Sarah Krull Abe, Eiko Saito, Kenji Shibuya

    BMC cancer 20 (1) 412-412 2020年5月12日

    DOI: 10.1186/s12885-020-06891-5  

    詳細を見る 詳細を閉じる

    BACKGROUND: Tuberculosis is associated with increased risk of cancer. However, the impact of tuberculosis on global cancer burden is unknown. METHODS: We performed random-effects meta-analyses and meta-regressions of studies reporting the association between tuberculosis and cancer risks by searching PubMed, Web of Science, Embase, Cochrane library, and CINAHL from inception to 1 June 2019. Population attributable fractions (PAFs) of cancer incidence attributable to tuberculosis were calculated using relative risks from our meta-analyses and tuberculosis prevalence data from Global Health Data Exchange by age, sex, and country. The study has been registered with PROSPERO (CRD42016050691). RESULTS: Fourty nine studies with 52,480 cancer cases met pre-specified inclusion criteria. Tuberculosis was associated with head and neck cancer (RR 2.64[95% CI 2.00-3.48]), hepatobiliary cancer (2.43[1.82-3.25]), Hodgkin's lymphoma (2.19[1.62-2.97]), lung cancer (1.69[1.46-1.95]), gastrointestinal cancer (1.62[1.26-2.08]), non-Hodgkin's lymphoma (1.61[1.34-1.94]), pancreatic cancer (1.58[1.28-1.96]), leukaemia (1.55[1.25-1.93]), kidney and bladder cancer (1.54[1.21-1.97]), and ovarian cancer (1.43[1.04-1.97]). We estimated that 2.33%(1.14-3.81) or 381,035(187145-623,404) of global cancer incidences in 2015 were attributable to tuberculosis. The PAFs varied by Socio-demographic Index (SDI)-ranging from 1.28% (0.57-2.31%) in the high-SDI countries to 3.51% (1.84-5.42%) in the middle-SDI countries. Individually, China and India accounted for 47% of all tuberculosis-related cancer cases. CONCLUSIONS: Tuberculosis is associated with increased risk of cancer at ten sites. The burden of tuberculosis attributable cancer skewed towards lower resource countries. Research priorities are to better understand regional disparities and underlying mechanism linking tuberculosis and cancer development.

  215. Mental health of family, friends, and co-workers of COVID-19 patients in Japan. 国際誌 査読有り

    Yuta Tanoue, Shuhei Nomura, Daisuke Yoneoka, Takayuki Kawashima, Akifumi Eguchi, Shoi Shi, Nahoko Harada, Hiroaki Miyata

    Psychiatry research 291 113067-113067 2020年5月6日

    出版者・発行元: Elsevier BV

    DOI: 10.1016/j.psychres.2020.113067  

    ISSN:0165-1781

    詳細を見る 詳細を閉じる

    As the coronavirus disease 2019 (COVID-19) pandemic rages on, the mental health of both the infected and non-infected is a rising concern. We used administrative survey data (16402 responses in the last two weeks) using a chatbot on LINE, the most popular social networking service (SNS) in Japan, to show that people with COVID-19 patients in a close setting had higher psychological distress level than those without. We believe that the results indicate an urgent need to prioritize the establishment and implementation of mental health and psychosocial support tailored to family, close relatives, and friends of COVID-19 patients.

  216. The relationship between fever rate and telework implementation as a social distancing measure against the COVID-19 pandemic in Japan 査読有り

    Takayuki Kawashima, Shuhei Nomura, Yuta Tanoue, Daisuke Yoneoka, Akifumi Eguchi, Shoi Shi, Hiroaki Miyata

    Public Health 2020年5月

    出版者・発行元: Elsevier BV

    DOI: 10.1016/j.puhe.2020.05.018  

    ISSN:0033-3506

  217. Tracking Japan's development assistance for health, 2012-2016. 国際誌

    Shuhei Nomura, Haruka Sakamoto, Maaya Kita Sugai, Haruyo Nakamura, Keiko Maruyama-Sakurai, Sangnim Lee, Aya Ishizuka, Kenji Shibuya

    Globalization and health 16 (1) 32-32 2020年4月15日

    DOI: 10.1186/s12992-020-00559-2  

    詳細を見る 詳細を閉じる

    BACKGROUND: Development assistance for health (DAH) is one of the most important means for Japan to promote diplomacy with developing countries and contribute to the international community. This study, for the first time, estimated the gross disbursement of Japan's DAH from 2012 to 2016 and clarified its flows, including source, aid type, channel, target region, and target health focus area. METHODS: Data on Japan Tracker, the first data platform of Japan's DAH, were used. The DAH definition was based on the Organisation for Economic Co-operation and Development's (OECD) sector classification. Regarding core funding to non-health-specific multilateral agencies, we estimated DAH and its flows based on the OECD methodology for calculating imputed multilateral official development assistance (ODA). RESULTS: Japan's DAH was estimated at 1472.94 (2012), 823.15 (2013), 832.06 (2014), 701.98 (2015), and 894.57 million USD (2016) in constant prices of 2016. Multilateral agencies received the largest DAH share of 44.96-57.01% in these periods, followed by bilateral grants (34.59-53.08%) and bilateral loans (1.96-15.04%). Ministry of Foreign Affairs (MOFA) was the largest contributors to the DAH (76.26-82.68%), followed by Ministry of Finance (MOF) (10.86-16.25%). Japan's DAH was most heavily distributed in the African region with 41.64-53.48% share. The channel through which the most DAH went was Global Fund to Fight AIDS, Tuberculosis, and Malaria (20.04-34.89%). Between 2012 and 2016, approximately 70% was allocated to primary health care and the rest to health system strengthening. CONCLUSIONS: With many major high-level health related meetings ahead, coming years will play a powerful opportunity to reevaluate DAH and shape the future of DAH for Japan. We hope that the results of this study will enhance the social debate for and contribute to the implementation of Japan's DAH with a more efficient and effective strategy.

  218. Associations between parental socioeconomic position and health-seeking behaviour for diarrhoea and acute respiratory infection among under-5 children in Myanmar: a cross-sectional study. 国際誌 査読有り

    Kaung Suu Lwin, Shuhei Nomura, Daisuke Yoneoka, Peter Ueda, Sarah Krull Abe, Kenji Shibuya

    BMJ open 10 (3) e032039 2020年3月26日

    DOI: 10.1136/bmjopen-2019-032039  

    詳細を見る 詳細を閉じる

    OBJECTIVES: To examine the associations of parental social and economic position with health-seeking behaviour for diarrhoea and acute respiratory infection (ARI) among under-5 children in Myanmar and explore potential underlying mechanisms. DESIGN: A cross-sectional study. SETTING: A secondary dataset from the nationwide 2015-2016 Myanmar Demographic and Health Survey (MDHS). PARTICIPANTS: All under-5 children in the sampled households with reported symptoms of diarrhoea and ARI during the 2-week period preceding the MDHS survey interview. PRIMARY AND SECONDARY OUTCOME MEASURES: Four parental health-seeking behaviours: 'seeking treatment', 'formal health provider', 'public provider' and 'private provider' were considered. Social and economic positions were determined by confirmatory factor analysis. Multilevel logistic regressions were employed to examine the associations of social and economic positions with health-seeking behaviours for diarrhoea and ARI. Mediation analyses were conducted to explore potential underlying mechanisms in these associations. RESULTS: Of the 4099 under-5 children from the sampled households in MDHS, 427 (10.4%) with diarrhoea and 131 (3.2%) with ARI were considered for the analyses. For diarrhoea, social position was positively associated with seeking treatment and private provider use (adjusted OR: 1.60 (95% CIs: 1.07 to 2.38) and 1.83 (1.00 to 3.34), respectively). Economic position was positively associated with private provider use for diarrhoea (1.57 (1.07 to 2.30)). Negative associations were observed between social and economic positions with public provider use for diarrhoea (0.55 (0.30 to 0.99) and 0.64 (0.43 to 0.94), respectively). Social position had more influence than economic position on parental health-seeking behaviour for children with diarrhoea. No evidence for a significant association of social and economic position with health-seeking for ARI was observed. CONCLUSIONS: Social and economic positions were possible determinants of health-seeking behaviour for diarrhoea among children; and social position had more influence than economic position. The results of this study may contribute to improve relevant interventions for diarrhoea and ARI among children in Myanmar.

  219. Impact of travel restrictions on importation of novel coronavirus infection: An effective distance approach 査読有り

    Shoi Shi, Shiori Tanaka, Ryo Ueno, Stuart Gilmour, Yuta Tanoue, Takayuki Kawashima, Shuhei Nomura, Hiroaki Miyata, Daisuke Yoneoka

    Bulletin of the World Health Organization 2020年3月18日

  220. Implementing a sustainable health insurance system in Cambodia: a study protocol for developing and validating an efficient household income-level assessment model for equitable premium collection. 国際誌 査読有り

    Haruyo Nakamura, Floriano Amimo, Siyan Yi, Sovannary Tuot, Tomoya Yoshida, Makoto Tobe, Shuhei Nomura

    International journal for equity in health 19 (1) 17-17 2020年1月31日

    DOI: 10.1186/s12939-020-1126-8  

    詳細を見る 詳細を閉じる

    BACKGROUND: As elsewhere in low- and middle-income countries, due to limited fiscal resources, universal health coverage (UHC) remains a challenge in Cambodia. Since 2016, the National Social Security Fund (NSSF) has implemented a social health insurance scheme with a contributory approach for formal sector workers. However, informal sector workers and dependents of formal sector workers are still not covered by this insurance because it is difficult to set an optimal amount of contribution for such individuals as their income levels are inestimable. The present study aims to develop and validate an efficient household income-level assessment model for Cambodia. We aim to help the country implement a financially sustainable social health insurance system in which the insured can pay contributions according to their ability. METHODS: This study will use nationally representative data collected by the Cambodia Socio-Economic Survey (CSES), covering the period from 2009 to 2019, and involving a total of 50,016 households. We will employ elastic net regression analysis, with per capita disposable income based on purchasing power parity as the dependent variable, and individual and community-level socioeconomic and demographic characteristics as independent variables. These analyses aim to create efficient income-level assessment models for health insurance contribution estimation. To fully capture socioeconomic heterogeneity, sub-group analyses will be conducted to develop separate income-level assessment models for urban and rural areas, as well as for each province. DISCUSSION: This research will help Cambodia implement a sustainable social health insurance system by collecting optimal amount of contributions from each socioeconomic group of the society. Incorporation of this approach into existing NSSF schemes will enhance the country's current efforts to prevent impoverishing health expenditure and to achieve UHC.

  221. The trajectories of local food avoidance after the Fukushima Daiichi nuclear plant disaster: A five-year prospective cohort study

    Yoshitake Takebayashi, Michio Murakami, Shuhei Nomura, Tomoyoshi Oikawa, MasaharuTsubokura

    International Journal of Disaster Risk Reduction 46 101513 2020年1月29日

  222. Assessing the quality of cause of death data in six high-income countries: Australia, Canada, Denmark, Germany, Japan and Switzerland. 国際誌 査読有り

    Lene Mikkelsen, Kim Moesgaard Iburg, Tim Adair, Thomas Fürst, Michael Hegnauer, Elena von der Lippe, Lauren Moran, Shuhei Nomura, Haruka Sakamoto, Kenji Shibuya, Annelene Wengler, Stephanie Willbond, Patricia Wood, Alan D Lopez

    International journal of public health 65 (1) 17-28 2020年1月

    DOI: 10.1007/s00038-019-01325-x  

    詳細を見る 詳細を閉じる

    OBJECTIVES: To assess the policy utility of national cause of death (COD) data of six high-income countries with highly developed health information systems. METHODS: National COD data sets from Australia, Canada, Denmark, Germany, Japan and Switzerland for 2015 or 2016 were assessed by applying the ANACONDA software tool. Levels, patterns and distributions of unusable and insufficiently specified "garbage" codes were analysed. RESULTS: The average proportion of unusable COD was 18% across the six countries, ranging from 14% in Australia and Canada to 25% in Japan. Insufficiently specified codes accounted for a further 8% of deaths, on average, varying from 6% in Switzerland to 11% in Japan. The most commonly used garbage codes were Other ill-defined and unspecified deaths (R99), Heart failure (I50.9) and Senility (R54). CONCLUSIONS: COD certification errors are common, even in countries with very advanced health information systems, greatly reducing the policy value of mortality data. All countries should routinely provide certification training for hospital interns and raise awareness among doctors of their public health responsibility to certify deaths correctly and usefully for public health policy.

  223. Limited alignment of publicly competitive disease funding with disease burden in Japan. 国際誌 査読有り

    Shuhei Nomura, Daisuke Yoneoka, Shiori Tanaka, Ryoko Makuuchi, Haruka Sakamoto, Aya Ishizuka, Haruyo Nakamura, Anna Kubota, Kenji Shibuya

    PloS one 15 (2) e0228542 2020年

    DOI: 10.1371/journal.pone.0228542  

    詳細を見る 詳細を閉じる

    OBJECTIVE: The need to align investments in health research and development (R&D) with public health needs is one of the most important public health challenges in Japan. We examined the alignment of disease-specific publicly competitive R&D funding to the disease burden in the country. METHODS: We analyzed publicly available data on competitive public funding for health in 2015 and 2016 and compared it to disability-adjusted life year (DALYs) in 2016, which were obtained from the Global Burden of Disease (GBD) 2017 study. Their alignment was assessed as a percentage distribution among 22 GBD disease groups. Funding was allocated to the 22 disease groups based on natural language processing, using textual information such as project title and abstract for each research project, while considering for the frequency of information. RESULTS: Total publicly competitive funding in health R&D in 2015 and 2016 reached 344.1 billion JPY (about 3.0 billion USD) for 32,204 awarded projects. About 49.5% of the funding was classifiable for disease-specific projects. Five GDB disease groups were significantly and relatively well-funded compared to their contributions to Japan's DALY, including neglected tropical diseases and malaria (funding vs DALY = 1.7% vs 0.0%, p<0.01) and neoplasms (28.5% vs 19.2%, p<0.001). In contrast, four GDB disease groups were significantly under-funded, including cardiovascular diseases (8.0% vs 14.8%, p<0.001) and musculoskeletal disorders (1.0% vs 11.9%, p<0.001). These percentages do not include unclassifiable funding. CONCLUSIONS: While caution is necessary as this study was not able to consider public in-house funding and the methodological uncertainties could not be ruled out, the analysis may provide a snapshot of the limited alignment between publicly competitive disease-specific funding and the disease burden in the country. The results call for greater management over the allocation of scarce resources on health R&D. DALYs will serve as a crucial, but not the only, consideration in aligning Japan's research priorities with the public health needs. In addition, the algorithms for natural language processing used in this study require continued efforts to improve accuracy.

  224. Reducing childhood malnutrition in Bangladesh: the importance of addressing socio-economic inequalities. 国際誌 査読有り

    Md Rashedul Islam, Md Shafiur Rahman, Md Mahfuzur Rahman, Shuhei Nomura, Angela de Silva, Pulani Lanerolle, Jenny Jung, Md Mizanur Rahman

    Public health nutrition 23 (1) 72-82 2020年1月

    DOI: 10.1017/S136898001900140X  

    ISSN:1368-9800

    詳細を見る 詳細を閉じる

    OBJECTIVE: To obtain projections of the prevalence of childhood malnutrition indicators up to 2030 and to analyse the changes of wealth-based inequality in malnutrition indicators and the degree of contribution of socio-economic determinants to the inequities in malnutrition indicators in Bangladesh. Additionally, to identify the risk factors of childhood malnutrition. DESIGN: Cross-sectional study. A Bayesian linear regression model was used to estimate trends and projections of malnutrition. For equity analysis, slope index, relative index and decomposition in concentration index were used. Multilevel logistic models were used to identify risk factors of malnutrition. SETTING: Household surveys in Bangladesh from 1996 to 2014. PARTICIPANTS: Children under the age of 5 years. RESULTS: A decreasing trend was observed for all malnutrition indices. In 1990, predicted prevalence of stunting, wasting and underweight was 55·0, 15·9 and 61·8 %, respectively. By 2030, prevalence is projected to reduce to 28·8 % for stunting, 12·3 % for wasting and 17·4 % for underweight. Prevalence of stunting, wasting and underweight were 34·3, 6·9 and 32·8 percentage points lower in the richest households than the poorest households. Contribution of the wealth index to child malnutrition increased over time and the largest contribution of pro-poor inequity was explained by wealth index. Being an underweight mother, parents with a lower level of education and poorer households were the key risk factors for stunting and underweight. CONCLUSIONS: Our findings show an evidence-based need for targeted interventions to improve education and household income-generating activities among poor households to reduce inequalities and reduce the burden of child malnutrition in Bangladesh.

  225. Low dose of external exposure among returnees to former evacuation areas: a cross-sectional all-municipality joint study following the 2011 Fukushima Daiichi nuclear power plant incident. 国際誌 査読有り

    Shuhei Nomura, Michio Murakami, Wataru Naito, Tetsuo Yasutaka, Toyoaki Sawano, Masaharu Tsubokura

    Journal of radiological protection : official journal of the Society for Radiological Protection 40 (1) 1-18 2019年12月6日

    DOI: 10.1088/1361-6498/ab49ba  

    ISSN:0952-4746

    詳細を見る 詳細を閉じる

    There is little information on the radiation dose levels of returnees to areas once designated as legal no-go zones, after evacuation orders were lifted subsequent to the 2011 Fukushima Daiichi nuclear power plant incident. This study used individual radiation dosimeter monitoring and a location history survey to conduct the most recent dose assessment of external exposure among returnees to former no-go zones. We specifically determined correlation and agreement between external doses and the air dose rate in residential areas and quantified both uncertainty and population variability of the observed data using Monte Carlo (MC) simulation methods. A total of 239 voluntary participants across ten municipalities were analysed; their representativeness of all affected municipal populations was confirmed in terms of air dose rate distribution in residential areas. We found that individual doses were statistically significantly correlated with the air dose rate based on government airborne monitoring. This implies that airborne monitoring can provide sufficient information for understanding dose levels among such returnees. The MC simulations demonstrated that the mean of the annual dose in 2019 (including natural background doses) was 0.93 (95% uncertainty interval 0.53-1.76) mSv, with limited variation between municipalities. As of 2019, this implies that doses from external exposure were very low among returnees and would be associated with a very low likelihood of physical effects according to current scientific consensus. However, these results should be taken with caution due to several study limitations, including selection and participation biases. Regardless, its findings will enhance societal debates about how both individual-dose and government airborne monitoring practices should operate in the future and how the government can improve the public outlook for radiation doses in incident-affected areas.

  226. A Comparative Survival Analysis Between Evacuees and Nonevacuees Among Dialysis Patients in Fukushima Prefecture After Japan's 2011 Fukushima Nuclear Incident. 国際誌 査読有り

    Shuhei Nomura, Yukie Matsuzaki, Yuko Sato, Jyunko Takasaki, Yuki Sonoda, Hiroaki Shimmura, Yuko Kodama

    Disaster medicine and public health preparedness 13 (5-6) 898-904 2019年12月

    DOI: 10.1017/dmp.2019.4  

    ISSN:1935-7893

    詳細を見る 詳細を閉じる

    OBJECTIVE: There has been little research on the health consequences of evacuation in the disaster context. A comparative analysis of survival between evacuated and nonevacuated hospital dialysis patients was conducted following Japan's Fukushima Dai-ichi nuclear power plant incident, which occurred on March 11, 2011. METHODS: The study included 554 patients (mean age: 70.9) receiving dialysis therapy at one of the Tokiwakai Group hospitals-all of which are located in and around Iwaki City, approximately 50 km from the Fukushima nuclear plant-as of the incident date. The patients' survival after the incident was tracked until March 3, 2017. Significant differences in mortality rates between postincident evacuees and nonevacuees were tested using the Bayesian survival analysis with Weibull multivariate regression. RESULTS: Out of 554 dialysis patients, 418 (75.5%) were evacuated after the incident. The postincident mortality rate (adjusted for covariates) of evacuees was not statistically significantly different from that of nonevacuees. The hazard ratio was 1.17 (95% credible intervals: 0.77-1.74). CONCLUSIONS: If performed in a well-planned manner with satisfactory arrangements for appropriate selection of evacuees and their transportation, evacuation could be a reasonable option, which might save more lives of vulnerable people.

  227. Meat subtypes and colorectal cancer risk: A pooled analysis of 6 cohort studies in Japan

    Zobida Islam, Shamima Akter, Ikuko Kashino, Tetsuya Mizoue, Norie Sawada, Nagisa Mori, Yoko Yamagiwa, Shoichiro Tsugane, Mariko Naito, Akiko Tamakoshi, Keiko Wada, Chisato Nagata, Yumi Sugawara, Ichiro Tsuji, Keitaro Matsuo, Hidemi Ito, Yingsong Lin, Yuri Kitamura, Atsuko Sadakane, Keitaro Tanaka, Manami Inoue, Motoki Iwasaki, Tetsuya Otani, Norie Sawada, Taichi Shimazu, Shoichiro Tsugane, Taiki Yamaji, Hadrien Charvat, Shizuka Sasazuki, Akiko Tamakoshi, Yoshikazu Nishino, Yoshitaka Tsubono, Tetsuya Mizoue, Shuhei Nomura, Hidekazu Suzuki, Hidemi Ito, Keitaro Matsuo, Isao Oze, Kenji Wakai, Yingsong Lin, Chisato Nagata, Keiko Wada, Yuri Kitamura, Tomio Nakayama, Mariko Naito, Kotaro Ozasa, Atsuko Sadakane, Mai Utada, Keitaro Tanaka

    CANCER SCIENCE 110 (11) 3603-3614 2019年11月

    DOI: 10.1111/cas.14188  

    ISSN:1347-9032

    eISSN:1349-7006

  228. Radiation doses and decontamination effects in Minamisoma city: airborne and individual monitoring after the Fukushima nuclear accident. 国際誌 査読有り

    Michio Murakami, Shuhei Nomura, Masaharu Tsubokura, Yoshitake Takebayashi, Kana Yamamoto, Tomoyoshi Oikawa

    Journal of radiological protection : official journal of the Society for Radiological Protection 39 (4) N27-N35-N35 2019年10月16日

    DOI: 10.1088/1361-6498/ab4e5a  

    ISSN:0952-4746

    詳細を見る 詳細を閉じる

    After the Fukushima accident, airborne monitoring was implemented to measure airborne radiation. We examined the relationships between airborne and individual radiation monitoring and clarified the use of airborne monitoring to evaluate the effects of decontamination on residents' received doses. We used the air dose rate data from four airborne monitors conducted between 2013 and 2016, and the dose data from four individual monitors (in which a total of 18 392 adults and 3650 children participated), conducted in Minamisoma City during the same period. We examined the Pearson correlation coefficients between the airborne and individual monitoring data and estimated exposure ratios (ERs; ratios of individual dose to air dose rates) among adults and children. We also estimated the effects of decontamination on residents' doses based on airborne monitoring data, adjusting this for timing and dosing through propensity score matching, which were then compared to individual monitoring data. There were significant correlations between airborne and individual monitoring doses among adults and children, and more than 80% of residents showed a good estimation-observation agreement within a factor of two. The median of ERs was 0.304 and 0.250 among adults and children, respectively. There was a significant difference between the two. Effects of decontamination on residents' doses estimated from airborne monitoring were significantly lower than those estimated from individual monitoring. These findings suggest that airborne monitoring can be used to estimate representative radiation doses within residential areas. It may be a useful tool for enhancing communication among stakeholders and supporting individual and policy decisions; however, it is less sensitive for evaluating individual effects of decontamination than individual monitoring. Combined use of airborne and individual monitoring also showed a lower median of ERs in children than in adults and in a Japanese government's model, possibly due to prioritised decontamination for children and differences between their behavioral patterns.

  229. Risk factors and regional variations of malnutrition among children under 5 in Myanmar: cross-sectional analyses at national and subnational levels. 国際誌 査読有り

    Hnin Thiri Khaing, Shuhei Nomura, Daisuke Yoneoka, Peter Ueda, Kenji Shibuya

    BMJ open 9 (9) e030894 2019年9月8日

    DOI: 10.1136/bmjopen-2019-030894  

    詳細を見る 詳細を閉じる

    OBJECTIVE: The levels, distributions of child malnutrition and its potential risk factors are not very well known in Myanmar. The objectives included in this study were: to estimate the current national and subnational prevalence of four types of malnutrition (stunting, wasting, underweight and overweight) among children under 5 in Myanmar; to identify potential risk factors associated with each type of malnutrition and to investigate how the identified risk factors' distributions explained the regional disparities in malnutrition prevalence. DESIGN/METHODS: Data from the Myanmar Demographic and Health Survey 2015-2016 were used to estimate the prevalence of four types of malnutrition at both national and subnational levels (15 regions). Logistic regression models were applied to examine the association between each type of malnutrition and its risk factors, including child's factors, parental social status and household conditions. The risk factor-adjusted prevalence of the malnutrition was estimated at the subnational level based on the estimated parameters from the regression models. RESULTS: The national prevalence of stunting, wasting, underweight and overweight in children under 5 was estimated to be 29.1% (95% CI 27.7% to 30.6%), 6.8% (6.0% to 7.6%), 18.3% (17.0% to 19.5%) and 1.5% (1.1% to 1.9%), respectively. Substantial regional variations in the prevalence of each type of malnutrition were observed. Several risk factors of each type of malnutrition were identified, including low birth weight (LBW) and inadequate maternal nutritional status. Except for overweight, regional variations largely persisted even after adjustment for the risk factors investigated. CONCLUSION: The prevalence of malnutrition among children under 5 is still high in Myanmar, most commonly stunting. Targeted interventions aimed at prevention of LBW, improving the maternal nutritional status, in addition to other sociodemographic conditions should be encouraged urgently. Further research is necessary to investigate the potential sources of regional variation in prevalence of malnutrition among children under 5 in the country.

  230. Breast Cancer Provider Interval Length in Fukushima, Japan, After the 2011 Triple Disaster: A Long-Term Retrospective Study. 国際誌 査読有り

    Akihiko Ozaki, Shuhei Nomura, Claire Leppold, Masaharu Tsubokura, Toyoaki Sawano, Manabu Tsukada, Tomohiro Morita, Tetsuya Tanimoto, Shigehira Saji, Shigeaki Kato, Kazue Yamaoka, Yoshinori Nakata, Hiromichi Ohira

    Clinical breast cancer 20 (2) e127-e150 2019年9月6日

    DOI: 10.1016/j.clbc.2019.07.008  

    詳細を見る 詳細を閉じる

    BACKGROUND: Minimizing the interval from symptom onset to treatment commencement is essential for a favorable outcome among breast cancer (BC) patients. This study examined whether provider interval (time elapsed from first consultation to treatment initiation) lengthened among BC patients after Japan's 2011 earthquake, tsunami, and nuclear disaster in Fukushima. Factors associated with the length of postdisaster interval and whether the interval was associated with BC stage were also investigated. PATIENTS AND METHODS: So-so District (study site) was an area damaged by the 2011 disasters. Data of all BC patients who made their first medical consultation and received initial treatment at the core medical institutions in the area 5 years before or after the disaster were extracted from patient medical records. We used several regression approaches to fulfill our study objectives. RESULTS: We included 263 (140 predisaster and 123 postdisaster) patients. After adjustment for covariates, the interval did not significantly change after the disaster compared to before the disaster. Those with 4 or 5 cohabiting family members experienced a shorter interval after the disaster than those with 0 or 1 cohabiting family members (relative length, 0.47; 95% confidence interval, 0.28-0.78). Those with an interval of > 60 days had lower odds of stage III or IV cancer after the disaster than those with an interval of < 30 days (odds ratio, 0.09; 95% confidence interval, 0.01-0.84). CONCLUSION: Overall, provider interval did not lengthen after the disaster. However, those with fewer cohabiting family members might have experienced a longer total interval. Cancer stage may not necessarily reflect the influence of interval on patient outcome.

  231. Impact of decontamination on individual radiation doses from external exposure among residents of Minamisoma City after the 2011 Fukushima Daiichi nuclear power plant incident in Japan: a retrospective observational study. 国際誌 査読有り

    Masaharu Tsubokura, Michio Murakami, Yoshitake Takebayashi, Shuhei Nomura, Kyoko Ono, Akihiko Ozaki, Toyoaki Sawano, Yurie Kobashi, Tomoyoshi Oikawa

    Journal of radiological protection : official journal of the Society for Radiological Protection 39 (3) 854-871 2019年9月

    DOI: 10.1088/1361-6498/ab280e  

    ISSN:0952-4746

    詳細を見る 詳細を閉じる

    Following the Fukushima incident, radiation doses from external exposure accounted for the majority of the total doses. Although countermeasures are being implemented, with the aim of reducing radiation exposure, little information is available on the effects of decontamination on individual doses among the residents of radioactively contaminated areas. To evaluate the effectiveness of the decontamination measures in reducing individual doses, and to examine the influence of the timing of decontamination and the district, data were analysed for 18 392 adults and 3 650 children in Minamisoma City, Fukushima, who participated in a voluntary screening programme using individual radiation dosimeters (Glass Badge) between June 2013 and September 2016. The dose reduction rates (DRR) were calculated for one year by comparing the first and last three-month measurement results between areas with and without decontamination. Using a regression approach and Monte Carlo simulation, the dose reduction rate by decontamination eliminating the effect of physical decay (DRRd') was also estimated as a function of the timing of the decontamination and the dose at the time of starting the decontamination. The annual DRR in areas with decontamination for both adults and children were significantly higher than those in areas without decontamination, depending on the timing of decontamination: 31%-36% for 2013-14 for adults in decontamination areas and 33%-35% for children in decontamination areas, compared to 12%-23% and 13%-23% for adults and children in areas without decontamination, respectively. There was a positive correlation between DRRd' and individual doses, and DRRd' was estimated at 30%-40% for adults and children with doses of 3 mSv y-1 in 2013 and 2014. This study demonstrated that decontamination does lower individual doses from external exposure. The higher the dose at the time of starting the decontamination, the greater the dose reduction rate by decontamination, regardless of the timing of the decontamination. Our study confirms that decontamination was useful for high-dose areas in the later phases of the incident.

  232. Internal exposure risk due to radiocesium and the consuming behaviour of local foodstuffs among pregnant women in Minamisoma City near the Fukushima nuclear power plant: a retrospective observational study. 国際誌 査読有り

    Kana Yamamoto, Shuhei Nomura, Masaharu Tsubokura, Michio Murakami, Akihiko Ozaki, Claire Leppold, Toyoaki Sawano, Morihito Takita, Shigeaki Kato, Yukio Kanazawa, Hiroshi Anbe

    BMJ open 9 (7) e023654 2019年7月9日

    DOI: 10.1136/bmjopen-2018-023654  

    詳細を見る 詳細を閉じる

    OBJECTIVES: This study aimed to evaluate the internal cesium (Cs) level among pregnant women in Minamisoma City (the area straddling the evacuation zones) over a 5-year period after Japan's 2011 Fukushima nuclear accident and assess the status and transition of their food-acquiring preferences during this period. DESIGN: A retrospective observational study of a screening along with a questionnaire survey. SETTING: This study was conducted in an obstetrics and gynaecology service in Minamisoma City in Fukushima, Japan. PARTICIPANTS: Participants included pregnant women who applied for the voluntary internal radiation exposure screening programme. PRIMARY AND SECONDARY OUTCOME MEASURES: Internal radiation exposure was evaluated using the whole-body counter (WBC) in the screening programme. Data from a food acquisition preference questionnaire administered to the participants were analysed and compared across the 5-year period after adjusting for covariates. RESULTS: Overall, 804 screening programmes were conducted with 579 participants during the study period. All participants had internal contamination levels below the detection limit of the WBC unit (220 and 250 Bq/body for Cs-134 and Cs-137, respectively). Based on the most conservative assumption, their maximum annual effective doses by Cs-134 and Cs-137 together were estimated at 16 µSv/year. Contrary to limited internal contamination risks and counter-dose initiatives by the government, a considerable number of pregnant women were still concerned about consuming potentially contaminated local food products when purchasing them at supermarkets between 2012 (78.4%) and 2015 (75.0%). CONCLUSIONS: Health effects from post-accident internal radiation exposure were likely to be insignificant in pregnant women. National/local action is urgently needed to promote scientific understanding in pregnant women regarding limited internal exposure risks from local food products in the market. However, few mothers chose to participate in the internal radiation exposure screening programme, and thus, caution is required in interpreting the results of analyses.

  233. Long-term trends of hospital admissions among patients with cancer following the 2015 earthquake: a single institution observational study in Kathmandu, Nepal. 国際誌 査読有り

    Anup Uprety, Akihiko Ozaki, Asaka Higuchi, Bikal Ghimire, Toyoaki Sawano, Kenji Tsuda, Shuhei Nomura, Claire Leppold, Masaharu Tsubokura, Tetsuya Tanimoto, Yogendra Prasad Singh

    BMJ open 9 (6) e026746 2019年6月28日

    DOI: 10.1136/bmjopen-2018-026746  

    詳細を見る 詳細を閉じる

    OBJECTIVES: Little is known regarding how natural disasters affect patients with cancer in low-income and middle-income countries. The objective of the present study was to assess the impact of the 2015 Nepal earthquake on the admission of patients with cancer at a core medical institution in Kathmandu. DESIGN, SETTING AND PARTICIPANTS: We considered all 3520 cancer patient admissions to Tribhuvan University Teaching Hospital, from 25 April 2013 to 24 April 2017 (2 years before and 2 years after the earthquake). OUTCOME MEASURES: The number of cancer patient admissions was calculated for each month. Using a negative binomial model, we estimated the incidence rate ratio (IRR) for admission numbers each month after the earthquake compared with the pre-earthquake baseline and investigated chronological change. RESULTS: The total admission number in the first month after the earthquake was decreased compared with that of the predisaster baseline (IRR=0.66, 95% CI 0.43 to 1.00), which largely reflected decreased admissions of patients from outside of the most disaster-affected districts. From the second month, the admission number consistently exceeded the predisaster baseline for the remaining postdisaster period. In contrast to the month of the disaster, the continuation of increased admissions was most prominent among those from outside of the most affected districts. CONCLUSIONS: After a transient decrease immediately following the 2015 Nepal earthquake, there was a long-term increase in cancer patient admissions in a core hospital in Kathmandu. These changes were seen most prominently in patients from outside the most disaster affected areas.

  234. Low dose from external radiation among returning residents to the former evacuation zone in Minamisoma City, Fukushima Prefecture. 国際誌 査読有り

    Shuhei Nomura, Tomoyoshi Oikawa, Masaharu Tsubokura

    Journal of radiological protection : official journal of the Society for Radiological Protection 39 (2) 548-563 2019年6月

    DOI: 10.1088/1361-6498/ab0f87  

    ISSN:0952-4746

  235. Worsening Health Status among Evacuees: Analysis of Medical Expenditures after the 2011 Great East Japan Earthquake and Nuclear Disaster in Fukushima. 査読有り

    Makoto Hasegawa, Michio Murakami, Shuhei Nomura, Yoshitake Takebayashi, Masaharu Tsubokura

    The Tohoku journal of experimental medicine 248 (2) 115-123 2019年6月

    DOI: 10.1620/tjem.248.115  

    ISSN:0040-8727

    詳細を見る 詳細を閉じる

    After Fukushima disaster in 2011, the health status of the region's residents deteriorated. We analyzed the health status, care needs, and access to health services among evacuees and non-evacuees using healthcare expenditure (for self-employed and unemployed individuals aged < 75 years) and long-term care expenditure (mainly for individuals aged ≥ 65 years). Fukushima Prefecture was divided into four areas according to their evacuation status: non-EOAs (municipalities that did not include evacuation order areas (EOAs)); EOAs/non-EOAs (municipalities that included both EOAs and non-EOAs); short-term EOAs (municipalities where the EOA designation was lifted in most areas by fiscal year (FY) 2011); and long-term EOAs (municipalities where most EOA designations remained in place until the end of FY 2015). Increases in expenditure on healthcare and long-term care per capita in short-term and long-term EOAs were greater in FY 2015 than the average values in FYs 2008-2010. The increases in expenditure were higher in short-term and long-term EOAs than those in non-EOAs and EOAs/non-EOAs. The increases in dental health expenditure were attributed to enhanced accessibility to dental health facilities. Furthermore, the evacuations contributed to increases in healthcare and long-term care expenditure, independent of aging and improved accessibly to health facilities. Possible explanations for these increases include the poor health status of the evacuees following the evacuations, reduced availability of informal care provided by family members and neighbors, and reduced patient copayments. The findings highlight the necessity of health promotion among evacuees.

  236. Trends in heterosexual inexperience among young adults in Japan: analysis of national surveys, 1987-2015. 国際誌 査読有り

    Cyrus Ghaznavi, Haruka Sakamoto, Daisuke Yoneoka, Shuhei Nomura, Kenji Shibuya, Peter Ueda

    BMC public health 19 (1) 355-355 2019年4月8日

    DOI: 10.1186/s12889-019-6677-5  

    ISSN:1471-2458

  237. JAPAN: EFFECTIVE SMOKEFREE LAWS URGENTLY NEEDED 査読有り

    Nomura Shuhei, Sakamoto Haruka

    TOBACCO CONTROL 28 (2) 123-124 2019年3月

    ISSN:0964-4563

  238. Trends in comparative efficacy and safety of malaria control interventions for maternal and child health outcomes in Africa: a study protocol for a Bayesian network meta-regression exploring the effect of HIV and malaria endemicity spectrum. 国際誌 査読有り

    Floriano Amimo, Troy D Moon, Anthony Magit, Jahit Sacarlal, Ben Lambert, Shuhei Nomura

    BMJ open 9 (2) e024313 2019年2月22日

    DOI: 10.1136/bmjopen-2018-024313  

    ISSN:2044-6055

  239. Change of access to emergency care in a repopulated village after the 2011 Fukushima nuclear disaster: a retrospective observational study. 国際誌 査読有り

    Yoshitaka Nishikawa, Masaharu Tsubokura, Yoshimitsu Takahashi, Shuhei Nomura, Akihiko Ozaki, Yuko Kimura, Tomohiro Morita, Toyoaki Sawano, Tomoyoshi Oikawa, Takeo Nakayama

    BMJ open 9 (2) e023836 2019年2月9日

    DOI: 10.1136/bmjopen-2018-023836  

    ISSN:2044-6055

  240. Does Japan's national nutrient-based dietary guideline improve lifestyle-related disease outcomes? A retrospective observational cross-sectional study. 国際誌 査読有り

    Daisuke Yoneoka, Shuhei Nomura, Kayo Kurotani, Shiori Tanaka, Keiji Nakamura, Hisayuki Uneyama, Naoki Hayashi, Kenji Shibuya

    PloS one 14 (10) e0224042 2019年

    DOI: 10.1371/journal.pone.0224042  

    詳細を見る 詳細を閉じる

    OBJECTIVE: The Japanese government has developed and promoted a national nutrient-based dietary guideline for preventing lifestyle-related chronic disease. However, its impact in a real-life setting has never been evaluated. We performed a critical appraisal of the guideline by examining the association between adherence to the guideline and lifestyle-related outcome indicators. METHODS: This is a retrospective observational cross-sectional study using nationally representative data on health and nutrition characteristics from the 2016 National Health and Nutrition Survey of Japan. We considered 3,861 participants aged ≥20 years, with evidence of low health risks of diabetes, hypertension, hyperlipidemia, and obesity. Five health outcome indicators (hemoglobin A1c (HbA1c), systolic blood pressure, diastolic blood pressure, high-density lipoprotein cholesterol, and body mass index), were employed. A summary score was developed to reflect adherence to the recommended intake of seven nutrients defined by the guideline, including proteins, fat, saturated fatty acid, carbohydrate, dietary fiber, sodium, and potassium. Multivariate quartile regression approaches were employed to examine the association between the adherence score and the health outcome indicators, adjusting for the covariates. RESULTS: Overall, the proportion of those who adhered to the guideline (adherence rate) for all seven nutrients was only 0.3%. There was considerable variation in the adherence rate between the different nutrients, from 24.2% to 61.8%. After adjustment for covariates, in most health outcome indicators, regardless of age category and quartile, there was no clear association between the guideline adherence score and indicators. CONCLUSIONS: There is plenty of scope for improving the guideline. Nutrient impact on health may not necessarily depend on the amount of each nutrient in the diet. The significance and contribution of synergies between nutrients and complex interactions within foods to health outcomes need to be explored in future guideline updates.

  241. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017 査読有り

    Collaborators, G. B. D. Causes of Death

    Lancet 392 (10159) 2170 2018年11月17日

    DOI: 10.1016/S0140-6736(18)32203-7  

    ISSN:0140-6736

  242. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: A systematic analysis for the Global Burden of Disease Study 2017 査読有り

    Hmwe Hmwe Kyu, Degu Abate, Kalkidan Hassen Abate, Solomon M. Abay, Cristiana Abbafati, Nooshin Abbasi, Hedayat Abbastabar, Foad Abd-Allah, Jemal Abdela, Ahmed Abdelalim, Ibrahim Abdollahpour, Rizwan Suliankatchi Abdulkader, Molla Abebe, Zegeye Abebe, Olifan Zewdie Abil, Victor Aboyans, Aklilu Roba Abrham, Laith Jamal Abu-Raddad, Niveen M.E. Abu-Rmeileh, Manfred Mario Kokou Accrombessi, Dilaram Acharya, Pawan Acharya, Ilana N. Ackerman, Abdu A. Adamu, Oladimeji M. Adebayo, Victor Adekanmbi, Zanfina Ademi, Olatunji O. Adetokunboh, Mina G. Adib, Jose C. Adsuar, Kossivi Agbelenko Afanvi, Mohsen Afarideh, Ashkan Afshin, Gina Agarwal, Kareha M. Agesa, Rakesh Aggarwal, Sargis Aghasi Aghayan, Anurag Agrawal, Alireza Ahmadi, Mehdi Ahmadi, Hamid Ahmadieh, Muktar Beshir Ahmed, Sayem Ahmed, Amani Nidhal Aichour, Ibtihel Aichour, Miloud Taki Eddine Aichour, Tomi Akinyemiju, Nadia Akseer, Ziyad Al-Aly, Ayman Al-Eyadhy, Hesham M. Al-Mekhlafi, Rajaa M. Al-Raddadi, Fares Alahdab, Khurshid Alam, Tahiya Alam, Alaa Alashi, Seyed Moayed Alavian, Kefyalew Addis Alene, Mehran Alijanzadeh, Reza Alizadeh-Navaei, Syed Mohamed Aljunid, Ala'A Alkerwi, François Alla, Peter Allebeck, Jordi Alonso, Ubai Alsharif, Khalid Altirkawi, Nelson Alvis-Guzman, Leopold N. Aminde, Erfan Amini, Mohammadreza Amiresmaili, Walid Ammar, Yaw Ampem Amoako, Nahla Hamed Anber, Catalina Liliana Andrei, Sofia Androudi, Megbaru Debalkie Animut, Mina Anjomshoa, Mustafa Geleto Ansha, Carl Abelardo T. Antonio, Palwasha Anwari, Jalal Arabloo, Olatunde Aremu, Johan Ärnlöv, Amit Arora, Megha Arora, Al Artaman, Krishna K. Aryal, Hamid Asayesh, Zerihun Ataro, Marcel Ausloos, Leticia Avila-Burgos, Euripide F.G.A. Avokpaho, Ashish Awasthi, Beatriz Paulina Ayala Quintanilla, Rakesh Ayer, Peter S. Azzopardi, Arefeh Babazadeh, Hamid Badali, Kalpana Balakrishnan

    The Lancet 392 (10159) 1859-1922 2018年11月10日

    DOI: 10.1016/S0140-6736(18)32335-3  

    ISSN:0140-6736

    eISSN:1474-547X

  243. Global, regional, and national age-sex-specific mortality and life expectancy, 1950-2017: A systematic analysis for the Global Burden of Disease Study 2017 査読有り

    GBD 2017 Mortality Collaborators

    The Lancet 392 (10159) 1684-1735 2018年11月10日

    DOI: 10.1016/S0140-6736(18)31891-9  

    ISSN:0140-6736

    eISSN:1474-547X

  244. Global, regional, and national incidence, prevalence, and years lived with disability for 354 Diseases and Injuries for 195 countries and territories, 1990-2017: A systematic analysis for the Global Burden of Disease Study 2017 査読有り

    GBD 2017 Disease and Injury Incidence and Prevalence Collaborators

    The Lancet 392 (10159) 1789-1858 2018年11月10日

    DOI: 10.1016/S0140-6736(18)32279-7  

    ISSN:0140-6736

    eISSN:1474-547X

  245. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: A systematic analysis for the Global Burden of Disease Study 2017 査読有り

    GBD 2017 Risk Factor Collaborators

    The Lancet 392 (10159) 1923-1994 2018年11月10日

    DOI: 10.1016/S0140-6736(18)32225-6  

    ISSN:0140-6736

    eISSN:1474-547X

  246. Public Health Preparedness for and Response to Nuclear Disasters: An Editorial. 国際誌 査読有り

    Shuhei Nomura, Michio Murakami

    International journal of environmental research and public health 15 (11) 2018年11月8日

    DOI: 10.3390/ijerph15112489  

    ISSN:1661-7827

  247. Population and fertility by age and sex for 195 countries and territories, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017 査読有り

    GBD 2017 Population and Fertility Collaborators

    The Lancet 392 (10159) 1995-2051 2018年11月1日

    DOI: 10.1016/S0140-6736(18)32278-5  

    ISSN:0140-6736

    eISSN:1474-547X

  248. Bibliometric Study of Obstetrics Articles Published in the Journal of the American Medical Association, 1997-2016. 国際誌 査読有り

    Kana Yamamoto, Akihiko Ozaki, Shuhei Nomura, Yuki Senoo, Izumi Yoshida, Yuto Maeda, Mutsuko Ohnishi, Tetsuya Tanimoto, Masahiro Kami

    Cureus 10 (10) e3448 2018年10月13日

    DOI: 10.7759/cureus.3448  

    ISSN:2168-8184

  249. Progress towards universal health coverage in Myanmar: a national and subnational assessment. 国際誌 査読有り

    Su Myat Han, Md Mizanur Rahman, Md Shafiur Rahman, Khin Thet Swe, Matthew Palmer, Haruka Sakamoto, Shuhei Nomura, Kenji Shibuya

    The Lancet. Global health 6 (9) e989-e997-e997 2018年9月

    DOI: 10.1016/S2214-109X(18)30318-8  

    ISSN:2214-109X

  250. The Great East Japan Earthquake, Tsunamis, and Fukushima Daiichi Nuclear Power Plant Disaster: Lessons for Evidence Integration from a WADEM 2017 Presentation and Panel Discussion. 国際誌 査読有り

    Claire Leppold, Sae Ochi, Shuhei Nomura, Virginia Murray

    Prehospital and disaster medicine 33 (4) 424-427 2018年8月

    DOI: 10.1017/S1049023X18000481  

    ISSN:1049-023X

  251. Balancing the risk of the evacuation and sheltering-in-place options: a survival study following Japan's 2011 Fukushima nuclear incident. 国際誌 査読有り

    Yuki Shimada, Shuhei Nomura, Akihiko Ozaki, Asaka Higuchi, Arinobu Hori, Yuki Sonoda, Kana Yamamoto, Izumi Yoshida, Masaharu Tsubokura

    BMJ open 8 (7) e021482 2018年7月28日

    DOI: 10.1136/bmjopen-2018-021482  

    ISSN:2044-6055

  252. Automatic anatomical classification of esophagogastroduodenoscopy images using deep convolutional neural networks. 国際誌 査読有り

    Hirotoshi Takiyama, Tsuyoshi Ozawa, Soichiro Ishihara, Mitsuhiro Fujishiro, Satoki Shichijo, Shuhei Nomura, Motoi Miura, Tomohiro Tada

    Scientific reports 8 (1) 7497-7497 2018年5月14日

    DOI: 10.1038/s41598-018-25842-6  

    ISSN:2045-2322

  253. Call for a new epidemiological approach to disaster response. 国際誌 査読有り

    Michio Murakami, Shuhei Nomura, Masaharu Tsubokura

    Journal of epidemiology and community health 72 (4) 267-268 2018年4月

    DOI: 10.1136/jech-2017-210397  

    ISSN:0143-005X

  254. Causes and risk factors for singleton stillbirth in Japan: Analysis of a nationwide perinatal database, 2013-2014. 国際誌 査読有り

    Rei Haruyama, Stuart Gilmour, Erika Ota, Sarah K Abe, Md Mizanur Rahman, Shuhei Nomura, Naoyuki Miyasaka, Kenji Shibuya

    Scientific reports 8 (1) 4117-4117 2018年3月7日

    DOI: 10.1038/s41598-018-22546-9  

    ISSN:2045-2322

  255. Comparison of external doses between radio-contaminated areas and areas with high natural terrestrial background using the individual dosimeter 'D-shuttle' 75 months after the Fukushima Daiichi nuclear power plant accident. 国際誌 査読有り

    Masaharu Tsubokura, Shuhei Nomura, Izumi Yoshida, Toyoaki Sawano, Makoto Miyazaki, Satoru Tomita, Oikawa Tomoyoshi, Masami Watanabe

    Journal of radiological protection : official journal of the Society for Radiological Protection 38 (1) 273-285 2018年3月

    DOI: 10.1088/1361-6498/aaa147  

    ISSN:0952-4746

  256. Support for UNRWA's survival

    Blanchet, K., El-Zein, A., Langer, A., Sato, M., Abdulrahim, S., Abouchacra, K., Afifi, R., Agnoletto, V., Akashi, H., Alameddine, M., Ansbro, ?, Ara{\'u}jo-Soares, V., Assefi, N., Baillie Smith, M., Bardus, M., Bhabha, J., Bjertness, E., Borghi, J., Busza, J., Cammett, M., Campbell, O., Chaaban, J., Chalmers, I., Checchi, F., Danaei, G., Dhaini, H., Diaconu, K., Diwan, I., Dominguez-Salas, P., Dubois, E., El Kak, F., El-Zein, A., Eng, E., Eyal, N., Fawzi, W., Feder, G., Fujiya, R., Furukawa, S., Furusawa, K., Futami, A., Germani, A., Ghattas, H., Giacaman, R., Goto, R., Grant, L., Greenough, P.G., Habib, R., Hagopian, A., Hajat, S., Hariga, F., Hatano, A., Hay, A., Holmboe-Ottesen, G., Horiuchi, S., Hsiao, W., Huber, D., Humble, D., Imano, T., Inoue, Y., Ishizuka, A., Ismail, R., Iwata, R., Jabbour, S., Jamal, D., Jamaluddine, Z., Jimba, M., Kabakian, T., Kamiya, Y., Karademas, E., Kashiwagi, K., Katsuma, Y., Kinjo, M., Kiriya, J., Kitamura, A., Kruk, M.E., Kubota, K., Leaning, J., Leng, M., Logam, L., Makhoul, J., Matsuno, A., Matsuo, Y., McCoy, D., McGovern, T., McKee, M., McPake, B., Melhem, N., Merriman, A., Michie, S., Millett, C., Mishima, C., Miyachi, T., Miyata, H., Moodie, R., Morioka, M., Mulholland, K., Mumtaz, G., Murphy, A., Nagasawa, E., Nagata, K., Najem Kteily, M., Nakamura, H., Nakkash, R., Nambu, M., Nava, M., Nelson, E.L., Nishikida, A., Nomura, S., Nozaki, S., Nuwayhid, I., O{'}Donnell, K., Ohashi, M., O{'}Laughlin, K., Palmer, J., Patel, P., Patel, R., Pham, P., Quezada-Yamamoto, H., Ramia, S., Rawaf, S., Rihani, M., Roberts, B., Roberts, L., Ruff, T.A., Sahyoun, N., Sakamoto, H., Salti, N., Sato, M., Sato, M., Sennett, R., Shallice, T., Shannon, P., Shiekh, S., Shin, K., Sibai, A.M., Sieverding, M., Singh, N., Sullivan, R., Takahara, T., Tanigawa, T., Taniguchi, H., Testa, A., Thomas, A., Tsutsumi, A., Uechi, M., Usuki, A., Valente de Almeida, S., Wareham, S., Watt, G., West, R., Wigg, P., Wigg, C., Wikler, D., Witter, S., Yassin, N., Yazdi, Y., Yoshino, Y., Yousafzai, A., Yudkin, J.S., Zaman, M.H., Zurayk, H.

    Lancet 392 (10152) 2018年

    DOI: 10.1016/S0140-6736(18)32264-5  

    ISSN:0140-6736 1474-547X

  257. Demographic transition and factors associated with remaining in place after the 2011 Fukushima nuclear disaster and related evacuation orders. 国際誌 査読有り

    Tomohiro Morita, Shuhei Nomura, Tomoyuki Furutani, Claire Leppold, Masaharu Tsubokura, Akihiko Ozaki, Sae Ochi, Masahiro Kami, Shigeaki Kato, Tomoyoshi Oikawa

    PloS one 13 (3) e0194134 2018年

    DOI: 10.1371/journal.pone.0194134  

    ISSN:1932-6203

  258. Assessment of medium-term cardiovascular disease risk after Japan's 2011 Fukushima Daiichi nuclear accident: a retrospective analysis. 国際誌 査読有り

    Haruka Toda, Shuhei Nomura, Stuart Gilmour, Masaharu Tsubokura, Tomoyoshi Oikawa, Kiwon Lee, Grace Y Kiyabu, Kenji Shibuya

    BMJ open 7 (12) e018502 2017年12月22日

    DOI: 10.1136/bmjopen-2017-018502  

    ISSN:2044-6055

  259. Application of Convolutional Neural Networks in the Diagnosis of Helicobacter pylori Infection Based on Endoscopic Images. 国際誌 査読有り

    Satoki Shichijo, Shuhei Nomura, Kazuharu Aoyama, Yoshitaka Nishikawa, Motoi Miura, Takahide Shinagawa, Hirotoshi Takiyama, Tetsuya Tanimoto, Soichiro Ishihara, Keigo Matsuo, Tomohiro Tada

    EBioMedicine 25 106-111 2017年11月

    DOI: 10.1016/j.ebiom.2017.10.014  

    ISSN:2352-3964

  260. Decontamination Work and the Long-term Increase in Hospital Visits for Hymenoptera Stings Following the Fukushima Nuclear Disaster. 国際誌 査読有り

    Akihiko Ozaki, Takeru Yokota, Shuhei Nomura, Masaharu Tsubokura, Claire Leppold, Tetsuya Tanimoto, Toru Miura, Kana Yamamoto, Toyoaki Sawano, Manabu Tsukada, Masahiro Kami, Yukio Kanazawa, Hiromichi Ohira

    Disaster medicine and public health preparedness 11 (5) 545-551 2017年10月

    DOI: 10.1017/dmp.2016.194  

    ISSN:1935-7893

    eISSN:1938-744X

  261. Excess mortality due to indirect health effects of the 2011 triple disaster in Fukushima, Japan: a retrospective observational study. 国際誌 査読有り

    Tomohiro Morita, Shuhei Nomura, Masaharu Tsubokura, Claire Leppold, Stuart Gilmour, Sae Ochi, Akihiko Ozaki, Yuki Shimada, Kana Yamamoto, Manami Inoue, Shigeaki Kato, Kenji Shibuya, Masahiro Kami

    Journal of epidemiology and community health 71 (10) 974-980 2017年10月

    DOI: 10.1136/jech-2016-208652  

    ISSN:0143-005X

    eISSN:1470-2738

  262. Population health and regional variations of disease burden in Japan, 1990-2015: a systematic subnational analysis for the Global Burden of Disease Study 2015. 国際誌 査読有り

    Shuhei Nomura, Haruka Sakamoto, Scott Glenn, Yusuke Tsugawa, Sarah K Abe, Md M Rahman, Jonathan C Brown, Satoshi Ezoe, Christina Fitzmaurice, Tsuyoshi Inokuchi, Nicholas J Kassebaum, Norito Kawakami, Yosuke Kita, Naoki Kondo, Stephen S Lim, Satoshi Maruyama, Hiroaki Miyata, Meghan D Mooney, Mohsen Naghavi, Tomoko Onoda, Erika Ota, Yuji Otake, Gregory A Roth, Eiko Saito, Takahiro Tabuchi, Yohsuke Takasaki, Tadayuki Tanimura, Manami Uechi, Theo Vos, Haidong Wang, Manami Inoue, Christopher J L Murray, Kenji Shibuya

    Lancet (London, England) 390 (10101) 1521-1538 2017年9月23日

    DOI: 10.1016/S0140-6736(17)31544-1  

    ISSN:0140-6736

    eISSN:1474-547X

  263. Towards a Long-Term Strategy for Voluntary-Based Internal Radiation Contamination Monitoring: Representativeness of the Monitoring Results in Fukushima, Japan. 国際誌 査読有り

    Shuhei Nomura, Masaharu Tsubokura, Michio Murakami, Kyoko Ono, Yoshitaka Nishikawa, Tomoyoshi Oikawa

    International journal of environmental research and public health 14 (6) 2017年6月20日

    DOI: 10.3390/ijerph14060656  

    ISSN:1661-7827

  264. Breast cancer patient delay in Fukushima, Japan following the 2011 triple disaster: a long-term retrospective study. 国際誌 査読有り

    Akihiko Ozaki, Shuhei Nomura, Claire Leppold, Masaharu Tsubokura, Tetsuya Tanimoto, Takeru Yokota, Shigehira Saji, Toyoaki Sawano, Manabu Tsukada, Tomohiro Morita, Sae Ochi, Shigeaki Kato, Masahiro Kami, Tsuyoshi Nemoto, Yukio Kanazawa, Hiromichi Ohira

    BMC cancer 17 (1) 423-423 2017年6月19日

    DOI: 10.1186/s12885-017-3412-4  

    ISSN:1471-2407

  265. Birth Outcomes after the Fukushima Daiichi Nuclear Power Plant Disaster: A Long-Term Retrospective Study. 国際誌 査読有り

    Claire Leppold, Shuhei Nomura, Toyoaki Sawano, Akihiko Ozaki, Masaharu Tsubokura, Sarah Hill, Yukio Kanazawa, Hiroshi Anbe

    International journal of environmental research and public health 14 (5) 2017年5月19日

    DOI: 10.3390/ijerph14050542  

    ISSN:1661-7827

  266. Towards a Long-Term Strategy for Voluntary-Based Internal Radiation Contamination Monitoring: A Population-Level Analysis of Monitoring Prevalence and Factors Associated with Monitoring Participation Behavior in Fukushima, Japan. 国際誌 査読有り

    Shuhei Nomura, Masaharu Tsubokura, Akihiko Ozaki, Michio Murakami, Susan Hodgson, Marta Blangiardo, Yoshitaka Nishikawa, Tomohiro Morita, Tomoyoshi Oikawa

    International journal of environmental research and public health 14 (4) 2017年4月9日

    DOI: 10.3390/ijerph14040397  

    ISSN:1661-7827

  267. Individual external doses below the lowest reference level of 1 mSv per year five years after the 2011 Fukushima nuclear accident among all children in Soma City, Fukushima: A retrospective observational study. 国際誌 査読有り

    Masaharu Tsubokura, Michio Murakami, Shuhei Nomura, Tomohiro Morita, Yoshitaka Nishikawa, Claire Leppold, Shigeaki Kato, Masahiro Kami

    PloS one 12 (2) e0172305 2017年

    DOI: 10.1371/journal.pone.0172305  

    ISSN:1932-6203

  268. Additional risk of diabetes exceeds the increased risk of cancer caused by radiation exposure after the Fukushima disaster. 国際誌 査読有り

    Michio Murakami, Masaharu Tsubokura, Kyoko Ono, Shuhei Nomura, Tomoyoshi Oikawa

    PloS one 12 (9) e0185259 2017年

    DOI: 10.1371/journal.pone.0185259  

    ISSN:1932-6203

  269. Degarelix treatment is compatible with diabetes and antithrombotic therapy in patients with prostate cancer. 国際誌 査読有り

    Suguru Tokiwa, Hiroaki Shimmura, Shuhei Nomura, Ryota Watanabe, Minoru Kurita, Naoto Yoshida, Kaori Yamashita, Yoshitaka Nishikawa, Alexander Kouzmenko, Shigeaki Kato

    Research and reports in urology 9 225-232 2017年

    DOI: 10.2147/RRU.S146180  

    ISSN:2253-2447

  270. Non-communicable diseases in decontamination workers in areas affected by the Fukushima nuclear disaster: a retrospective observational study. 国際誌 査読有り

    Toyoaki Sawano, Masaharu Tsubokura, Akihiko Ozaki, Claire Leppold, Shuhei Nomura, Yuki Shimada, Sae Ochi, Manabu Tsukada, Tsuyoshi Nemoto, Shigeaki Kato, Yukio Kanazawa, Hiromichi Ohira

    BMJ open 6 (12) e013885 2016年12月14日

    DOI: 10.1136/bmjopen-2016-013885  

    ISSN:2044-6055

  271. Assessment of Nutritional Status of Iodine Through Urinary Iodine Screening Among Local Children and Adolescents After the Fukushima Daiichi Nuclear Power Plant Accident. 国際誌 査読有り

    Masaharu Tsubokura, Shuhei Nomura, Hajime Watanobe, Yoshitaka Nishikawa, Chiaki Suzuki, Sae Ochi, Claire Leppold, Hirokatsu Kinoshita, Shigeaki Kato, Yasutoshi Saito

    Thyroid : official journal of the American Thyroid Association 26 (12) 1778-1785 2016年12月

    DOI: 10.1089/thy.2016.0313  

    ISSN:1050-7256

    eISSN:1557-9077

  272. Factors affecting dilation force in balloon dilation of severe esophageal strictures: an experiment using an artificial stricture model. 国際誌 査読有り

    Yoshitaka Nishikawa, Hirokazu Higuchi, Osamu Kikuchi, Yasumasa Ezoe, Ikuo Aoyama, Atsushi Yamada, Masataka Kanki, Shuhei Nomura, Motoo Nomura, Takahiro Horimatsu, Manabu Muto

    Surgical endoscopy 30 (10) 4315-20 2016年10月

    DOI: 10.1007/s00464-016-4749-5  

    ISSN:0930-2794

  273. School restrictions on outdoor activities and weight status in adolescent children after Japan's 2011 Fukushima Nuclear Power Plant disaster: a mid-term to long-term retrospective analysis. 国際誌 査読有り

    Shuhei Nomura, Marta Blangiardo, Masaharu Tsubokura, Sae Ochi, Susan Hodgson

    BMJ open 6 (9) e013145 2016年9月28日

    DOI: 10.1136/bmjopen-2016-013145  

    ISSN:2044-6055

  274. Impacts of the 2011 Fukushima nuclear accident on emergency medical service times in Soma District, Japan: a retrospective observational study. 国際誌 査読有り

    Tomohiro Morita, Masaharu Tsubokura, Tomoyuki Furutani, Shuhei Nomura, Sae Ochi, Claire Leppold, Kazuhiro Takahara, Yuki Shimada, Sho Fujioka, Masahiro Kami, Shigeaki Kato, Tomoyoshi Oikawa

    BMJ open 6 (9) e013205 2016年9月28日

    DOI: 10.1136/bmjopen-2016-013205  

    ISSN:2044-6055

  275. Sociodemographic patterning of long-term diabetes mellitus control following Japan's 3.11 triple disaster: a retrospective cohort study. 国際誌 査読有り

    Claire Leppold, Masaharu Tsubokura, Akihiko Ozaki, Shuhei Nomura, Yuki Shimada, Tomohiro Morita, Sae Ochi, Tetsuya Tanimoto, Masahiro Kami, Yukio Kanazawa, Tomoyoshi Oikawa, Sarah Hill

    BMJ open 6 (7) e011455 2016年7月7日

    DOI: 10.1136/bmjopen-2016-011455  

    ISSN:2044-6055

  276. Estimated association between dwelling soil contamination and internal radiation contamination levels after the 2011 Fukushima Daiichi nuclear accident in Japan. 国際誌 査読有り

    Masaharu Tsubokura, Shuhei Nomura, Kikugoro Sakaihara, Shigeaki Kato, Claire Leppold, Tomoyuki Furutani, Tomohiro Morita, Tomoyoshi Oikawa, Yukio Kanazawa

    BMJ open 6 (6) e010970 2016年6月29日

    DOI: 10.1136/bmjopen-2015-010970  

    ISSN:2044-6055

  277. Social determinants of mid- to long-term disaster impacts on health: A systematic review 査読有り

    Shuhei Nomura, Alexander J. Q. Parsons, Mayo Hirabayashi, Ryo Kinoshita, Yi Liao, Susan Hodgson

    INTERNATIONAL JOURNAL OF DISASTER RISK REDUCTION 16 53-67 2016年6月

    DOI: 10.1016/j.ijdrr.2016.01.013  

    ISSN:2212-4209

  278. Protecting human security: proposals for the G7 Ise-Shima Summit in Japan 査読有り

    Kenji Shibuya, Shuhei Nomura, Hiromasa Okayasu, Satoshi Ezoe, Seigo Hara, Yuriko Hara, Takashi Izutsu, Takuma Kato, Shunsuke Mabuchi, Yujiro Maeda, Yuki Murakami, Hiroko Nishimoto, Tomoko Ono, Kayoko Shioda, Atsushi Sorita, Amina Sugimoto, Kazuo Tase, Akihito Watabe, Anne Smith, Sarah K. Abe, Stuart Gilmour, Lawrence O. Gostin, Gavin Yamey, Marco Schaeferhoff, Elina M. Suzuki, Jessica Kraus, Takashi Oshio, Reiko Hayashi, Naoki Kondo, Koichiro Shiba, Hideo Yasunaga, Yusuke Sasabuchi, Yohsuke Takasaki, Naoki Akahane, Shingo Kasahara, Munehito Machida, Satoshi Maruyama, Shuushou Okada, Tadayuki Tanimura, Tomohiko Sugishita, Ikuo Takizawa, Maki Ozawa, Yoshiharu Yoneyama, Hidechika Akashi, Chiaki Miyoshi, Hitoshi Murakami, Toshiro Kumakawa, Satoko Horii, Kenichiro Taneda, Hideaki Shiroyama, Yasushi Katsuma, Makiko Matsuo, Sayako Kanamori, Chiaki Sato, Kayo Yasuda, Jonas Kemp, B. T. Slingsby, Kei Katsuno, Bumpei Tamamura, Keizo Takemi, Hideki Hashimoto, Michael R. Reich

    LANCET 387 (10033) 2155-2162 2016年5月

    DOI: 10.1016/S0140-6736(16)30177-5  

    ISSN:0140-6736

    eISSN:1474-547X

  279. An evaluation of early countermeasures to reduce the risk of internal radiation exposure after the Fukushima nuclear incident in Japan. 国際誌 査読有り

    Shuhei Nomura, Masaharu Tsubokura, Stuart Gilmour, Ryugo S Hayano, Yuni N Watanabe, Masahiro Kami, Yukio Kanazawa, Tomoyoshi Oikawa

    Health policy and planning 31 (4) 425-33 2016年5月

    DOI: 10.1093/heapol/czv080  

    ISSN:0268-1080

  280. Postnuclear disaster evacuation and chronic health in adults in Fukushima, Japan: a long-term retrospective analysis. 国際誌 査読有り

    Shuhei Nomura, Marta Blangiardo, Masaharu Tsubokura, Akihiko Ozaki, Tomohiro Morita, Susan Hodgson

    BMJ open 6 (2) e010080 2016年2月4日

    DOI: 10.1136/bmjopen-2015-010080  

    ISSN:2044-6055

  281. Living in Contaminated Radioactive Areas Is Not an Acute Risk Factor for Noncommunicable Disease Development: A Retrospective Observational Study. 国際誌 査読有り

    Takeaki Ishii, Masaharu Tsubokura, Sae Ochi, Shigeaki Kato, Amina Sugimoto, Shuhei Nomura, Yoshitaka Nishikawa, Masahiro Kami, Kenji Shibuya, Yasutoshi Saito, Yukihide Iwamoto, Hidekiyo Tachiya

    Disaster medicine and public health preparedness 10 (1) 34-7 2016年2月

    DOI: 10.1017/dmp.2015.102  

    ISSN:1935-7893

  282. Overview of health impacts caused by the Fukushima nuclear disaster and our opportunity to 'Build Back Better'

    Sae Ochi, Shigeaki Kato, Claire Leppold, Toyoaki Sawano, Shuhei Nomura, Tomohiro Morita, Masaharu Tsubokura, Tomoyoshi Oikawa, Ryuzaburo Shineha

    Proceedings of the 6th International Disaster and Risk Conference: Integrative Risk Management - Towards Resilient Cities, IDRC Davos 2016 481-484 2016年

    出版者・発行元: Global Risk Forum (GRF)

  283. Post-nuclear disaster evacuation and survival amongst elderly people in Fukushima: A comparative analysis between evacuees and non-evacuees. 国際誌 査読有り

    Shuhei Nomura, Marta Blangiardo, Masaharu Tsubokura, Yoshitaka Nishikawa, Stuart Gilmour, Masahiro Kami, Susan Hodgson

    Preventive medicine 82 77-82 2016年1月

    DOI: 10.1016/j.ypmed.2015.11.014  

    ISSN:0091-7435

  284. Dependence of radiation dose on the behavioral patterns among school children: a retrospective analysis 18 to 20 months following the 2011 Fukushima nuclear incident in Japan. 国際誌 査読有り

    Shuhei Nomura, Masaharu Tsubokura, Tomoyuki Furutani, Ryugo S Hayano, Masahiro Kami, Yukio Kanazawa, Tomoyoshi Oikawa

    Journal of radiation research 57 (1) 1-8 2016年1月

    DOI: 10.1093/jrr/rrv051  

    ISSN:0449-3060

  285. Compliance with the proper use of an individual radiation dosimeter among children and the effects of improper use on the measured dose: a retrospective study 18-20 months following Japan's 2011 Fukushima nuclear incident. 国際誌 査読有り

    Shuhei Nomura, Masaharu Tsubokura, Ryugo Hayano, Daisuke Yoneoka, Akihiko Ozaki, Yuki Shimada, Tomoyuki Furutani, Yukio Kanazawa, Tomoyoshi Oikawa

    BMJ open 5 (12) e009555 2015年12月30日

    DOI: 10.1136/bmjopen-2015-009555  

    ISSN:2044-6055

  286. Whole body counter assessment of internal radiocontamination in patients with end-stage renal disease living in areas affected by the Fukushima Daiichi nuclear power plant disaster: a retrospective observational study. 国際誌 査読有り

    Hiroaki Shimmura, Masaharu Tsubokura, Shigeaki Kato, Junichi Akiyama, Shuhei Nomura, Jinichi Mori, Tetsuya Tanimoto, Koichiro Abe, Shuji Sakai, Hiroshi Kawaguchi, Michio Tokiwa

    BMJ open 5 (12) e009745 2015年12月7日

    DOI: 10.1136/bmjopen-2015-009745  

    ISSN:2044-6055

  287. Long-Term Changes in Stroke-Related Hospital Admissions After the Fukushima Triple Disaster. 国際誌 査読有り

    Stuart Gilmour, Amina Sugimoto, Shuhei Nomura, Tomoyoshi Oikawa

    Journal of the American Geriatrics Society 63 (11) 2425-6 2015年11月

    DOI: 10.1111/jgs.13812  

    ISSN:0002-8614

  288. Emergency medical service delay following Japan's 2011 Fukushima nuclear disaster 査読有り

    MORITA Tomohiro, TSUBOKURA Masaharu, FURUTANI Tomoyuki, OCHI Sae, KATO Shigeaki, TSUBOKURA Seiji, KAMI Masahiro, TSUBOKURA Seiji, SHIMADA Yuki, FUJIOKA Masaru, OIKAWA Tomoyoshi, NOMURA Shuhei, TAKAHARA Kazuhiro

    日本救急医学会雑誌 26 (8) 353-353 2015年8月15日

    出版者・発行元:

    ISSN:0915-924X

    eISSN:1883-3772

  289. Comparison between direct measurements and modeled estimates of external radiation exposure among school children 18 to 30 months after the Fukushima nuclear accident in Japan. 国際誌 査読有り

    Shuhei Nomura, Masaharu Tsubokura, Ryugo Hayano, Tomoyuki Furutani, Daisuke Yoneoka, Masahiro Kami, Yukio Kanazawa, Tomoyoshi Oikawa

    Environmental science & technology 49 (2) 1009-16 2015年1月20日

    DOI: 10.1021/es503504y  

    ISSN:0013-936X

    eISSN:1520-5851

  290. Absence of internal radiation contamination by radioactive cesium among children affected by the Fukushima Daiichi nuclear power plant disaster. 国際誌 査読有り

    Masaharu Tsubokura, Shigeaki Kato, Shuhei Nomura, Tomohiro Morita, Amina Sugimoto, Stuart Gilmour, Masahiro Kami, Tomoyoshi Oikawa, Yukio Kanazawa

    Health physics 108 (1) 39-43 2015年1月

    DOI: 10.1097/HP.0000000000000167  

    ISSN:0017-9078

  291. An assessment of the characteristics and quality of diagnostic accuracy studies for positron emission tomography conducted in Japan: a systematic review. 国際誌 査読有り

    Shuhei Nomura, Akinori Hisashige, Daisuke Yoneoka, Mikiko Kanda, Karin Miyamoto, Miwako Segawa, Erika Ota, Kenji Shibuya

    EJNMMI research 5 6-6 2015年

    DOI: 10.1186/s13550-015-0084-4  

    ISSN:2191-219X

  292. Managing Type 2 Diabetes Mellitus through Periodical Hospital Visits in the Aftermath of the Great East Japan Earthquake Disaster: A Retrospective Case Series. 国際誌 査読有り

    Yoshitaka Nishikawa, Yuji Fukuda, Masaharu Tsubokura, Shigeaki Kato, Shuhei Nomura, Yasutoshi Saito

    PloS one 10 (5) e0125632 2015年

    DOI: 10.1371/journal.pone.0125632  

    ISSN:1932-6203

  293. Assessment of the Annual Additional Effective Doses amongst Minamisoma Children during the Second Year after the Fukushima Daiichi Nuclear Power Plant Disaster. 国際誌 査読有り

    Masaharu Tsubokura, Shigeaki Kato, Tomohiro Morita, Shuhei Nomura, Masahiro Kami, Kikugoro Sakaihara, Tatsuo Hanai, Tomoyoshi Oikawa, Yukio Kanazawa

    PloS one 10 (6) e0129114 2015年

    DOI: 10.1371/journal.pone.0129114  

    ISSN:1932-6203

  294. Was the Risk from Nursing-Home Evacuation after the Fukushima Accident Higher than the Radiation Risk? 国際誌 査読有り

    Michio Murakami, Kyoko Ono, Masaharu Tsubokura, Shuhei Nomura, Tomoyoshi Oikawa, Tosihiro Oka, Masahiro Kami, Taikan Oki

    PloS one 10 (9) e0137906 2015年

    DOI: 10.1371/journal.pone.0137906  

    ISSN:1932-6203

  295. Whole-body counter survey results 4 months after the Fukushima Dai-ichi NPP accident in Minamisoma City, Fukushima. 国際誌 査読有り

    Ryugo S Hayano, Yuni N Watanabe, Shuhei Nomura, Tsuyoshi Nemoto, Masaharu Tsubokura, Tatsuo Hanai, Yuki Kumemoto, Satoshi Kowata, Tomoyoshi Oikawa, Yukio Kanazawa

    Journal of radiological protection : official journal of the Society for Radiological Protection 34 (4) 787-99 2014年12月

    DOI: 10.1088/0952-4746/34/4/787  

    ISSN:0952-4746

    eISSN:1361-6498

  296. Assessment of the risk of medium-term internal contamination in Minamisoma City, Fukushima, Japan, after the Fukushima Dai-ichi nuclear accident. 国際誌 査読有り

    Amina Sugimoto, Stuart Gilmour, Masaharu Tsubokura, Shuhei Nomura, Masahiro Kami, Tomoyoshi Oikawa, Yukio Kanazawa, Kenji Shibuya

    Environmental health perspectives 122 (6) 587-93 2014年6月

    DOI: 10.1289/ehp.1306848  

    ISSN:0091-6765

    eISSN:1552-9924

  297. Detection of 131I in a patient with thyroid cancer by internal radiation exposure screening using a whole-body counter in Fukushima. 国際誌 査読有り

    Masaharu Tsubokura, Shuhei Nomura, Takeaki Ishii, Masahiro Kami, Shigeaki Kato

    Clinical nuclear medicine 39 (3) 281-2 2014年3月

    DOI: 10.1097/RLU.0000000000000338  

    ISSN:0363-9762

    eISSN:1536-0229

  298. The immediate physical and mental health crisis in residents proximal to the evacuation zone after Japan's nuclear disaster: an observational pilot study. 国際誌 査読有り

    Masaharu Tsubokura, Kazuo Hara, Tomoko Matsumura, Amina Sugimoto, Shuhei Nomura, Masamitsu Hinata, Kenji Shibuya, Masahiro Kami

    Disaster medicine and public health preparedness 8 (1) 30-6 2014年2月

    DOI: 10.1017/dmp.2014.5  

    ISSN:1935-7893

    eISSN:1938-744X

  299. Are Japanese randomized controlled trials up to the task? A systematic review. 国際誌 査読有り

    Daisuke Yoneoka, Akinori Hisashige, Erika Ota, Karin Miyamoto, Shuhei Nomura, Miwako Segawa, Stuart Gilmour, Kenji Shibuya

    PloS one 9 (3) e90127 2014年

    DOI: 10.1371/journal.pone.0090127  

    ISSN:1932-6203

  300. Reduction of high levels of internal radio-contamination by dietary intervention in residents of areas affected by the Fukushima Daiichi nuclear plant disaster: a case series. 国際誌 査読有り

    Masaharu Tsubokura, Shigeaki Kato, Shuhei Nomura, Stuart Gilmour, Masahiko Nihei, Yu Sakuma, Tomoyoshi Oikawa, Yukio Kanazawa, Masahiro Kami, Ryugo Hayano

    PloS one 9 (6) e100302 2014年

    DOI: 10.1371/journal.pone.0100302  

    ISSN:1932-6203

  301. Measurement of internal radiation exposure among decontamination workers in villages near the crippled Fukushima Daiichi Nuclear Power Plant. 国際誌 査読有り

    Masaharu Tsubokura, Masahiko Nihei, Katsumi Sato, Shin Masaki, Yu Sakuma, Shigeaki Kato, Amina Sugimoto, Shuhei Nomura, Tomoko Matsumura, Makoto Miyazaki, Ryugo Hayano, Kenji Shibuya, Masahiro Kami, Taro Sasaki

    Health physics 105 (4) 379-81 2013年10月

    DOI: 10.1097/HP.0b013e318297ad92  

    ISSN:0017-9078

  302. Interventions for reduction of stigma in people with HIV/AIDS 査読有り

    Windy M.V. Wariki, Shuhei Nomura, Erika Ota, Rintaro Mori, Kenji Shibuya

    Cochrane Database of Systematic Reviews 2013 (6) 2013年6月18日

    出版者・発行元: John Wiley and Sons Ltd

    DOI: 10.1002/14651858.CD006735.pub2  

    ISSN:1469-493X

    eISSN:1469-493X

  303. Mortality risk amongst nursing home residents evacuated after the Fukushima nuclear accident: a retrospective cohort study. 国際誌 査読有り

    Shuhei Nomura, Stuart Gilmour, Masaharu Tsubokura, Daisuke Yoneoka, Amina Sugimoto, Tomoyoshi Oikawa, Masahiro Kami, Kenji Shibuya

    PloS one 8 (3) e60192 2013年

    DOI: 10.1371/journal.pone.0060192  

    詳細を見る 詳細を閉じる

    BACKGROUND: Safety of evacuation is of paramount importance in disaster planning for elderly people; however, little effort has been made to investigate evacuation-related mortality risks. After the Fukushima Daiichi Nuclear Plant accident we conducted a retrospective cohort survival survey of elderly evacuees. METHODS: A total of 715 residents admitted to five nursing homes in Minamisoma city, Fukushima Prefecture in the five years before 11th March 2011 joined this retrospective cohort study. Demographic and clinical characteristics were drawn from facility medical records. Evacuation histories were tracked until the end of 2011. The evacuation's impact on mortality was assessed using mortality incidence density and hazard ratios in Cox proportional hazards regression. RESULTS: Overall relative mortality risk before and after the earthquake was 2.68 (95% CI: 2.04-3.49). There was a substantial variation in mortality risks across the facilities ranging from 0.77 (95% CI: 0.34-1.76) to 2.88 (95% CI: 1.74-4.76). No meaningful influence of evacuation distance on mortality was observed although the first evacuation from the original facility caused significantly higher mortality than subsequent evacuations, with a hazard ratio of 1.94 (95% CI: 1.07-3.49). CONCLUSION: High mortality, due to initial evacuation, suggests that evacuation of the elderly was not the best life-saving strategy for the Fukushima nuclear disaster. Careful consideration of the relative risks of radiation exposure and the risks and benefits of evacuation is essential. Facility-specific disaster response strategies, including in-site relief and care, may have a strong influence on survival. Where evacuation is necessary, careful planning and coordination with other nursing homes, evacuation sites and government disaster agencies is essential to reduce the risk of mortality.

  304. The relationship between media consumption and health-related anxieties after the Fukushima Daiichi nuclear disaster. 国際誌 査読有り

    Amina Sugimoto, Shuhei Nomura, Masaharu Tsubokura, Tomoko Matsumura, Kaori Muto, Mikiko Sato, Stuart Gilmour

    PloS one 8 (8) e65331 2013年

    DOI: 10.1371/journal.pone.0065331  

    ISSN:1932-6203

  305. Limited internal radiation exposure associated with resettlements to a radiation-contaminated homeland after the Fukushima Daiichi nuclear disaster. 国際誌 査読有り

    Masaharu Tsubokura, Shigeaki Kato, Masahiko Nihei, Yu Sakuma, Tomoyuki Furutani, Keisuke Uehara, Amina Sugimoto, Shuhei Nomura, Ryugo Hayano, Masahiro Kami, Hajime Watanobe, Yukou Endo

    PloS one 8 (12) e81909 2013年

    DOI: 10.1371/journal.pone.0081909  

    ISSN:1932-6203

  306. The voice of the most vulnerable: lessons from the nuclear crisis in Fukushima, Japan 査読有り

    A. Sugimoto, S. Krull, S. Nomura, T. Morita, M. Tsubokura

    BULLETIN OF THE WORLD HEALTH ORGANIZATION 90 (8) 629-630 2012年8月

    DOI: 10.2471/BLT.11.094474  

    ISSN:0042-9686

︎全件表示 ︎最初の5件までを表示

書籍等出版物 20

  1. 2026 Global Nutrition Report: Integrating food and health systems for climate-resilient nutrition

    Shibani Ghosh, Giacomo Zanello, Costanza Conti, Mariachiara Di Cesare, Cecilia Fabrizio, Eileen Kennedy, Shuhei Nomura, Marco Springmann

    PATH 2026年5月28日

  2. Africa-Japan Common Vision on Health: Co-creating Health Security and Sustainable Growth

    Africa-Japan Common Vision on Health Working Group

    公益財団法人 日本国際交流センター 2025年8月21日

  3. Subnational Dependency Ratios Adjusted by Health in the People’s Republic of China, India, Indonesia, Japan, Pakistan, and the Philippines, 1990–2021

    Shuhei Nomura, Jose Navarro, Vegard​ Skirbekk, Nishali Patel, Joseph​ Dieleman, Angela​ Chang

    Asian Development Bank Institute 2025年5月

  4. 新型コロナウイルス感染症 対応記録(続編)〈2022年-2024年〉

    橋爪真弘, 野村周平, 鈴木基

    一般財団法人 日本公衆衛生協会 2024年12月26日

  5. 第3期「健康・医療戦略」策定に向けた提言―求められるグローバルな視点—

    「グローバルヘルスと人間の安全保障」運営委員会 有志一同

    公益財団法人 日本国際交流センター 2024年10月

  6. Financing Global Health 2023: The Future of Health Financing in the Post-Pandemic Era

    Angela Micah, Joseph Dieleman, Katherine Leach-Kemon, Enis Bariş, Ian E. Cogswell, Hans Elliot, Brendan Lidral-Porter, Christopher J.L. Murray, Seong Nam, Shuhei Nomura, Nishali K. Patel, Carolyn Shyong, Juan Solorio, Golsum Tsakalos, Wesley Warriner, Asrat A. Wolde, Dereje Y. Yada, Yingxi Zhao, Bianca Zlavog

    2024年5月14日

  7. Complex Landscape of Vaccine Hesitancy in Japan: A Public Health Challenge

    Shuhei Nomura, Mami Ueta, Alton Cao, Hana Tomoi

    Center for Asia-Pacific Resilience and Innovation 2024年5月

  8. An incomplete picture: understanding the burden of long Covid

    Economist Impact

    Economist Impact 2024年4月28日

  9. Modernizing Global Health Security to Prevent, Detect, and Respond

    Qudsia Huda, Erin L. Downey, Ali Ardalan, Shuhei Nomura, Ambrose Otau Talisuna, Ankur Rakesh

    Elsevier 2023年11月1日

    ISBN: 9780323909457

  10. Promoting Global Solidarity to Advance Health System Resilience: Recommendations for the G7 Meetings in Japan

    Hiroshima Global Health Task Force (in alphabetical order: Keishi Abe, Sarah Krull Abe, Takanori Fujita, Yoshiaki Gu, Masahiro Hashizume, Chieko Ikeda, Masaki Inaba, Kazuaki Jindai, Naoki Kondo, Osamu Kunii, Makiko Matsuo, Hiroki Nakatani, Yoshitaka Nishino, Shuhei Nomura, Haruka Sakamoto, Hideaki Shiroyama, Tomoko Suzuki, Ayako Takemi, Kayo Takuma)

    2023年4月28日

  11. Understanding the economic consequences of the covid-19 pandemic

    Economist Impact

    Economist Impact 2023年2月27日

  12. Financing Global Health 2021: Global Health Priorities in a Time of Change

    Angela Micah, Joseph Dieleman, Kevin O'Rourke, Kayleigh Bhangdia, Ian Cogswell, Simon I. Hay, Dylan Lasher, Brendan Lidral-Porter, Emilie Maddison, Christopher J.L. Murray, Trang Nguyen, Shuhei Nomura, Nishali Patel, Paola Pedroza, Juan Solorio, Hayley Stutzman, Golsum Tsakalos, Wayne Wang, Wesley Warriner, Yingxi Zhao, Bianca Zlavog

    2023年1月23日

    ISBN: 9781734130607

  13. 日本の保健医療システムの持続可能性と強靭性

    野村 周平, マット・マカナニ, 菅原 丈二, 乗竹 亮治, 宮田 裕章

    医療システムの持続可能性と回復力のためのパートナーシップ(PHSSR) 2022年11月

  14. 実践グローバルヘルス : 現場における実践力向上をめざして

    日本国際保健医療学会

    杏林書院 2022年4月

    ISBN: 9784764405417

  15. 国際的な連帯に基づくグローバルヘルス・ガバナンスの再構築―ポスト・コロナ時代の日本の役割とは

    グローバルヘルス・ガバナンス研究会

    公益財団法人 日本国際交流センター 2022年3月

  16. ポスト・コロナのわが国の国際保健外交:求められるODA政策等のパラダイムシフト

    保健分野のODAのあり方を考える特別委員会

    公益財団法人 日本国際交流センター 2020年11月

  17. WHO Guidance on Research Methods for Health Emergency and Disaster Risk Management

    Shuhei Nomura, Aya Ishizuka

    World Health Organization 2020年9月

  18. Innovative Asia: Innovation Policy and the Implications for Healthcare and the Life Sciences

    Shuhei Nomura, Kenji Shibuya

    The National Bureau of Asian Research 2018年3月

  19. Japan Health System Review

    Haruka Sakamoto, Md. Mizanur Rahman, Shuhei Nomura, Etsuji Okamoto, Soichi Koike, Hideo Yasunaga, Norito Kawakami, Hideki Hashimoto, Naoki Kondo, Sarah Krull Abe, Matthew Palmer, Cyrus Ghaznavi

    World Health Organization 2018年2月

    ISBN: 9789290226260

  20. グローバルヘルス:日本の時代の到来 - 医学のあゆみ

    Shuhei Nomura, Munehito Machida, Kenji Shibuya

    医歯薬出版株式会社 2017年3月

︎全件表示 ︎最初の5件までを表示

講演・口頭発表等 50

  1. Utilizing Frontier Technologies for a Healthy Society 招待有り

    Shuhei Nomura

    アジア太平洋強靭性研究基金会(CAPRI)主催「Global Innovation Reimagined Conference: AI Resilience」@インターコンチネンタル 東京 2026年6月19日

  2. 母子保健への投資の意義と投資効果 招待有り

    野村周平

    公益社団法人セーブ・ザ・チルドレン・ジャパン主催「UHCハイレベルフォーラム院内集会-母子の命と健康を守る未来への投資」@参議院議員会館 2025年12月5日

  3. Global Health Landscape – Leveraging Insights from the Global Burden of Disease Study 招待有り

    野村周平

    滋賀医科大学NCD疫学研究センター特別セミナー@滋賀医科大学 2025年9月2日

  4. 世界の健康を測る – 世界の疾病負荷研究(GBD)から読み解くグローバル・ヘルス 招待有り

    野村周平

    WHO健康開発総合研究センターサマースクール2025@大阪大学 2025年8月15日

  5. PHSSR(保健医療システムの持続可能性と強靭性を向上するためのパートナーシップ)政策ロードマップ 招待有り

    野村周平

    PHSSRサミット「より強靭な保健医療システムの共創」ーすべての人のためのトランスフォーム・ケア@大阪万博 2025年6月30日

  6. 国際シンポジウム "The Future Role of Pediatrics" 招待有り

    Shuhei Nomura

    第128回 日本小児科学会学術集会@オンライン 2025年4月20日

  7. Exploring Opportunities for Nutrition Improvement: Involving Multi-stakeholders with Differential Approaches Based on Diverse Country Experiences 招待有り

    Shuhei Nomura

    Nutrition for Growth (N4G) Summit 2025 @パリ日本文化会館 2025年3月26日

  8. Health Communication amid Misinformation and Disinformation: Vaccine Hesitancy in Japan, Vietnam, and Taiwan 招待有り

    Shuhei Nomura

    アジア太平洋強靭性研究基金会(CAPRI)ラウンドテーブル@オンライン 2025年2月19日

  9. 人材育成 招待有り

    野村周平

    第11回 日経・FT感染症会議@ホテルニューオータニ 2024年10月23日

  10. Partnering for Sustainable Health Innovation 招待有り

    Shuhei Nomura

    Healthcare Denmark 主催「Tour de Health'24」@ DI - Danish Industry 2024年10月1日

  11. データで健康を拓く〜食と栄養政策におけるデータ駆動型アプローチ 招待有り

    野村周平

    第71回 日本栄養改善学会学術総会@大阪公立大学 2024年9月7日

  12. Disaster Resilience for Earthquakes, Typhoons, and Tsunamis 招待有り

    Shuhei Nomura

    アジア太平洋強靭性研究基金会(CAPRI)2024年次フォーラム@ Taipei New Horizon 2024年5月6日

  13. パンデミックとデータ駆動型社会 招待有り

    野村周平

    慶應義塾大学医学部「信濃町データサイエンスフォーラム」@慶應義塾大学 2024年3月14日

  14. パンデミックとデータ駆動型社会 招待有り

    野村周平

    大阪大学感染症総合教育研究拠点(CiDER)適塾セミナー@大阪大学 2024年2月28日

  15. Navigating the Methods Maze: A Roadmap for Replicable Research Writing 招待有り

    Shuhei Nomura

    WHO Scientific Writing Series @ オンライン 2024年2月28日

  16. Quantitative Research Methods: Statistical Thinking and Research Process 招待有り

    Shuhei Nomura

    WHO Centre for Health Development Forum at the 29th Annual Meeting of Japanese Association for Disaster Medicine @みやこめっせ 2024年2月23日

  17. Effective Ways to Write Research Funding Proposals 招待有り

    Shuhei Nomura

    第34回 日本疫学会学術総会@びわ湖大津プリンスホテル 2024年2月1日

  18. 減塩と疾病負荷:持続的食環境のためのコミットメントとステークホルダーの役割 招待有り

    野村周平

    第34回 日本疫学会学術総会@びわ湖大津プリンスホテル 2024年2月1日

  19. Approaches to Social Implementation in Communities, Regions, and Nations, and the Alliances for It 招待有り

    Shuhei Nomura

    PMAC 2024 @ Centara Grand & Bangkok Convention Centre 2024年1月23日

  20. Mismatch between International Aid and Issues as Seen Through Data 招待有り

    Shuhei Nomura

    PMAC 2024 @ Centara Grand & Bangkok Convention Centre 2024年1月23日

  21. How to create the well-being world for all, affordable access to healthy products in polycrisis 招待有り

    Shuhei Nomura

    PMAC 2024 @ Centara Grand & Bangkok Convention Centre 2024年1月23日

  22. データで読み解く 'NCDs × 食・栄養' の動向と展望 招待有り

    野村周平

    日本リザルツ主催「GGG+フォーラム」@ルポール麹町 2023年11月28日

  23. Battling the Silent Epidemic: Why We Can't Ignore NCDs – Insights from a Statistical Lens 招待有り

    Shuhei Nomura

    WHO Centre for Health Development Forum 2023 on Health Emergency and Disaster Risk Management @ WHO神戸センター 2023年11月14日

  24. Health Beyond Borders – データで読み解くグローバルヘルス 招待有り

    野村周平

    WHO Centre for Health Development Forum 2023 "Build the world we want; A healthy future for all" @ WHO神戸センター 2023年10月1日

  25. がんの疾病負荷の均てん化 世界の疾病負荷研究(GBD)のアプローチ 招待有り

    野村周平

    第82回 日本癌学会学術総会@パシフィコ横浜 2023年9月21日

  26. コロナ禍の死因別・人口動態別の超過死亡分析とその課題 招待有り

    野村周平

    日本人口学会第75回大会@南山大学 2023年6月11日

  27. 結核対策への開発援助と疾病負荷の変遷 – 世界の疾病負荷研究(GBD)から 招待有り

    野村周平

    日本リザルツ主催「GGG+フォーラム」@ルポール麹町 2023年3月5日

  28. 地球規模で再考する感染症対策 招待有り

    野村周平

    医療政策サミット2023 @帝国ホテル 2023年2月18日

  29. Developing a Food Compass system in Japan 招待有り

    Shuhei Nomura

    第22回 国際栄養学会議(IUNS-ICN)@東京国際フォーラム 2022年12月7日

  30. Health Effects of Dietary Risks – Evidence from the Global Burden of Disease Study 招待有り

    Shuhei Nomura

    第22回 国際栄養学会議(IUNS-ICN)@東京国際フォーラム 2022年12月7日

  31. Understanding and tackling inequalities in health 招待有り

    Shuhei Nomura

    2022 PHSSR Global Summit @ オンライン 2022年11月23日

  32. 世界の疾病負荷研究:エビデンスを形成し、日本の政策を導く 招待有り

    野村周平

    第60回 日本癌治療学会学術集会@大宮ソニックシティ 2022年10月20日

  33. An Alternative Japanese Approach to Reducing Sodium while Enhancing Taste and Desirability 招待有り

    野村周平

    第29回 国際高血圧学会@国立京都国際会館 2022年10月16日

  34. National Disability Weights in Japan: Findings from the Japanese Disability Weight Measurement Study 招待有り

    Shuhei Nomura

    European Burden of Disease Network 主催「International Burden of Disease Conference」@ Golden Tulip Zira Belgrade 2022年9月15日

  35. アフリカと援助資金とUHC:変貌する状況とデータ駆動型アプローチ 招待有り

    野村周平

    日本リザルツ主催・日本・アフリカ連合(AU)友好議員連盟後援「TICAD8 プレイベント」@ルポール麹町 2022年8月22日

  36. 変貌する援助の流れ:公的資金の流れと援助構造のトレンド 招待有り

    野村周平

    世界銀行主催ラウンドテーブル@世界銀行東京事務所 2022年6月22日

  37. GGGを経由した援助資金の流れ 招待有り

    野村周平

    日本リザルツ主催「GGG+フォーラム秋田2022」@秋田キャッスルホテル 2022年6月19日

  38. データ利活用の意義を社会全体で定着させるために 招待有り

    野村周平

    日本医療政策機構主催メディアセミナー「コロナ危機の先にある新しい社会とヘルスケア」@大手町フィナンシャルシティグランキューブ 2022年5月17日

  39. Pandemic and Data-Driven Society 招待有り

    Shuhei Nomura

    第62回 日本熱帯医学会大会@オンライン 2021年11月5日

  40. Disease Burden: Generating Evidence, Guiding Policy 招待有り

    Shuhei Nomura

    The 11th Conference of the. International Society for Integrated Disaster Risk Management @オンライン 2021年9月21日

  41. A Case Study from Japan: A National BoD in Collaboration with the IHME 招待有り

    Shuhei Nomura

    サウジアラビア保健省主催ワークショップ@オンライン 2021年9月8日

  42. 災害と被災地科学と『人中心』のアプローチ:福島原発事故からのケーススタディ 招待有り

    野村周平

    WHO Centre for Health Development Forum at the 25th Annual Meeting of Japanese Association for Disaster Medicine @神戸国際会議場 2020年2月21日

  43. Reformulating Japan’s Global Health ODA to Meet Changing Global Needs

    Shuhei Nomura

    PMAC 2020 UHCフォーラム 2020 @ Centara Grand & Bangkok Convention Centre 2020年1月30日

  44. Improving Population Health in Japan: Opportunities and Challenges in the Era of Super-Aging 招待有り

    Shuhei Nomura

    国立台湾大学主催「Asia Forum of National Burden of Disease」@国立台湾大学 2019年11月29日

  45. 我が国の糖尿病の疾病負荷とリスク要因─世界の疾病負荷研究2017から─ 招待有り

    野村周平

    第56回 日本臨床生理学会総会@大宮ソニックシティ 2019年10月27日

  46. 世界の疾病負荷研究 – エビデンスを形成し、政策を導く 招待有り

    野村周平

    第42回 日本がん疫学・分子疫学研究会総会@国立がん研究センター 2019年7月11日

  47. The Global Burden of Disease Study: Measuring Progress and Guiding Policy 招待有り

    Shuhei Nomura

    WHO Thematic Platform for Health Emergency and Disaster Risk Management at the 21st WADEM Congress on Disaster and Emergency Medicine @ Brisbane Convention & Exhibition Centre 2019年5月9日

  48. Improving Population Health in Japan: Opportunities and Challenges in the Era of Super-Aging 招待有り

    Shuhei Nomura

    Korea Institute of Health and Social Affairs 主催「The 19th Global Social Security Forum」@ソウル・ホテル プレジデント 2019年2月13日

  49. 世界の疾病負荷研究 招待有り

    野村周平

    日本人口学会第70回大会@明海大学 2018年6月2日

  50. 疾病負荷と喫煙 – 我が国の都道府県レベル疾病負荷研究から 招待有り

    野村周平

    第82回 日本循環器学会学術集会総会@大阪国際会議場 2018年3月24日

︎全件表示 ︎最初の5件までを表示

共同研究・競争的資金等の研究課題 26

  1. 気候変動下の感染症リスク評価のための基盤整備

    米岡 大輔, 野村 周平, 橋爪 真弘, 鈴木 基, 齋藤 英子, 神垣 太郎

    提供機関:Japan Society for the Promotion of Science

    制度名:Grants-in-Aid for Scientific Research

    研究種目:Grant-in-Aid for Scientific Research (B)

    研究機関:Japan Institute for Health Security

    2026年4月1日 ~ 2031年3月31日

  2. A comprehensive assessment of the long-term effects of COVID-19 on population health in Japan

    ギルモー スチュアート, 野村 周平, NGUYEN THE, PHUONG, 米岡 大輔, 小野 洋平, 村野 弥生

    提供機関:Japan Society for the Promotion of Science

    制度名:Grants-in-Aid for Scientific Research

    研究種目:Grant-in-Aid for Scientific Research (B)

    研究機関:St. Luke's International University

    2024年4月 ~ 2029年3月

  3. 新たな国際情勢を踏まえた我が国としての国際保健外交への提言に向けた研究

    梅田 珠実, 磯 博康, 橋爪 真弘, 城山 英明, 武見 綾子, 小松隆一, 詫摩 佳代, 野村 周平, 細澤 麻里子, 齋藤 英子

    2025年4月 ~ 2028年3月

  4. 自治体データを活用した、児童虐待リスクの同定ならびに効果的な早期介入に関する研究

    鈴木有佳, 宮田裕章, 立森久照, 野村周平, 櫻井桂子

    提供機関:Japan Society for the Promotion of Science(JSPS)

    制度名:Grant-in-Aid for Scientific Research (C)

    研究種目:Grant-in-Aid for Scientific Research (C)

    研究機関:Keio University

    2025年4月 ~ 2028年3月

  5. 糖尿病及び腎疾患の発症/増悪の関連要因の同定と健康アウトカムへの影響に関する研究

    櫻井 桂子, 宮田裕章, 立森久照, 野村周平, 五十嵐中, 塘由惟, 金森 由晃

    提供機関:Japan Society for the Promotion of Science

    制度名:Grants-in-Aid for Scientific Research

    研究種目:Grant-in-Aid for Scientific Research (C)

    研究機関:Keio University

    2024年4月 ~ 2027年3月

    詳細を見る 詳細を閉じる

    糖尿病や腎疾患の国内における疾病負荷は増大しており、これらの疾患に伴う合併症や透析導入が患者のQOL及び医療財政に及ぼす影響は深刻である。疾病の予防や進行抑制を目指す健康医療政策の立案や改良は喫緊の課題である。本研究は、糖尿病・腎疾患の把握及び健康アウトカム評価を行うことを目的とする。①レセプトデータを活用し、糖尿病・慢性腎臓病及びその後の合併症に関する性年齢別の発症率の推定、②発症/疾患増悪の関連要因の同定、③要因のシナリオ分析による集団健康アウトカムへの影響の推定を行う。 <BR> 取得したレセプトデータを用いて、本研究課題に必要なデータベースの構築を実施した。データ整備においては、重複レコードの除去、患者単位でのデータ統合など、基本的なデータクリーニングを実施した上で、本研究で対象とする疾患(糖尿病、腎症、心血管疾患等)の定義の明確化と、それに基づく症例の抽出基準の整備を進めた。診断名(ICD-10)・診療行為コード・処方情報の組み合わせにより、臨床的妥当性の高い定義づけを行い、再現性の高い形で分類できるよう検討を重ねている。さらに、今後の発症率・発生数の解析に向けて、疾患発症日を推定するためのルール設計や、複数のデータソースを統合した突合データセットの構築準備も進めている。 <BR> 分析の一環として、1年度分のデータを用い、国民健康保険加入者のうち40歳から74歳を対象に、糖尿病の受診者数を地域・性別・年齢階層別に集計した。初期分析の結果、糖尿病の受診者は男性約6割、女性約4割を占め、地域間の顕著な差異は認められなかった。また、年齢層では、65歳から74歳における受診者数が、全体の7割以上を占めていた。

  6. 令和時代の自然災害と健康危機管理:WHOの研究手法ガイダンスを見据えた研究推進

    原田 奈穂子, 小坂 健, 香田 将英, 野村 周平, 大塚 理加, 西岡 大輔, 笠岡 宜代, 坪井 基浩, 市川 学, 冨尾 淳

    提供機関:Ministry of Health, Labour and Welfare

    研究機関:Okayama University

    2024年4月 ~ 2027年3月

  7. 我が国の疾病負荷の再評価と活用:ポストコロナ時代の都道府県分析と新方法論への挑戦

    野村 周平, 田淵 貴大, 橋爪 真弘, 大田 えりか, 山本 依志子, 坂元 晴香, 鈴木 基, 齋藤 英子, 米岡 大輔, 井上 真奈美, 宮田 裕章, 西浦 博

    提供機関:Japan Society for the Promotion of Science

    制度名:Grants-in-Aid for Scientific Research

    研究種目:Grant-in-Aid for Scientific Research (A)

    研究機関:Keio University

    2024年4月 ~ 2027年3月

    詳細を見る 詳細を閉じる

    本研究は、死亡および障害の両側面を統合的に捉えた包括的な健康指標である「疾病負荷(Burden of Disease)」に基づき、日本の保健医療政策の優先順位づけや研究開発資源の配分に資するエビデンスの構築を目的としている。特に、新型コロナウイルス感染症(COVID-19)が社会全体の健康ニーズや保健医療システムに及ぼした影響を科学的に評価し、将来的な制度設計や政策立案の根拠となる知見を提供することを重視している。 <BR> 当該年度には、Global Burden of Disease(GBD)2021の成果を発展させるかたちで、査読付きの国際学術誌に英語論文12本を発表した。そのうち7本は、成人および小児の肥満、鉄欠乏性貧血、自殺、死産、喫煙、脳卒中といった日本の主要な健康課題に関する分野別の負荷推計結果を報告するものであり、統一されたGBD手法に基づいて年齢別・性別・地域別に定量評価を行った結果を提示している。これらの論文は『The Lancet』誌およびその姉妹誌を含む有力医学誌に掲載され、国際的にも大きな注目を集めた。 <BR> また、日本における最大の食事関連リスクとされる高塩分摂取に関連し、減塩に対する国民の意識や態度に影響を与える心理的・社会的要因の同定を目的とした研究を実施し、2本の論文として発表した。さらに、新型コロナパンデミックの前後における医療機関の受療行動の変化に着目した実態分析も行い、その成果も論文化した。これらの研究成果は、予防施策や保健資源の効率的配分のあり方に対する重要な示唆を提供するものである。

  8. 次のパンデミックに向けた合理的な感染対策の実施等に資する調査研究

    野村周平

    提供機関:The Cabinet Agency for Infectious Disease Crisis Management

    2025年4月 ~ 2026年3月

  9. 新しい保健システム構築のための実証的な疾病負荷研究

    野村周平

    提供機関:Japan Science and Technology Agency

    2022年10月 ~ 2026年3月

    詳細を見る 詳細を閉じる

    包括的で比較可能な保健指標「疾病負荷」は、保健政策の優先決定に重要な情報ですが、諸外国に比べ我が国での政策活用は限定的です。本研究は、これまで私が行ってきた疾病負荷研究を発展させ、コロナ危機の先にある、社会経済活動を維持しつつ、公平で強靭で持続可能な新しい国内外の保健システムの構築に疾病負荷を活用する基盤を確立し、そして我が国の喫緊の国内保健政策とグローバルヘルス政策の議論に資する知見を創出します。

  10. 科学的根拠に基づくがんリスク評価とがん予防ガイドライン提言に関する研究

    野村周平

    提供機関:National Cancer Center Japan

    制度名:National Cancer Center Research and Development Fund

    研究機関:The University of Tokyo

    2021年4月 ~ 2025年3月

  11. 新しい保健システム構築のための実証的な疾病負荷研究

    野村 周平

    2022年 ~ 2025年

    詳細を見る 詳細を閉じる

    包括的で比較可能な保健指標「疾病負荷」は、保健政策の優先決定に重要な情報ですが、諸外国に比べ我が国での政策活用は限定的です。本研究は、これまで私が行ってきた疾病負荷研究を発展させ、コロナ危機の先にある、社会経済活動を維持しつつ、公平で強靭で持続可能な新しい国内外の保健システムの構築に疾病負荷を活用する基盤を確立し、そして我が国の喫緊の国内保健政策とグローバルヘルス政策の議論に資する知見を創出します。

  12. 医療デジタルトランスフォーメーション時代の重層的な感染症サーベイランス体制の整備に向けた研究

    野村周平

    提供機関:Ministry of Health, Labour and Welfare

    研究機関:National Institute of Infectious Diseases

    2023年4月 ~ 2024年3月

  13. with/postコロナ時代の保健医療課題への疾病負荷の活用と実証分析

    野村 周平

    提供機関:Japan Society for the Promotion of Science

    制度名:Grants-in-Aid for Scientific Research

    研究種目:Grant-in-Aid for Scientific Research (B)

    研究機関:Keio University

    2021年4月 ~ 2024年3月

    詳細を見る 詳細を閉じる

    本研究は、新型コロナウイルス感染症(COVID-19)が日本の疾病負荷にもたらした影響を多角的に分析したものである。感染症データの統計モデリングにより、超過死亡の推定や感染拡大の予測を行った。また、コロナ禍における非感染性疾患の疾病負荷増加と関連するリスク要因の分析、日本の保健分野の政府開発援助の動向分析なども行った。これらの成果は、政策立案者や一般市民に有益な情報を提供し、ウィズ/ポストコロナ時代の保健医療政策の課題と将来展望を提示するものである。最新の世界疾病負荷研究の枠組みを用いた分析では、新型コロナが平均寿命や健康寿命に一定の影響を与えたことが示された。

  14. 幸福余命の算出と環境及び災害関連健康リスク評価への適用

    野村 周平

    提供機関:Japan Society for the Promotion of Science

    制度名:Grants-in-Aid for Scientific Research

    研究種目:Grant-in-Aid for Scientific Research (B)

    研究機関:Fukushima Medical University

    2020年4月 ~ 2023年3月

    詳細を見る 詳細を閉じる

    本研究では、「幸福余命(幸福な気分で過ごす生涯の長さ)」と「損失幸福余命(失われる幸福余命の長さ)」の指標をリスク評価に適用する。男女別に幸福余命を算出し、損失幸福余命の指標を様々な環境及び災害関連健康リスク評価に用いる。本研究は、5つのサブテーマ(1. 男女別幸福余命の算出、2. 放射線及び環境関連健康リスク、3. 災害による疾病などの有病率と罹患率の算定、4. 各疾病などによる幸福度低下の評価、5. 環境及び災害関連健康リスク要因による損失幸福余命の算出)に分けて研究を実施している。 2020年度には、福島災害後の周辺自治体における生活習慣病の増加等の調査のまとめや水道水等のモニタリングデータの収集を進めるとともに、災害後における地域密着型科学のあり方や幸福余命指標の適用の意義などについて整理してきた。 具体的には、2010年と2017年の特定健康診断に参加した南相馬市民の生活習慣病リスクを、避難シナリオ別に評価したところ、避難シナリオにかかわらず、2010年から2017年にかけて、糖尿病は増加傾向、高血圧は減少傾向、高脂血症には顕著な変化がないことが明らかとなった。このように、環境関連のデータに加えて、災害関連健康リスク評価に活用するデータの準備が整った。また、災害後において、科学への住民の信頼を維持する上で、地域密着型科学の深化が求められ、どのような研究を行うべきかなどの価値観を、科学者、行政、被災者が一体となって議論したり、それらの研究の成果について被災者を含む社会の人々と共有したりすることが重要であると整理した。とりわけ、地域に密着したコミュニケーターと住民との対話において幸福の向上は主要な目標として設定されていることから、幸福余命の概念を用いたリスク評価の重要性が確認された。 このように、幸福余命の概念を用いたリスク評価に向けた準備を着実に進めることができた。

  15. 包括的な疾病負荷分析に基づく我が国の保健政策課題の実証的研究

    野村周平

    提供機関:Japan Society for the Promotion of Science

    制度名:Grants-in-Aid for Scientific Research

    研究種目:Grant-in-Aid for Scientific Research (A)

    研究機関:The University of Tokyo

    2019年4月 ~ 2022年3月

    詳細を見る 詳細を閉じる

    本研究は我が国の疾病負荷を包括的に分析し、政策分析にも応用する試みである。これまでの疾病負荷研究をさらに発展させ、最新の疾病負荷推計が行われた。健康寿命は着実に伸びている一方で、高齢化に関連するアルツハイマー病含む認知症や糖尿病等の慢性疾患による疾病負荷の急激な増加、それらに寄与するリスク要因の増加、そして健康格差の拡大などの課題が認められた。これらのNCDsやリスク要因は、COVID-19による重症化・死亡リスク関連していることは注目に値する。COVID-19のような健康危機に対してより強い保健システムを構築するために、公衆衛生の取り組みを強化することが急務であることが示唆される。

  16. 日本の都道府県別の保健システムパフォーマンス評価方法の開発

    研究機関:The University of Tokyo

    2018年4月 ~ 2021年3月

  17. 国内外研究連携基盤の積極的活用によるがんリスク評価及び予防ガイドライン提言に関する研究

    提供機関:National Cancer Center Japan

    制度名:National Cancer Center Research and Development Fund

    研究機関:The University of Tokyo

    2018年4月 ~ 2021年3月

  18. 我が国の都道府県別健康アウトカムの比較リスク評価とその活用に関する包括的研究

    野村周平

    提供機関:Japan Society for the Promotion of Science

    制度名:Grants-in-Aid for Scientific Research

    研究種目:Grant-in-Aid for Scientific Research (C)

    研究機関:The University of Tokyo

    2018年4月 ~ 2021年3月

    詳細を見る 詳細を閉じる

    本研究は国レベルではなく都道府県別の保健アウトカムの危険因子を包括的に詳細分析する試みである。①都道府県別の各種危険因子の分布及びその推移の推計し、②都道府県別の保健アウトカム指標への各種危険因子の寄与割合を推定する。また、③分析結果をより多くの研究者や一般の方が利用できるようにデータのビジュアル化を行う。 <BR> 危険因子に関する入手できる限りのデータと最新の統計手法を駆使して包括的に分析を行った。2017年における我が国の全死亡に寄る疾病負荷のうち、46.6%は危険因子が同定可能であった。行動様式に由来するリスクが31.4%、代謝リスク24.9%、環境および職業上のリスクが6.1%であった。同様に、障害も鑑みた疾病負荷(DALYs:障害調整生命年)のうち38.0%は危険因子が同定可能であった。行動様式に由来するリスクが25.7%、代謝リスク17.8%、環境および職業上のリスクが6.3%であった。都道府県別に見ても、顕著な違いは見られず、全国的に代謝系リスクに寄る疾病負荷(死亡及びDALYs)が増大している。特に高血圧、高血糖、高BMI、高LDLコレステロールリスクの寄与が大きい。一方、行動リスクの中では喫煙と不健康な食習慣(高塩分、低穀物、低果物)が、全ての都道府県において主要な健康の危険因子であった。喫煙は死亡・DALYsどちらにおいても、疾病負荷に繋がる危険因子の第一位であった。 <BR> また、広く研究者や市民社会へ研究成果の還元や疾病負荷研究の活用を推進する目的で、国内外のセミナー(国立がん研究センター主催の国際がん研究機関との第3回合同セミナー)やシンポジウム(韓国保健社会研究院(KIHASA)主催の社会保障フォーラム:The 19th Global Social Security Forum)で講演を行なった。

  19. 日本の空気汚染による健康と生活への影響

    野村周平

    提供機関:Dyson Technology Limited

    研究機関:The University of Tokyo

    2019年10月 ~ 2020年9月

  20. 健康寿命延伸に向けたDALYを指標とした栄養食生活における研究

    野村周平

    提供機関:Ajinomoto Co., Inc.

    研究機関:The University of Tokyo

    2019年4月 ~ 2020年9月

  21. 福島県における Well-being を高める保健医療体制の追求―福島原発事故からの真の復興を目指して―

    野村周平

    提供機関:The Toyota Foundation

    制度名:共同研究助成

    研究機関:Minamisoma Municipal General Hospital

    2018年5月 ~ 2020年4月

  22. ネパール地震による中・長期的な健康影響評価:災害に強い保健医療体制の構築に向けて

    野村周平

    提供機関:Japan Society for the Promotion of Science

    制度名:Bilateral Collaborations

    研究機関:Institute for Global Health Policy Research

    2018年4月 ~ 2020年3月

  23. 我が国の世界保健総会等における効果的なプレゼンスの確立に関する研究

    野村周平

    提供機関:Ministry of Health, Labour and Welfare

    研究機関:The University of Tokyo

    2017年4月 ~ 2019年3月

  24. 我が国の都道府県別の疾病負荷とその活用に関する包括的研究

    野村周平

    提供機関:Japan Society for the Promotion of Science

    制度名:Grants-in-Aid for Scientific Research

    研究種目:Grant-in-Aid for Scientific Research (A)

    研究機関:The University of Tokyo

    2016年4月 ~ 2019年3月

    詳細を見る 詳細を閉じる

    本研究は、国レベルではなく都道府県別の疾病負荷を包括的に分析し、それを具体的政策分析にも応用する我が国で初めての試みである。平成29年度の研究成果をさらに発展させ、データ収集の拡大、最新の統計技術の適用、方法論の改善が成された。1990年から2017年にかけて、日本全体の健康寿命は69.7歳から73.1歳まで伸びた。現在の主要死因のトップは全国的に脳血管疾患・心血管疾患であり、障害も鑑みる(DALYs:障害調整生命年)と腰痛が第一位の要因である。長寿者ほどより多くの障害を抱えて生活していおり(特に感覚・運動器)、さらに変性疾患(アルツハイマー病)の負荷が全国的に著しく、喫緊な対応が求められる。

  25. 福島第一原子力発電所事故による中・長期的な健康影響に関する研究―災害に強い保健医療体制の構築を目指して―

    野村周平

    提供機関:The Toyota Foundation

    制度名:Joint Research Grants

    研究機関:Imperial College London

    2016年5月 ~ 2018年4月

  26. 原発事故後の長期的な医療・看護マネジメントと広域搬送された透析患者の長期予後

    児玉 有子, 新村 浩明, 高崎 順子, 松崎 幸江, 佐藤 裕子, 野村 周平

    提供機関:Japan Society for the Promotion of Science

    制度名:Grants-in-Aid for Scientific Research

    研究種目:Grant-in-Aid for Scientific Research (C)

    2015年4月1日 ~ 2018年3月31日

    詳細を見る 詳細を閉じる

    東日本大震災により避難搬送された透析患者は、研究期間中(2011年3月11日~2017年3月3日)、分析対象537人中120名が死亡、非避難者の死亡率は0.14/1,000人日、避難者は0.10/1,000人日だった。年齢と入院回数が統計学的有意に死亡に関連し、避難者と非避難の間には統計的に有意な差はなかった。適切な選択のもとに搬送が行われたと推察される。条件を限定しながらも継続でき、さらには避難後速やかに透析を開始できれば、長時間の避難に関連する健康リスクを回避できる可能性があると示唆される。 また、長期的な医療・看護のマネジメントにおいては、地域内での人材育成急務の課題である。

︎全件表示 ︎最初の5件までを表示

担当経験のある科目(授業) 15

  1. 乃木坂スクール「日本型健康長寿を支える食と栄養」 国際医療福祉大学

  2. Global Health Course University of Indonesia

  3. ヒューマンセキュリティとグローバルヘルス 東北大学

  4. 公衆衛生マネジメント 慶應義塾大学

  5. 国際看護学特論 I 聖路加国際大学

  6. 国際保健政策学特論 I 東京大学

  7. 国際保健政策学特論 II 東京大学

  8. Social Design and Global Leadership 東京大学

  9. 健康・医療ビッグデータ概論 静岡社会健康医学大学院大学

  10. Introduction to Medical Science 早稲田大学

  11. 国際保健学 東京大学

  12. Measuring Burden of Disease: Methods and Applications National Taiwan University

  13. ヘルステクノロジーⅡ 神奈川県立保健福祉大学

  14. 環境物質化学概論 東京農工大学

  15. ヘルス・サイエンス概論 東京大学

︎全件表示 ︎最初の5件までを表示